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The problem. The expe.riments were intended to
elucidat.e any intrahepat.ic act.ions of the drugs employed
as presinusoidal or posts!nusoidal and t.o identify any
anta90nism of the drugs to others.
Prooedure.Liverswereexcisedand. perfused at a
constant rate through the portal vein with different drugs
and at different concentrations.. Absolute pressure and
change of weight were recorded continuously.
Findin<Js. No consistent effects were found with
the methods employed. Several factors were not important
to this lack of action and several others appear possibly
important.
Recommendations. Further investigation should be
undertaken to IdentIfy a procedure that will show actions
for those drugs and oxytocin. Once a procedure is
identified, any actions of the drugssnould be characterized
as pre- or poatsinusoidal, and the adrenergic agonists,
histamine, and vasopressin should be tested for antagonism
of each other. Dog livers as well as rat livers and
healthy as well as cirrhotic livers should be tested be-
cause they would prOVide important data to compare with
other research.
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INTR.OOUCTION AND :REVIEW OF THE LITERATURE
The action of vasopceaa in on flow through rat
livers was the subject. of the investigations reported here ..
Vasopressin is an effective drug fo·r the treatment of
hemorrhage from esophageal varices. Typically, varices are
associated with portal hypertension~ and both portal hyper-
tension and varices are important complications of liver
disease. The architecture of a healthy liver will undergo
change a.s liver disease progresses, and liver disease of
almost any etiology will produce the Bame changes.. with
this progression of most liver disease comes portal hyper-
tension, 'Which may be thought of in simple terms as increased
blood pressure in the hepatic portal vein (HPV) in response
to increased resistance to flow through the liver. Portal
hypertension gives rise to secondary changes in the venous
system. llifi th increased HPV pressure, hepatofugal collateral
veins are recruited to carry increased amounts of flow.
The esophageal veins are important hepatofugal collaterals
that connect the gastric veins of the portal system ",11th
the azygos veins of the caval system.. When UPV' pressure is
high, the esophageal veins carry a great deal of flow and
become enlarged and twisted. In this condition, they are
referred to as esophageal varices and they often hemorrhage.
Vasopressin has been used successfully to control variceal
bleeding. The means by which vasopressin stops bleeding is
the ject of some disagreement.
2Vasopressin treatment of bleeding varices is strong-
ly linked tosevera.l theories of the mechanism of action:
thus, one needs to be familiar with a.ll the facts before
deciding on the importance of anyone mechanism. Specifi-
cally, vasopressin may control bleedi.nq by constriction of
esophageal smooth muscle, or vasopressin may produce de-
creases in HPV pressure and flow that decreases flow through
the esophageal veins enough to prevent bleeding. Further-
more, a number of theories are available to explain how
vasopressin might decrease HPV pressure and flow. Vaso-
pressin may decrease flo,\" into the liver and HPV by oon-
striction of the splanohnic arterioles (the most popular
theory) or by closure of intestinal, submucosal a.rterio-
venous shunts. It may also decrease pressure by HPV
dilation or by deoreasing the resistance to flow through the
liver by dilation of the sphincters oontrolling intrahepatic
flow. The experiments reported here hoped to determine if
vasopressin haa an intrahepatic action in rat livers and to
identify any action as pre- or postsinusoidal.
'r'he effectiveness of vasopressln therapy for bleed-
ing varices and portal hypertension depends in part on
aspects of variceal bleeding and portal hypertension that
vasopressin cannot change. Elements of variceal bleeding
unresponsive to vasopressin therapy are simple in the case
of varices and more complicated for portal hyperten.sion.
Elements of varLceaI bleeding unresponsive to vasopressin
3therapy oan be alteredp$rmanently only by surgioal inter-
ruption of flow into the esophageal veins.. Elements of
portal hypertension unresponsive to vasopressin therapy fall
into two oategories: those amenable to alteration by means
other than vasopressin and those that are difficult to
alter. Elements of portal hypertension unresponsive to
vasopressin and amenable to alteration have been treated
by surgery of the portal system and lymph system, and they
might be treated with drug therapy direoted againstsuta....
coidal factors.. The most common surgical alterations
involve simple plumbing changes. Several different shunts
can be created. Portacaval and mesooaval shunts do not
reduce the factors originally responsible for portal hyper-
tension, but they do decompress the portal system by con-
necting the small, high-pressure portal syste.mdireotly to
the large, low-pressure caval system and by-passing the
high resistanoe in the liver. One of the causes of portal
hypertension, increased flow into the portal system, is
reduced by another plumbing change, a splenorenal shunt ..
This shunt diverts splenic flow into the renal vein which
decreases the total flow into the HPV. Spleneotomy, splenic
artery ligation, and subtotal gastrect.omy with gastric
devascularization also attack the problem of increased flow.
Venting the thoracic duct alters HPV pressure by reducing
resistance to flow in the liver. Reduction in resistance
results from an increase in thoracic duct drainage, giving
all the .RBCls 2100 larger plasma an e.x:ps,nd,ed
alternate drainage liver ..
possible
factors , compounda alter
most probablyaet.ionon hepat.ics:phinct.ers ..
is an old term revived Douglas (lg15a) to describe com-
poundst'hat are not hOrtriOfHlSOr
actions in the body similar to hormones or ..
autacoidal fact.ors possibly involved nepaticflow are
released from dead and dyin.g cells in t.he liver I
and clotting reactions in liver, and healt.hy cells
out.side the liver that. depend on liver t.o inactivate
compounds.. The importance aut.aeoidal factors is a
matter of speculation beca:use present.ly their role is
hypothetical.
All the factors contributing' to portal hypertension
that are unresponsive to vasopressin and difficult to alter
concern resistance to :flow through the liver: bulging of
cells into the sinusoidal lumen; fibrous tissue deposition
in the hepatic vein (HV), BPV, and the space of Disse:
capillarization of the sinusoids, connective tissue contrac-
tion, compression of IN radicles by nodules of parenchymal
cells encased by connective tissue capsules; intrahepatic
shunting; and increased fIA flow into the liver.
5Physical principles
Three physical principles are important in the
study of portal hypertension and esophageal varices: Ohm's
law, Poisseuille's law, and La Place's law.
Ohm's law, or more precisely the counterpart of
Ohm's law in a fluid system, is the most i.mportant of the
three physical principles. It describes the relati.onship
between pressure (P), flow (F), and resistance (R)t
P-F·R
This relationship is important to all the theories of por-
tal hypertension and vasopressin action. It describes how
either increased resistance or increased flow can increase
pressure and how a small increase in one can exacerbate the
effect of increasing the other. Conversely, this relation-
ship explains the hypotensive effects of decreases in flow
or resistance.
Poisseuille's original relationship is a useful
means for approximating the contribution of different factors
to flow through blood vessels:
F= L
where F refers to flow; k is a constant dependent upon fluid
viscosity; P is pressure; d i
4 is the fourth power of the
internal diameter of the vessel, a.nd L is the length of the
vessel. This equation assumes uniform flow velocity within
6blood vessels.. This assu.m.pti.on limits the applicability of
the equation because laminar flow, with lowest velocity
floW' at the periphery of the vessel and highest. velocity
flow in the center, is thought to be a better description
of flow within blood vessels ..
l?oisseuille's law can be applied to laminar flow
when d i
4 is defined in terms of radius and k is replaced
with a formula reflecting laminar flow:
k-eta=-(tau) .~
where dr/d.v refers to the point-by-point descript..ion of
laminar parabolic flow, tau refers to the force at each
point, and eta may be thought of as viscosity" ltath these
substitutions, Poisseuille's original formula undergoes
integration to become:
In this new equation, 'It is the constant for circles and r
is the internal radius of the vessel (Strandness and Sumner,
1975) "
When studying portal hypertension, it is often more
useful to th.ink in terms of the contribution of specific
factors to resistance to flo\'l. Ohm I S equation can be re-
arranged to reflect this thinking:
P=F"R
7
PR=-F
Poiseuille's integrated formula can undergo this same trans-
formation. First it must be changed to the form of Ohmts
law by rearranging:
Tf 4
F=P-- ." rgeL-eta
to:
P=F.B"L·eta
1rer 4
This equation m.ay be rearranged to reflect the factors
important to resistance:
These mathematical statements describe the physical
factors important to resistance, assuming that the fluid is
a perfect solution and that the system corresponds to laminar
flow in a non-compliant tube. Noteworthy in this relation-
ship is the internal radius of the vessel taken to the fourth
power. Small changes in the radius have large effects on
resistance. In contrast to the indirect fourth powerrela-
tionship with radius, resistance is directly proportional to
the first power of ves
fluid viscosity.
length and the first power of
La place's law explains some of the forces respons-
iole for variceal hemorrhage. This physical relationship
explains how increased flow pressure in the esophageal
8veins can lead to rupture of the vessel wall; it explains
the relationship between pressure in a blood vessel (P),
the internal radius of the vessel (r), and the tension on
the walls of the vessel ('1'):
pc=!
r
AS collateral flow into the esophageal veins increases,
they dilate. When they can dilate no more and the flow
continues to increase, the pressure increases according to
the dictstes of Ohm I slaw. 'ttl!th a fixed radius as pressure
increases, force on the wall of the blood vessel increases
until varices and, later, bleeding result. Sustained pres-
sure over long periods of time causes progressive weakening
of the vessels, which leads to varices and eventual
hemorrhage. Varicosities of the Hl?V, HA, and HV do not
often occur because these vessels are well supported. The
HPV and the 8A both possess vascular smooth muscle and
travel through the substance of the liver encased by the
connective tissue of Glisson's capsule. The HV possesses a
muscular coat and is surrounded by hepatocytes.
Vasopressin Side-Effects
Vasopressin is a specific nonapeptide with a disul-
fide bond linking two cysteines at positions one and six.
(Reference to vasopressin as an octapeptide considers the
two disulfide-bonded cysteines as one amino acid, cystine.)
9Vasopres.sin posse.sses .important: antidiuretic properties:
thus it. is known as antidiuretic hormone or ADa:. Antidiure-
tic action ianot. important to this discussion.
Vasopressin therapy has two side-effects that are
significant in the management of its administrat.ion and
several relatively less.... importa.nt side-effects. The two
major side-effects of vasopressin are On the heart and sys-
temic vasculature. The effects on the heart are thought to
result from a combination of a vasopressin-induced decrease
in coronary artery flow (Green et al., 1942; Drapanas et al .. ,
1961; Corliss et a1., 1968) and refle.xly-induces cha.nqes in
vagal and sympathetic control of the heart (Brazeau, 1975).
The most lmportant question is whether the vasopressin
administered will decrease coronary artery flow enough to
create cardiac arrythmias. The question is important
because either non-fatal arrythmias (Drapanas et al., 1961;
Conn at al., 1972; Johnson at al., 1977) or fatal arrythmias
(Slotnik and Tieg1ano, 1951) are possible. Other important
considerations concerning cardiac function are decreased
cardiac output (Drapanas et a1 .. , 1961: Segel et a1., 1963;
Corliss et a1 .. , 1968; Barr et a1., 1975; Millette et a1.,
1975; Thromford and Sirinek, 1975; Erwa1d, 1976; Sirinek
et a1., 1976b) and bradycardia (Segel at a1 .. , 1963; Cort
et a1., 1968; Conn et a1., 1912; Nusbaum et al., 1974;
Aronsen et a1 .. , 1975; Erwa1d, 1976, Sirinek et al .. , 1976b;
Johnson at a1., 1977). Vasopressin-induces smooth muscle
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contractions also are responsible for increased systemic
pressures, the second major side-effect. These contractions
are the result of direct action on vascular smooth muscle;
it is neither antagonized by adrenergic blocking agents or
eliminated by vascular denervation (Brazeau, 1975). On a
molecular level, vasopressin has been hypothesized to act
on smooth muscle by increasing intracellula.r Mg++ concen-
trations which could either free intracellular ca++ or
change the actinomyosin directly (Altura, 1915b). A
number of other side-effects are relatively less important.
Abdominal cramps (Reynolds et al., 1960, Kessler, 1969;
Nusbaum and Conn, 1975; Thromford and Sirinek, 1915;
Bengmark, 1976: Rabfl$l et a1., 1916), defecation (Baber at
al., 1960: Reynolds et a L, , 19EiOJ Kessler, 1969; Boesby and
Pedersen, 1974; Nusbaum and Conn, 1975; Erwald, 1976;
Palmer and De Carle, 1976), substernal pain ('1'hromford and
Sirinek, 1975), as well as cutaneous blanching (Baber et
al., 1960) may be related to smooth muscle contraction,
although headaches (Baber et. al., 1960) appear more likely
to result from vasopressin-induced di1a.tion of the
cephalic vasculature (Aronsen and Nylander, 1966a and b)
than smooth muscle contraction. In the special case of
long-term vasopressin administration by superior mesenteric
artery infusion, a not-infrequent complication is enteric
bacteriemia (Conn at al., 1972, Bar-Meir and Conn, 1976).
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Increased gut permeability as a result of splanchnic
vasoconst.riction decreasino: blood flow to the area is
-,
blamed (Cirrincione and Francona, 1932; Evans et al., 1949,
cited in Bar-Meir and Conn, 1976; Ranert et al., 1972).
rJIesenteric vein throrabosis and small bowel infraction have
also been reported as complications of superior mesenteric
artery vasopressin infusion. Johnson et a1. (1977) report
complications from superior mesenteric artery vasopressin
infusion related to the presence of indwelling catheters
for long time periods and not to the effects of vasopressin.
Vasopressin can also produce a significant reduction in
blood loss and operating time in shunt operations for portal
hypertension (Nusbamu et al., 1914: Sirinek et al., 1916a).
vasopressin and Variceal. Bleeding. Sources of flow
into the esophageal veins and the locations of the
esophageal veins within the esophagus are important to forma-
tion of varices, their bleeding, and vasopressin control of
bleeding. Variceal bleeding further involves the lymph
systerl1, the law of La Place, and the vulneranili ty of the
submucosal esophageal veins. Vasopressin is thought to
arrest variceal bleeding indirectly by decreasing flow into
the HPV and directly by constriction of esophageal smooth
muscle which selectively decreases flow into the submucosal
esophageal veins. Surgically, flow into all the esophageal
veins can be restricted or flow may be selectively rerouted
away from the submucosal esophageal veins.
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Flow into the esophageal veins can come from sev-
eral sources. Arterial blood arrives at the esophageal
veins from five SOurces: direct branches off the aorta,
branches of the left gastric a.rtery, bra.nches of the phrenic
artery, bra.nches of the thyrocervical truck of the sub-
clavian artery, and branches of the branchial artery
(Warwick and Williams, 1973). In a healthy individual, the
esophageal veins arise from and get most of their flow from
the left gastric vein (also called the coronary vein).
Although varices accompany portal hypertension or obstruc-
tion to HPV flow the vast majority of the time, their
presence is not always so easily explainable (~leinber9, 19491
Garret and Gall, 1953). In the case of portal hypertension,
flow from the stomach into the esophageal veins increases
as resistance to HPV drainage of the gastric veins increases
with increased HPV pressure. Also, when resistance to
splenic vein drainage into the HPV is high, slenia flow can
be diverted into the esophageal veins by travelling through
the short gastric veins (also called the vasa breva) to the
stomach and on to the left gastric vein. When HPV pressure
is substantial, both the left and right gastric vein (also
called the pyloric vein) may carry flow from the HPV into
the esophageal veins, and the right gastroepiploic vein may
also carry flm"J' from the superior mesenteric vein to the
stomach, from where it can travel to the gastric veins and
into the esophageal veins. Two anomolies of the portal
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venous system encourage the diversion of flow into the left
gastric vein. Netter and Oppenheimer (1964) report that
the left gastric vein enters the splenic vein in about 24%
of the population and that the left gastric vein enters the
junction of the splenic vein and superior l:nE!senteric vein
in a smaller percentage of the population. These anomalies
aid the diversion of splenic vein flow into the left gastric
vein and, thus, into the esophageal veins. A study of flow
diversion in alcoholics was conducted by Lebrec et 13.1.
(1976b) • In 17 patients with gastric or esopha.geal bleeding
and a history of alcoholism, flow studies were done within
a week after an episode of bleeding. An average of 95% of
splenic artery flow and 70% of superior mesenteric artery
flm'! bypassed the liver. They also noted that a great
variation existed in the amount of superior mesenteric
artery shunting, from very little to total shunting, and
that very little variation existed in splenic artery shunt-
ing, it was uniformly substantial. From their results, one
may presume that the pattern of shunting varies among indi-
viduals and that splenic artery flow is the most likely to
be diverted. On the basis of the anatomy of the venous
system, flow through the esophageal vei.ns is probably the
result of diversion of splenic and gastric flows, and diver-
sion of superior mesenteric vein flow seems likely to occur
through other channels.
Increased hepatofugal collateral circulation through
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the esophageal veins results in the presence of esophageal
veins at three levels in the esophagus from veins normally
present in only two layers. The esophagus contains an
external fibrous layer, a muscle layer that consists of
thick longitUdinal and circular muscles, a submucosal layer
connecting the muscle layer, and an inner mucous layer.
This inner mucous layer is composed of a thin muscle a.nd
connective tissue layer external to a layer of stratified
squamous epithelial cells (Warwick and Williams, 1973). In
patients with portal hypertension, esophageal veins are
found in three layers: the submucosal layer, the external
fibrous layer, and the muscle layer. Bleeding esophageal
varices appear predominantly in the submucosal layer, where
the esophageal veins are primarily found in a healthy indi-
vidual. Here, the blood vessels are poorly supported by
connective tissue (Som and Garlock, 1941), explaining, in
part, their tendency to bleed. veins, referred to as
periesophageal esophageal veins, are present in the external
connective tissue layer in healthy individuals but are more
marked in individuals suffering from portal hypertension
(Som and Garlock, 19471 Aronsen and Nylander, 1966b1
Yamamoto at al., 1976). A third set of esophageal
collaterals arise in cases of portal hypertension within
the muscle layer. A plexus appears in the muscle layer,
between the circular and longitudinal muscles, connecting
the submucosal and periesophageal veins (Yamamoto et al.,
15
1976).
Bleeding from esophageal varices is relat.ed t.o a
number of fact.ors. The lymph syst.em may int.eract, though
less directly t.han t.he art.erial and venous flows, wit.h t.he
esophageal veins t.o promot.e portal hypertension and
variceal bleeding. The lymph system probably cont.ributes
to portal hypertension and bleeding varices as its ability
to drain excess ext.racellu1ar fluid decreases. Increased
lymph production from the liver and intestines tax t.he
capacity for lymph drainage through the thoracic duct as
high pressures in the esophageal veins from increased
collateral flow increase the need for esophageal lymph
drainage. Another, more direct mechanism may result as a
consequence of common developmental features of the lymph
system and venous system, especially the azygos syst.em and
the thoracic duct. The role of the lymph system in variceal
bleeding, as well as portal hypertension, will be discussed
later, in detail (pp. 53-64). Doubtless, the law of La
Place plays a role in venous weakening and possibly pre-
cipitates hemorrhage, because distended veins are less able
to resist pressure from additional flow. Submucosal
esophageal veins receive little support or protection from
connective tissue or musculature 1 thus they are especially
sensit.ive to the forces of La Placa's law and to trauma.
Their close proximity to the esophageal lumen and the fact
that they sometimes lie in the mucosal layer (Som and Garlock,
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1947) contribute to their fragility. Bere, they can be
injure.d from the reflux of acid chyme, and this has been
postulated. to precipitate variceal bleeding (Gray and
Whitesell, 1950, Netter and Oppenheimer, 1964). The danger
of physical trauma from swallowing is illustrated by the
report of a fatal case of variceal hemorrhage ascribed to
trauma from swallowing several large A.P.C. tablets with
little fluid to lUbricate their passage down the esophagus
(Duffy and Fraser, 1944).
Vasopressin-induced esophageal smooth muscle con-
striction may control bleeding from esophageal varices by
interrupting the flow into the submucosal veins and re-
~outing the flow into the stronger, periesophageal veins.
Surgically, the flow into the esophageal veins can be
directly decreased; surgically, flow may also be rerouted
from the submucosal veins into the periesophageal veins.
Vasopressin cannot directly decrease the flow into the
esophageal veins. If constriction of splanchnic arterioles
reduces variceal bleeding by decreasing HPV flow which in
turn reduces esophageal vein flow, as will be discussed
later (p. 88), this is an indirect reduction of flow into
the esophageal veins.
Vasopressin's hemostatio action on varioeal bleeding
is theorized to depend upon compression of the esophageal
veins by constriction of esophageal smooth muscle (Aronsen
and Nylander, 1966b; Nusbaum and Conn, 1975, Bengmark,
17
1976~ Rab$lSl et al., 1976). Constriction of esophageal
smooth muscle will reduce flow in the submucosal esophageal
veins because it will compress tributary veins passing
through the muscle layer. t4ith closure of this pathway,
flow into the esophageal veins is routed into the peri-
esophageal esophageal veins, which are stronger and better
protected from traurl1a resulting from st'lallowing. Strong
support for this theory comes from Aronsen and Nylander
(196Gb). They observed dilated periesophageal veins and
no trace of submucosal veins after vasopressin administra~
tion to dogs, presumably because constriction of esophageal
smooth muscle blocked flow to the submucosal veins and
routed it through periesophageal veins. Abdominal crmmps,
defecation, nausea, and substernal pain, mentioned earlier
(pp. 10-11), support the idea of vasopressin-induced
contraction of esophageal smooth muscle. Johnson et al.
(1977) question this theory on the basis of Inglefinger's
(1943) statements that posterior pituitary extract
increased propulsive movements but decreased the tone of
intestinal musculature in dogs and humans. One may ques-
tion the applicability of work with posterior pituitary
extract, that is a combination of compounds, to work
employing only one of the compounds in that combination.
Also, although the defecation and nausea observed with
vasopressin administration could be the result of increased
propulsive movements only and not of increased muscle tone,
18
abdominal cramps and substernal pain seem likely to be the
result of increased muscle tone.
Surgery can permanently and directly interrupt :flow
into the esophageal veins. Interruption of flow into the
esophageal veins by ligation of the arteries supplying blood
and tributary veins is exemplified by the procedure of
Yamamoto et al. (1976). Their procedure ligates the arteries
to and removes any external varicosities in the greater and
lesser curvatures and the cranial portion of the stomach.
This procedure also includes the removal of the periesopha-
geal veins from the 5 em of the thoracic esophagus proximal
to the esophagogastric junction, splenectomy, and are'"
section of a 5 em sleeve of the esophagogastric junction and
anastomosis of the esophagus within 2 em of the closed
gastric stump. Arterial ligation and removal of external
veins decrease flow into the esophageal veins: resection of
a sleeve of the esophagogastric junction also decreases
flow, but interrupts flow into the submucosal esophageal
veins more directly than other elements of the procedure:
splenectomy removes a major source of flow into the HPV
and a major source of flow into the e sophaqeaI veins in
cases of portal hypertension.
Surgically, the flow into the relatively weak and
vulnerable submucosal veins may be rerouted into the rela-
tively strong and protected periesophageal veins. This re-
distribution of flOt'l/' can be accomplished by a procedure
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described by Som and Garlock (1947). They performed a
mediastinotomy and packing, which causem the formation of
granulation tismue between the esophagus and the surrounding
prevertebral fascia and establishes new anastomotic channels
between the periesophageal veins, embedded in the external
connective tissue, and the posterior body wall. Because
the periesophageal collaterals are better supported by sur-
rounding connective tissue and better protected from trauma
associated with swallowing, they are better able to handle
the flow.. They also drain into the low-pressure venous
system of the posterior body wall rather than into the
azygos system which has high pressures and flows in indi-
viduals with portal hypertension 1 thus hemodynamic advantage
is gained over flow through the submucosal veins.. One year
post-operation, Som and Garlock (1947) report shrun.ken sub-
mucosal varices from esophagoscopy.
Vasopressin and Portal HYf:ertension
e Lement.s of portal hypertension, the major
cause of variceal bleeding, can be altered by vasopressin;
others cannot. Among the elements unresponsive to vaso-
pressin therapy are some amenable to alteration by some
other treatment and some not easily altered by any treat-
rnent.,
Portal hypertension is created and prolonged
tors resistant to vasopressin and most other types of
th Y ~.ll relate directlY to architectural changes in•. erap_. .t~ _.
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the liver: therefore, the architecture of a healthy liver
is important for understanding the abnormal organ. The
illustrations of Netter and Oppenheimer (1964) and Elias
and Sherrick (1969) facilitate the visualization of the
liver's morphology.
The parenchymal cells are arranged in a complex
three-dimensional structure to form sinusoidal channels
whLch provide a patht'lay connecting the hepatic artery UtA)
and HPV in£lO'tl\1 tracts with the HV outflow tracts (called
central veins). The rIA and HPV, as 'VJell as the bile ducts
and lymph channels, are enclosed by the connective tissue of
Glisson's capsule within the substance of the liver. This
collection of vessels and their connective tissue sheath is
called the portal tract. The parenchymal cells delineate
the sinusoidal channels. Typically, the parenchymal cells
are one-cell thick in the dimension betlt'\"een the sinusoids
and several cells thick in other dimensions. The sinusoids
are not direct pathways between the portal tracts and the
HV: intrasinusoidal sinusoids exist which connect adjacent
sinusoids. The area around the portal tract has a particu-
lar architecture. The parenchymal cells form a 1 sur-
rounding portal tract.. This wall (called the limiting
plate) also serves to delineate the space of r1all, which is
defined as the open area between the connective tissue of
131 son's capsule and the paxenohyma.I cells of the 1
plate. Branches of the HPV may COIne off HPV and
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directly pierce the lirn.iting plate or they may travel along....
side the HPV for some distance and then send channels
th.rough the limiting plate. The channels running parallel
to the HPV are called the distributing veins. All t.he
branches which pierce the limiting plate (called inlet
venules) give rise to candelabra-like projections of
s Lnusotda,
The HA supplies a capillary plexus around the bile
ducts; what else and how else it supplies the human liver
is a topic of disagreement. Elias and Petty (1953) state
that the HA has paraportal arterioles supplying the areas
adjacent to the portal tracts as well as intralobular
arterioles supplying the rest of the lobule. They comment
additionally that the intralabular arterioles are more
numerous than paraportal ones. Also, they report the pres-
ence of veins from the biliary capillary plexus to the
intralobular HPV's. Nakata and Kanbe (1966) state that the
HA nourishes the portal tract and may nourish a few peripheral
layers of parenchymal cells. They specifically deny the
presence of paraportal or intralobular arterioles, veins
from the biliary plexus, or direct HA-HPV anastomoses.
Mitra (19660.), on the other hand, found HA-HPV anastomoses
and small lobular arteries emptying into the periphery of
the lobule, but no evidence of large, intralobular arteries.
Although the structure of the HV system in the rat liver
ffers substantially from the structure of the human liver
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(Elias and Popper, 19'55), it is interest.ing t.o note that
intralobular arterioles have been ident.ified in rat livers
by Kanbe (1965) and McCuskey (1966), but not observed by
Nakata (1967).
Two common microscopic observations of the living
livers of amphibians, primarily frogs, and mammals, primar-
ily rats (Wakim and Mann, 1942; Seneviratne, 1949; ~1cCuskey,
1966), are likely also to apply to human livers. To begin
with, not all sinusoids are in use at anyone time. Inter-
pretation of physical data from flow studies (Brauer et al.,
1953; Mit2:ner, 1974a) is consistent with the idea that
resistance to flow may vary with the number of sinusoids
recruited to handle flow. These observations coupled ""11th
descriptions of intrasinusoidal sinusoids suggest the liver
perfusion can be increased and decreased. Increasing per-
fusion would pool blood; decreasing perfusion would result
in mobilizing blood into the systemic circulation. These
observations correlate with ideas about the liver's blood
reservoir function., t.o be discussed later (pp , 98-105>. A
second observat.ion is rhythmic and pulsatile flow in the
sinusoids. It has been observed that the contents of the
sinusoids get well-mixed. Observations of rhythmic and
pulsatile flow appear consistent 'llrith reports of sphincters
at the IiPV and HV ends of the sinusoids (Knisely et al.,
1948, cited in Elias and Sherrick, 1969). Nakata (1967)
did not find sphincters for control of sinusoidal flow in
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rat livers1 and Gibson (1959) specifically denies the
pre.sence of muscular sphincters at the sinusoidal-central
vein junction in humans.
The architecture of healthy sinusoids is primarily
dependent upon endothelial cells and Kupffer cells because
these cells delineate the sinusoidal lumen and the space of
disse. Kupffer cells differ from endothelial cells pri-
marily by an ability to phagocytize. The lumen of the sinu-
soidal channel is defined by these cells. Since these cells
and the sinusoidal lamen do not totally occupy the space
between the parenchymal cells, an additional space (the
apace of Disse) is defined, first described by MacGilvary
(1865, cited in Child, 1954). A fibrous tissue network
forms a sparse basement membrane for the Kupffer and endo-
thelial cells. Relatively thick fibres run parallel to the
path of the sinusoid, and relatively thin fibres encircle
the cells and the lumlen they define. Communication between
the sinusoidal lumen and the space of Disse is provided by
fenestrations in the endothelial and Kupffer cells and gaps
between the cells. Fenestrated cells are called sieve
plates. At the HPV end of the sinusoid, the d Lame t ex of
the fenestrations approaches 2.0 micrometers; along the
length of the sinusoid, the diameter is 0.1 to 0.2 micrometers
(Grisham, 1975). ivtany gaps may be found between the cells,
and cells overlap in other places. Many of the interactions
between the blood and the liver t.ake place in the space of
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Diese, into which the microvilli of the parenchymal cells
extend. In rats, the fenestrations and gaps between the
endothelial and Kupffer cell membranes extends for at least
90% of the length of the admrsoLds, At the fU?V and HV ends
of the sinusoid, the lining is continuous for a short dis-
tance, apparently a continuation of the HPV or HV radicles
(¥offey and Courtice, 1970).
Eleme~ts of Portal Hy;pertension Not Easily Alter~d
That Exist Within the Architecture of a Healthy Liver.
Three architectural changes at the sinusoidal level con-
tribute to portal hypertension and are relatively irrever-
sible: cells bulging into the sinusoidal lumen: fibrosis of
the IfV, HPV, and the space of Disse; and capillarization of
the sinusoids.
The first change concerns the protrusion of fat-
filled cells into the lumen of the sinusoids. In mice,
swelling of fat-filled parenchymal cells has been observed
after administration of a lipotrope-deficient diet (Rogers
and rJ!.acDonald, 1965; Rappaport et 1'11., 1970), and unspeci-
fied tledema ft of parenchymal cells is reported after fulvine
injection (Rappaport at al., 1970). In carbon tetrachloride-
treated rats, an increase in the size of parenchytnal cells
is correlated with decreases in hepatic flow (Nakata et al.,
1973). Also in carbon tetrachloride-treated rats, sinu-
soidal flow decreases over a period of time caused by
sinusoidal occlusion have been quantitated (Nakata, 1967)
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as well as correlated with an increase in cell size
(Fujimoto and Nakata, 1972). In addition, swelling of fat-
filled parenchymal and Kupffer cells (MacDonald, 1962) as
well as fat-filled parenchymal cells only (Wada et al.,
1974) have been reported in rats after carbon tetrachloride
administration. Endotoxin administration a prepared rat
causes hepatic congestion, yielding immediate swelling of
Kupffer cells into the sinusoidal lumen (!.fcKay et al.,
1966). Hypoxia produces hydropt.ic swelling of Kupffer and.
parenchymal cells (Nakata at al., 1971), and this blockage
of flow may be involved in a positive feedback system. with
decreased flow causing greater hypoxia and worse swelling
and blockage. Rats fed a butter-rich diet developed fat-
filled parenchymal cells and higher portal pressures than
control rats (Latour et al., 1974); among rats on a
lipotrope-deficient diet, only those livers having suffi-
cient fat to cause distention of parenchymal and Kupffer
cells developed cirrhosis (MacDonald, 1962). In dogs,
Kupffer cell enlargement along with dilation of the
lymphatics has been observed in in situ livers subject to
Lchemd a of up to four hours (Grana et ale t 1968). Injection
of distilled water into the livers of dogs and cats pro-
duced swelling of liver cells and an increase in HPV pressure
(Bainbridge and Trevan, 1917). Sundet (1975) presents data
from flow studies and hypothesizes that olive oil injection
into rats results in fat accumulation that increases
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resistance to hepatic flow. Histologic evidence is not
presented to support this hypothesis, but it does not seem
unreasonable when compared to the work of others.
Swollen parenchymal and Kupffer cells have been
thought to have a role in the creation of liver damage and
portal hypertension in humans. Observations that cell
swelling may be able to create liver damage in humans may
be extended to infer support for cell swelling producing
portal hypertension: perhaps s1f1011en cells can interrupt
enough flow to create portal hypertension if they can
cause cell damage and necrosis and a cirrhotic liver re-
sults. Lieber (197S) established that alcoholic fatty
livers can progress to cirrhotic livers. Hinsworth (1947)
theorizes that parenchymal cell swelling in humans de-
creases flot'l and that the decreased £10\'J' is responsible for
necrosis aroun.d the central veins. Baxter and van Slyke
(1948) and Wallach and Popper (1950) support Hinsworth's
(1947) theory. The presumption that cell swelling can
cause liver damage is disputed by Thaler (1975). He be-
lieves call damage and cirrhosis result, not from the cell
swelling, but from whatever caused the swelling. Cell
swelling in cirrhosis may be the result of fat accumulation
and it may be the result of fat accumulation due to a
decreased export ability (Baraona et al., 1975). Cell
swelling has been theorized to be able to create portal
hypertension. Moschowitz (1948) observed fat-filled liver
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cells in patients with cirrhosis and postulated that they
had a role in creating portal hypertension. In 1954,
Madden et al. theorized that outflow blockage could be
caused by cellular edema. Hales et al. (1959), writing
about corrosion casts of human livers, theorized that
swollen, fatty, and necrotic parenchymal cells were
responsible for the decreased venous bed observed early in
the cirrhotic process; they theorized that an entirely dif-
ferent change, contraction of fibrous tissue, '\lIas important
later on. MacDonald (1962), writing about nutritional
cirrhosis, described swelling of parenchymal, Rupffer, and
sinusoidal cells occluding the sinusoidal lumen and postulated
a concomitant obstruction to flow. Correlations have been
made that firmly establish the role of swollen cells and
occlusion of the sinusoidal lumen in the etiology of portal
hypertension. Increases in the size of liver cells con-
current ",'lith increases in HPV pressure have been documented
in a study of the effects of non-surgical therapy. Leevy
et al. (1958) found that HPV pressure decreased when therapy
reduced the amount of fat in the liver cells. A close
reverse correlation has been observed in humans between the
size of the sinusoidal lumen and pressures in a study of
surgical biopsy specimens and HPV pressures (Nakata et al.,
1973) and in a study of needle biopsy specimens and wedged
HV pressures (Nakamura et I'll., 196B, cited in Nakata at al.,
1973). Wedged HV pressures are recorded by occluding a iN
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with a venous catheter and are believed to be a direot
measure of sinusoidal pressure (Reynolds at al., 19541
Reynolds et al., 1970). The idea of cell swelling occlud-
ing sinusoids and creating portal hypertension is not
plainly stated by Leavy et al. (1964) in their work with
radioactively-labelled liver cells of alcoholics; however,
the implication from their observations is unmistakable.
They reported Kupffer cell and connective tissue prolifer-
ation accompanied by decreased £10\'7 and increa.sed wedged
fN pressures. Kupffer cell enlargement during prolifera-
tion presumably is the important factor to decreased flow,
because connective tissue proliferation would not be sub-
stantial enough in a short period to block flow. These
observations are similar to observations from similar
later work by Leevy (1966) wit.h bot.h alcoholic and viral
cirrhosis.
~10 reports support cell swelling and per LsLnusoLda I
fibrosis aa factors in the creation of port.al hypertension.
Russell et. al. (1974) report t.wo pat.ients with portal hyper-
tension and ascites whose only liver pathologies were
increased connective tissue in the space of Disse and
en.Larqed fat.-st.oring cells (Ito oe11s) occluding the lumen
of the sinusoids. This condit.ion was apparently the result.
of chronic hyperVitaminosis A as a health fad. These cases
represent a good example of pcrtal hypertension that is
probably dependent on these two factors. In a report four
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years earlier, portal hypertension without ascites 'Was re-
ported in a patient presenting perisinusoidal fibrosis and
swollen Kupffer cells as the only likely causes (Kluge,
1970) •
Perisinusoidal and mt fibrosis appear to be able to
create portal hypertension in combination, and perisinu-
soidal fribrosis by itself appears to be able to create
portal hypertension. A form of liver disease peculiar to
the alcoholic (called schlerosing hyaline necrosis) is
characterized by portal hypertension; hyaline degeneration:
fibrosis, primarily of the central vein: but no swollen
cells or nodular architecture. The earliest lesion is re-
ported to be perisinusoidal fibrosis and it is associated
with portal hypertension (Edmondson et al., 1963: Edmondson
et al., 1967, Reynolds et al., 1969). Portal hypertension
presenting only perisinusoidal fibrosis also is reported by
Tandon et al. (1970).
BPV fibrosis appears to be able to create portal
hypertension, and perisinusoida1 fibrosis may be unrecog-
nized or recognized but not thought to be important in the
fibrosis of the HPV bed reported by several investigators
(Ramalingswami et al., 1962; Mikkelsen et al., 1965; Boyer
et al., 1967r Donovan et al., 1969). They report portal
hypertension associated with HPV fibrosis, but not
associated with any derangement of the lobular architecture.
Donovan at al. (1969) cite similarities between their
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patients and those of !l1ikkelsen et al. (1965). Donovan et
a1. (1969) theorize that the HPV fibrosis can be caused by
increased HPV prEu3sure from arteriovenous fistulae and that
after several years of the HPV fibrosis is the primary cause
of portal hypertension. Boyer et al. (1967) state that they
observe a pathology similar to that observed by Mikkelsen at
al. (1965), but they believe the cause is different. Boyer
at al. (1967) attribute the HPV fibrosis they observe to
result of the high incidence of sepsis, pyelophlebitis, and
intra-abdominal disease present in children of the popula-
tion from which they obtained patients (India). Boyer et ale
(1967) also report the presence of perisinusoidal fibrosis,
but ascribe it a secondary role in the production of portal
hypertension. The possibility exists that the patients of
Boyer et ale (1967) as well as Ramalingswami et ale (1962),
Mikkelsen et ale (1965), and Donovan et ale (1969) all
possess perisinusoidal fibrosis and that it plays a role in
the creation of portal hypertension.
The third change i13 sinusoidal architecture that can
create portal hypertension ie the capillarization of the
sinusoid13, and it involves changes in endothelial cells and
connective tissue in advanced cirrhosis. The endothelial
cells lose their fenestrations, become continuous with each
other, and gain a basement membrane (Shaffner and Popper,
1963). Flow into and through the space of DiBse is re-
stricted, and thus the effective radius available to handle
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flow is reduced by whatever fraction is provided by free
communication ''lith the space of Disse. The implications
for hepatic. function are important.. If sinusoidal blood
cannot reach the sinusoidal membranes of the hepatocytes
easily, the hepatocytes will Buffer from lack of nutrit.ion
and the individual will suffer because of poor parenchyntal
cell interaction with substances in the blood. That the
space of Disse is reported. to be filled with cell debris,
fibrous tissue, and various mesenchymal cells does not
detract from the role capillarlzation plays.. These other
features only make matters worse. Capillarization of the
sinusoids has been observed in rats treated with carbon
tetrachloride (Steigner, 1966). Quinn and Higginson (1965)
are not convinced that capillarization of the sinusoids is
always extensive in cirrhotic livers ..
Elements of Portal Hypertension not.E:asily Altered
That Result from Changes in the Liver's Architecture.. The
elements of portal hypertension that are not easily altered
that have been discussed up to this point are factors that
operate within the architecture of a healthy liver. Four
additional elements of portal hypertension that are not
easily altered exist within the disturbed architedture of
cirrhotic livers.. An overview of the gross morphological
changes of cirrhotic livers can help one understand these
four elements of portal hypertension. In addition, the
cirrhotic process in general is important to understand
32
because portal hypertension can result from liver diseases
of different etiologies. The liver reacts in a similar
manner to a variety of liver diseases, therefore, the end
stage of cirrhosis from several different causes will in-
volve the same kind of structure despite the fact that the
etiology and early stages were entirely different (Baggenstoss,
1975) •
A number of changes are common events in the develop....
ment of the cirrhotic liver (a liver characterized by nodu-
lar parenchyma and divided by connective tissue at the
expense of the normal architectural pattern). Although all
of the follo\'Jing characteristics may not apply to every
disease, the majority are cownon to cirrhosis as the result
of any etiologyt
1) Ductular, central vein, and portal tract inflam-
mation and fibrosis with ductular cell proliferation
as ductules, singUlarly or in clumps. It may be
significant that connective tissue serves as the
inducer for ductular cell differentiation in the
embryo (Bloom, 1926: Moolten, 1943) and that
ductular cells are suspected of being derived from
parenchymal cells (Popper and Zak, 1958).
2) Swelling of cells in the sinusoida, especially
at the IN ends, as ~ilell as the collection of inflam-
matory cells and fibrosis blocking flow and eventual
causing necrosis.
3) Some sinusoids remain open and carry the flow
from the blocked sinusoids, enlarging, fibrosing, and
acquiring the continuous endothelial lining and
basement membrane characteristic of extrahepatic
capillaries. Portal tract destruction and central
vein destruction also give rise to shunts. The HA
supply to the paxenchyrna is important here because
the fewer HA radicles traversing the parenchyma the
less the likelihood that cirrltlotic changes in that
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region will produce HA-HV and HA-HPV shunts.
f,loschowitz (1948) and MacDonald (1962) have ideas
about the genesis of shunts distinct from recruit-
ment of e Inusof.ds , ~1oschco·witz (1948) theorizes
that in cirrhosis angiogenesis occurs from within
the connective tissue strands to fono HA-HPV shunts
and HPV-HV shunts. Anqiogenesis results from
fibroblastic transformation to vascular endothelium.
He relates this process to the differentiation of
the primitive mesenchymal cell in the embryo.
I:~1acDonald (1962) theorizes that in nutritional
cirrhosis the endothelial cells proliferate to
form new or larger venous and lymph channels. The
new venous channels become HPV-HV shunts surrounded
by connective tissue \'1h08e fibers radiate from the
portal tracts and central veins and eventually
connect with other fibers from similar or different
origin.s. ~.qith time, thf~se fibrous tracts widen into
the paxenohyrae ,
4) Phagocytosis of necrotic hepatocytes and sinu-
soidal cells leaves an empty connective tissue frame-
work (called the trabecula or stroma) that
eventually collapses and condenses.
5) Bands of the collapsed connective tissue frame-
work and bands formed by shunts within connective
tisaue traverse the parenchyma and divide it into
nodules.
6) Cells sequestered by fibrous bands lose the
typical acinar/lobular structure and either
continue to prosper or die. Cell death leads to
greater areas of collapsed fra~ework results
in breaks or fissures in healthy tissue due to
mechanical stress. In time, the fissures
breaks fill in with connective tissue. Continued
prosperity for cells eventually can lead to
restoration of the original acinar/lobular
within the nodule (Popper Zak,
195B) •
Connective tissue contraction, EN compression by
growing parenchymal cells encased by connective tissue
oapsules, as well as intrahepatic shunting and the
increased contribution of HA flow to the total hepatic flow
are all causes of oirrhotic portal hypertension that are
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not easily altered and operate within the disturbed struc-
ture of cirrhotic l.:ivers to increase portal pressure.
Contraction of the connective tissue around intra-
hepatic shunts is a straight-forward mechanism to increase
portal pressure (McIndoe, 1928~ Moachccrwitz, 1948; Hales
et al., 1955; Hales et al., 1959; MacDonald, 1962r
Edmondson, 1963).
Nodules of parenchymal cells surrounded by connec-
tive tissue, structures characteristic of cirrhotic livers,
provide the means for compression of IiV radicles, an
important architectural element of portal hypertension,
and two additional, less.... important elements. Parenchymal
cells encased in a connective tissue capsule will expand
untiltthe limits of the capsule are reached; at which time
they will expand at the expense of tissue and vascular
space within the capsule, often an IN radicle (Kelty et al.,
1950). The fIV is not protected by Glisson's capsule; there-
fore the HV is vulnerable to encroachment by expanding cells.
Popper and Zak (1958) further theori:z:e that the nodules
expand and compress their connective tissue capsules and in
turn compress other nodUles. MacDonald (1962) also
theorizes that connective tissue contraction may compress
the HV indirectly by compressing parenchymal cells which
in turn compress the HV. If parenchymal cells compress
connective tissue capsules, the shunts which are found
within those ca.psules also may suffer compression (Popper
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and Zak, 1958). Quinn and Higginson (1965) offer an inter....
esting hypothesi.s on the nature of the cells within the
capsule # they theorize that these cells may have become
neoplastic. Mice treated with carbon tetrachloride,
thioacetamide; and choline-deficient, high-fat, low....
protein diets all developed these nodules. Transplatable
and metastasizing tumors have been induced by all three of
these methods. Also, the nodules continue to grow after
the stimulation is removed, and the progression of the
nodules cannot be correlated with the extent of fibrosis,
inflammation, necrosis, or bile duct proliferation.
Intrahepatic shunting may increase portal pressure
by bypassing the pressure drop available from a capillary
bed, decreasing the volume of the HPV and HV vascular beds,
increasing IN pressure as the result of shunting, and
increasing the HA percentage of total hepatic flow.
Shunting maintains HPV pressure at high levels
because the flow is channelled through a smaller effective
radius. Shunts are created when several sinusoids in a
sinusoidal bed become clogged as a result of the cirrhotic
process and one or two inherit flow from closed sinusoids.
The flow capacity of the shunts is not great enough to
compensate for the flow capacity lost with clogged sinu-
soids although the flow capacity of a shunt may be greater
than the flow capacity of the original sinusoid. HPV-fIV
shunts (Moschcowitz, 1948; Popper et al., 1952; Hales et al.,
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1955; Popper and Zak, 1958; IliacDonald, 1962; Miyake at al.,
1964; Mitra, 1966b). HA-HPV shunts (Moschcowitz, 1948;
Popper et al., 1952; Mann at al., 1953; Rales at aI., 1955;
Miyake et al., 1964; ~,Utra, 196Gb), and HA-H\l shunts
(Miyake et al., 1964; Appelman, 1972), have been reported.
The volume of the vascular bed perfused by the BFV
and HV is decreased in a cirrhotic liver (McIndoe, 1928;
Hales et al., 1955, Bales et al., 1959; Carter et al., 1961,
Miyake at al., 1964; Mitra, 196Gb) presumably as a result
of cell death and the creation of shunts. This results in
a decrease in the effective radius to handle the BPV
inflow and HV outflow which increases portal pressure.
HPV-BV and HA-HV shunting delivers blood to the HV
at higher pressures and results in an increased IiV pres-
sure. Increased HV pressure results in an increased
resistance to hepatic flow. A cirrhotic liver is less able
to absorb increased HV pressures and not pass them on to
the HPV because of the simultaneous increase in the number
of shunts, decrease in the capillary bed, and a decrease in
lymph drainage capacity, Which will be discussed later (pp.
53-63) •
The HA component of total hepatic flow increases in
cirrhosis and increases portal pressure because HA flow
enters the liver at arterial flow rates and pressures. The
classic experiments of Herrick (1907) demonstrate this in
cirrhotic livers. Herrick (1907) perfused healthy and
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cirrhotic human livers at autopsy through the HPV and HA
and monitored the pressures in each channel. In a healthy
liver, a forty millimeter increase in HA pressure ':rlas
necessary to increase HPV pressure one millimeter: in a
cirrhotic liver, only six millimeters of increase in HA
pressure was required to increase HPV pressure one milli-
meter. Herrick's (1907) results have been reproduced by
others (Dock, 1942; Hales et al., 1959; Miyake et al.,
1964; Takahashi and Tezuka, 1974).
The increased HA contribution to hepatic flow re-
sults from three changes in a cirrhotic liver. First, the
:rIA bed is greater in a cirrhotic liver than in a healthy
liver (McIndoe, 1928; Hales et al., 1955; Popper and Zak,
1956; Hales et al., 1959; Carter et al., 1961; Miyake at
al., 1964; Mitra, 1966b). Secondly, EA-HPV shunts bypass
the pressure drop offered by the capillary bed and send
arterial flow more directly into the HPV system. Thirdly,
the HA autoregulatory system may go awry. Evidence of an
autoregulatory system for the IIA decreasing EA flow as HPV
flow increases has been observed in calf livers (Condon et
a1., 1962) and dog livers (Torrance, 1961: Hanson and Johnson,
1963 J Hanson, 1964; Hanson and Johnson, 1966: Takeuchi et a1.,
1969). Geumi et ale (1968) did not observe P'A autoregulation
in dog livers. The presence of autoregulation of flow is
ordinarily deduced from a change in resistance calculated
from measured flows and pressures or from changes in the
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slope of flow-vs.-pressure graphs (resistance is the slope
of the line whi.ch demonstrates the relationship between the
two). In cirrhotic livers, autoregulation may be intar-
farred with and result in an increased HA flow and a sub-
sequent increase in portal hypertension. H1?V autoregula-
tion may exist, and UPV pressure is reported to regulate
splanchnic resistance. Although these two requlation
systems. do not provide direct proof of HA autoregulation,
their presence makes HA autoregulation appear more plausible.
HPV autoregulation has been reported by Borne investigators
in calves (Condon et 81.1., 1962) and dogs (Torrance, 1961;
Hanson, 1964; Hanson and Johnson, 1966) , and found to be
absent by other investigators in dogs (Takeuchi et al.,
1966) and rats (Brauer, 1964). Brauer (1964) states that
almost no BP"-HA reciprocity of f10\>1 exists in calf livers
and only a small amount of H1?V-HA reciprocity of flow exists
in dog and rat livers. Splanchnic resistance has been
shown to be a function of HPV pressure in healthy dogs, and
splenectomy increases the dependence of splanchnic resist-
ance on HPV pressure (Mitzner, 1974b).
Retrograde flow through the HPV is theoretically
possible when increased hepatic outflow resistance
accompanies increased HA flow. This phenomenon has been
observed in humans (Hales et al., 1959; Warren and Muller,
1959; Mikkelsen et al., 1962; Johnson et 81.1., 1966; Smith
et al., 1971; Nusbaum at al., 1974; Galambos et al., 1976;
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~1orano, 1976; Smith, 1976) ..
Elements of Portal Hypertension that can be Altered
by 'llreatments Other than Vasopressin.. Four elements of
portal hypertension that are not responsive to vasopressin
therapy can be altered by various treatments.. Increased
flow into the portal system is commonly altered by surgery ..
Increased blood volume is also commonly altered, and it is
attractive because of the relative ease with which it can be
accomplished with diuretics. Increasing lymph drainage
through the thoracic duct is not a popular procedure for the
treatment of portal hypertension, ascites, or bleeding
varices, but it has both a theoretical basis and clinical
results to support it. The role of autacoidal factors is
not well-understood, but if they do playa role, they
could be sensitive to specific treatments.. Autacoids
important to portal hypertension may be thought to include
those substances released by healthy, unhealthy, and dead
cells; immunOlogical reactions; and clotting reactions that
have vasoactive properties. Presently, their role is not
established; consequently, this approach to portal hyperten-
sion, ascites, and bleeding varices is not an important one.
Increased Flow. Increased flow into the HPV can
increase portal pressure according to the dictates of Ohm's
law even though four differences exist between a rigid tube
and the HPV and hepatic vascular beds. Uncomplicated cases
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of increased flow and cases of increased flow in combina-
tion with increased resistance have been reported to he
responsible for portal hypertension. Inoreased flow into
the HPV other than from a major arteriovenous fistula is
reported to come primarily from the spleen and stomach.
Al terations of flo,,", are primarily surgi.cal and are related
to either a splenectomy or an anastomosis of a portion of
the portal system to a portion of the oaval system ..
To the extent that the HPV and the hepatic vascular
beds resemble a set of rigid tubes, pressure will increase
with flow acoording to Ohm's law, to the extent that t.."1ey
differ, an increase in flow can be compensated for by other
factors and not result in increased pressure. The BPV and
the hepatic vascular beds possess four differences in com-
parison with a theoretioal rigid tube: vasoular and hepatic
compliance, architeotural changes, l:Ytnph drainage, and the
availability of hepatofugal collateral circulation. Each of
these factors has its individual effects on pressure and
may also interact with the other factors. Some flow
increases will be absorbed '\tlith minimal increase or no
inorease in back pressure by the expansion of vessels within
the portal system and the liver. H~~an livers, if similar
to rat livers, have seoond complianoe mechanism by virtue
of their ability to mobilize unused sinusoids at higher
pressures (Brauer et a1., 19531 Mitzner, 19748). The effect
of this vascular and hepatic compliance is to change the
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system by increa.sinq the effective radius to handle flow ..
The second difference, architectural alterations brought
about by progressing liver disease, increase the resistance
of the system by decreasing the effective radius available
to handle flow.. The lymph system is able to drain excess
extracellular fluid away from the tissues and is the third
difference.. According to Starling's capillary hypothesis,
when all other factors are equal, increased capillary
pressure will put more fluid into the extracellular spaces
from the capillaries.. By removing extracellular fluid,
lymph drainage can drain some extra flow and absorb pres-
sure. Lymph production will be discussed in detail, lat.er
(pp. 53-64). The creation and expansion of collateral
circulation is fourth difference between a hypothetical
rigid tube and the HPV and hepatic vascular beds. Alterna-
tive vascular channels are created and expand when flow in
one channel becomes difficult or blocked. McIndoe (1928)
classified the collateral channels resulting from portal
hypertension on embryological grounds. nis first group
results from the union of glandular epithelium from the
gastrointestinal tract with squamous epithelium of what was
once ectoderm. The esophageal veins fall into this category
as do the superior hemorrhoidal veins connecting the portal
system with the middle and inferior hemorrhoidal veins of
the caval system. McIndoe's (1928) second group is com-
posed of the remnants of the fetal circulation. The
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umbilical and paraumbilical veins conduct HPV blood to t.he
anterior abdominal wall and cause the characteristic caput
medusae of visible, enlarged veins on the abdomen of some
patients with portal hypertension. His third group con-
sist of vessels formed where abdominal viscera become
adherent to the abdominal wall, primarily retroperitoneally.
These veins (called the veins of Retziua) include veins
arising from adhesions due to pathologic or surgical pro-
cesses.
Increased flow into the HPV can increase HPV pres-
sure both by itself and by working in concert with increased
resistance. Cases of portal hypertension that result
solely from increased flow are ordinarily the result of
substantial arteriovenous fistulae. Increased flow into the
portal system also can occur without an arteriovenous
fistula, and the stomach and spleen are reported to be the
primary sources of this increased flow. This kind of
increased flow must work together with an increase in
resistance to overcome the body's adaptive responses and
create portal hypertension.
Increased flow with or without the help of increased
resistance must overcome the body's adaptive responses in
order to create portal hypertension. The adaptive responses
of humans and Mac&ca mulatta monkeys (Child et al., 1950;
Child at al., 1952) to t.ota1 HPV blockage provide good
examples of the interplay of vaacuLar compliance, lymph
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flow, and collateral circulation in response to increased
resistance and pressure. Veins dilate, lymph flow increases
from the region, and collateral veins (called the veins of
sappey) expand and develop to bypass the blockage and con-
duct blood to the liver. In the lJJ:aC2lca mulatta monkey, RPV
pressure returned to nonnal within a week after the total
blockage of flow. In cirrhosis, hepatofugal collaterals
develop to bypass the blockage in the liver and conduct
blood back to the inferior vena cava (IVe), but the
responses are similar: veins dilate, HPV system lymph pro-
duction increases with increased HPV pressure and hepatic
lymph production increases as postsinusoidal blockage
increases, and collaterals expand and develop (as discussed
by McIndoe (1928» to bypass the blockage in the liver. To
create portal hypertension, one must overwhel:rn the body's
compensatory responses. According to the theory of C. L.
and M. H. Witte (Witte et al., 1974a; Witte and Witte, 1975:
Witte et al., 1976a), portal hypertension is rarely the
result of uncomplicated increa flow or increased resist-
ance; they believe it is ordinarily the result of the two
working together. The multiplicative effect on pressure of
simultaneous increases of flow and resistance detailed by
Ohm's law explains how simultaneous increases of flow and
resistance can be powezfuL enough to overwhelm the body's
substantial adaptive responses.
Increased flow from an arteriovenous fistula can
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create portal hypertension without the help of increased
resistance. Uncomplic.ated extrahepatic lIA-UPV fistulae
(Strickler at a1.., 1952; Madding et al., 1954; Wheeler and
Warren, 1957; Boyer et al., 1967) and uncomplicated splenic
arteriovenous fistulae (Cassel et al., 1957; Murray at al.,
1960; Stone et al., 1965; Berman et al., 196B; Donovan at
al., 1969; Nissan and Bar-Maar, 1971) have been reported to
cause portal hypertension.
Splenic and gastric a.rteriovenous shunts are con-
sidered the primary causes of increased splenic and gastrio
flow into the portal system other than major arteriovenous
fistulae in cirrhotic portal hypertension. Splenic and
gastric shunting is not one large anastoltlosis or a few
smaller ones; rather, it is a diffuse collection of many
very small shunts. Clinical signs of arteriovenous shunt-
ing can be observed in many cases of cirrhotic portal
hypertension.
Increased splenic flotr~r due to intrasplenic arterio-
venous shunting is observed in many cases of oirrhotic
portal hypertension presenting enlarged spleens, and
reciprocal reticuloendothelial system function is thought
to provide the stimulus for this increased splenic flow.
The condition is called hypersplenism. The enlarged spleen
found in cirrhotic portal hypertension is the result of a
great number of open arteriovenous shunts, increased flow
through the slower-moving channels of the spleen, and a
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great deal of oonnectd.ve tissue (Tumen, 1970). ~'lomack and
Peters (1961) and Dumont et ala (1970b) believe the arterio....
venous shunting is the primary cause of the increased flow.
Dwnont et ala (1970 band 0) theorize that splenomegaly and
increased splenic flow result from an increase in splenic
reticuloendothelial system activity reciprocal with a
decrease in hepatic reticuloendothelial system function.
Dumont at al. (1970 b and c) attribute the decreased hepatic
reticuloendothelial system activity to the decrease in the
number of healthy cells in the liver and the increase of
capillarization of the sinusoidsf extra- and intrahepatic
shunting seem likely to be additional, important factors
decreasing hepatic reticuloendothelial system activity.
c. L. and M. H. Witte (1975) expanded the theory of recipro-
cal reticuloendothelial system activity. They theorize that
splenomegaly and increased splenic flow are the reeu1t of
splenic reticuloendothelial system hyperplasia in response
to depression of the hepatic reticuloendothelial and/or a
decrease in transhepatic flow. They support their theory
with observations of splenomegaly and increased splenic
flow in cases of: 1) the production of abnormal erythrocytes
in hereditary spherocyt.osis, 2) the accumulation of roacro-
mcj.ecul.ar cerebrosides in Gaucher I a disease, and 3) primary
disorders of the reticuloendothelial system and blood-
forming organs such as myeloid metaplasia and disproteine-
mias. Increased splenic reticuloendothelial system
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activity can explain the observation of increased. flow
through the slolt1er-moving channels. Splenic fibrosis can
be explained by the presence of increased portal pressures
and the theory of Thoma (1920, cited by ~ioschcowitz, 1948).
As portal pressure increases, pressure in the spleen 'Will
increase. Thoma (1920,cited by Moschcowitz, 1948) states
that the caliber of the blood vessel lumen increases with
increases of the flow through it and that the thickness of
vessels increases "dth increases of the pressure in them.
In the case of the spleen, portal hypertension promotes
splenic fibrosis.
The theory of increased splenic flow due to the
reciprocal nature of the hepatic and splenic reticuloendo-
thelial systems is consistent with the theories of Ravenna
(1940) and the observations of Mitzner (1974b). Ravenna
(1940) theorized that the spleen is a rnajor regUlator of
flow into the HPV; l-Utzner (1974b) observed that splenectomy
in dogs resulted in a closer relationsh.ip between splanchnic
resistance and HPV pressure than before the splenectomy ..
Both Ravenna's (1940) theory and Mitzner's (1974b) observa-
tions suggest that splenic and splanchnic flows are
reciprocal to some extent, and such reciprocity would be
expected if the activities of the splenic and hepatic
retiCUloendothelial systems were reciprocal.. Ravenna (1940)
also further theorized that splenomegaly in cirrhotic
portal hypertension is the result of the spleen's role as a
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regulator of hepatic flow. This additional theory of
Ravenna's (1940) needs only to further specify the retic-
uloendothelial system as the controlling element to become
the theory of Dumont et al. (1910 b and c) and the wittes
(1975) •
Clinically,. hypersplenism is manifest by anemia and
leukocytopenia reSUlting from splenic sequestration, nutri-
tional and metabolic disturbances associated t4ith increased
RBC formation, and the presence of an enlarged spleen
(Blaustein and Diggs, 1963~ Tumen, 1970).
Increased gastric flow into the HPV is thought to
be created by humoral factors dilating the sphincters that
control flow through gastric arteriovenous shunts (Ravenna,
1940; Peters and Womack, 1961; Johnson, 1971). The shunts
are thought to remain open as forces explained by the law
of La Place overcome the ability of the sphincters to close
and eventually over\;.thelm the sphincter muscles (Peters and
Womack, 1961).
No clinical manifestations are peculiar to gastric
arteriovenous shunting, however, both splenic and gastric
arteriovenous shunting can produce a clinical picture
similar to that observed with syst.emic arteriovenous
fistulae: a hyperdynamic cardiovascular state characterized
by increased cardiac output, decreased peripheral resist-
ance, and increased blood volume. Because the fistula
offers a low-pressure channel, it captures some of the
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arterial circulation and diminishes circulation to the rest
of the body. In compensatory respon.se to decreased peri-
pheral perfusion, peripheral resistance decreases and
cardiac output increases (Strandness and Sumner, 1975) ..
Blood volume increases because of two factors.. One is
increased sodium retention as decreased flow to the kidneys
accompanying the generalized decreased peripheral perfusion
produces increased aldosterone secretion.. The second is
the increase in the volume of the vascular bed due to the
vo Lume of the fistulae (Strandness and Sunmer r 1975). The
hyperdynamic cardiovascular state involving increased car-
diac output, increased blood volume, and decreased
peripheral resistance has been observed in cirrhotics
{Kowalsky and Abelman, 1953: Abelman at al., 1955: Murray
et al., 1958; Murray at al., 1960; Womack and Peters r 1961;
Johnson at al., 1966; Van Way at al., 1971; Johnson, 1971 v
Siegel et a1., 1974}. In addition, warm flushed extremities
(liver palms), pounding pulses, capillary pulsations, and
clubbing of the fingers are also observed and may be
attributed to the effects of the hyperdynamic cardiovascular
state (Murray et al., 1958; Peters and tiomack, 1961).
HPV flow can be altered two ways. Increased flow
into the HPV from the spleen may be selectively eliminated
by splenectomy or splenic artery ligation. Also, some part
of the portal system may be anastomosed to some part of the
caval system to decompress the portal system diverting
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f10\;,1.
Splenectomies or splenic artery ligations decrease
portal hypertension and varices bleeding beCaUtiiUil: they de-
crease HPV flow. The spleen ordinarily provides 40% of the
HPV flow (Dumont et a1., 1970b). Splenectomies or splenic
artery ligations are the operation of choice l\7nen portal
hypertension can be id.entified as primarily the result of
increased splenic flow (Peters and tlffomack, 1961: Berman at
al., 1960; Dumont at 211., 1972: Witte at al., 1914 a and b;
Witte and Witte, 1975). In addition, splenectomy offers
relief for many patients with unspecified portal hyperten....
sion (Gray and t~\itese11, 1950, Dunlont and Witte, 1966a);
although the importance of increased splenic flow may have
been unrecognized in these patients. Lebrec et al. (197Gb)
describe almost total splenic artery shunting in cirrhosics,
and one may assume that most of this flow is shunted away
from the liver via the esophageal veins; thus, much of the
relief offered by splenectomy or splenic artery ligation
for bleeding esophageal varices may result from decreasin9'
esophageal vein flow.. This would decrease HPV pressure by
allowing more HPV flow to bypass the liver through the
esophageal veins and further decrease flow into the liver.
Splenic artery ligation may be preferable to splenectomy
because some splenic function remains by virtue of
collateral arterial channels into the spleen (Witte at al.,
1976b: tl1itte 1976). Any benefit from splenic artery
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ligation must be balanced against. the risks from splenic
infarction. The effectiveness of splenectomies and splenic
artery ligations support the idea of a role for increased
splenic flow in the creation of portal hypertension.
Anastomosing a portion of the portal system to a
portion of the syst.emic caval circulation decreases HPV flow
by diverting some of the high-pressure portal flow into the
low-pressure caval circulation. The relative merits of
gastrocaval, portacaval, mesocaval, and splenorena1 shunts,
their variations, and other shunting procedures are being
actively discussed and studied now, and for the most part
they are beyond the province of this discussion.
Encephalopathy and diversion of hepatotrophic substances
away from the liver are side-effects of surgical shunting
of blood away from the liver as well as of shun.ting the
result of pathological process.
The exact etiology of encephalopathy is not under-
stood, but it involves the gut, gut bacteria, and SUbstances
of nitrogenous origin (Fischer, 1974: Fischer and
Baldessarini, 1976). Encephalopathy begins as confusion
and disorientation, and it progresses through asterixis and
aphasia to coma. A.ttlmonia and false neurotransmittors have
been theorized to be responsible for encephalopathy.
papenberg et ale (l975) believe ammonia creates encephal-
opathy by interferring with cerebral oxidative metabolism.
Arterial, venous, and cerebrospinal fluid levels of ammonia
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correlate poorly to the degreaof encephalopathy observed
(Fischer and Baldessarini, 1916). False neurotransmittors
are believed to create encephalopathy by virtue of competi-
tion for pre- and postsynaptic receptor sites with regular
neurotransmitters, because t.hey do not cause depolarization
when they bind to the postsynaptic membrane. t'llhan enough
false neurotransmittors are sequestered within the synaptic
vesicles, the vesicles empty upon stimulation but do not
depolarize the postsynaptic membrane; thus, the impulse
stops at that junction. This interruption of nerve impulses
is thought to cause encephalopathy (Fischer, 1974; Faraj
at al., 1916; Fischer and Baldessarini, 1916). Candidate
false neurotransmittors are primarily analogues of
epinephrine and norepinephrine and are thought to result
from altered synthetic and destructive pathways for
epinephrine and norepinephrine (Fischer, 1974; Faraj et al.,
1976: Fischer and Baldessarini, 1916). Octopamine is
thought to be an important false neurotransmittor (Fischer,
1914, Faraj et al., 1916: Fischer and Baldeasarini, 1976).
Substances in the portal blood of rats (Fischer et
al., 1911) and dogs promote hepatic regeneration. In dogs,
some of the substances involved have been identified. It
is believed that insulin and other factors from the proximal
portion of the portal bloodstream promote hepatic regenera-
tion in dogs (Starzl et al., 1973; Starzl at al., 1975 a
hi starzl et al., 1916). r,lucagon has no regenerative
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influence (Starzl at al., 1975b; St.arzl at al., 1976) and
appears to reduce insulin's effectiveness (starzl et al.,
1976). Rat livers, too, regenerate in response t.o insulin
(Younger et al., 1966). In addit.ion, lymphocytes from
healthy partially-hepatectomized rats have the capacity to
cause hepae.Lc regeneration (Sakai et al., 1975). Sub-
stantial pathologic or surgical shunting diverts hepato-
trophic substances away from the liver and therefore
reduce the stimulus to regenerate and creates a self ....
Bustaining insufficiency.
Blood Volume. The second cause of portal hyperten-
sion which is Bn\enable to alteration by treatment other than
vasopressin is blood volume. Portal pressure has been
positively correlated with blood volume (Lieberman and
Reynolds, 1967; Zimmon and Kessler, 1974). Zirnmon and
Kessler go so far as to state that diuretic therapy can
reduce HPV pressure without impairing tissue perfusion in
a majority of cirrhotics. Increased blood volume can
result from the hemodynamic effects of portal-systemic
shunting, the loss of hepatic control of venous return, and
from increased aldesterone concentrations in the blood.
Portal-systemic shunting is thought to act like arterio-
venous fistulae (p. 48) in the production of portal hyper-
tension (Lieberman and Reynolds, 1967). A healthy liver in
man and dogs acts like a blood reservoir during inspiration
and empties during expira.tion (Moreno, 1964 f l'toreno et al ~ r
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1967). This requlation is absent in a cirrhotio liver and
contributes to the hyperdynamic cardiovascular state of
cirrhotics (see p. 49) and to hypervolemia by increasing
venous return (Moreno, 1964). Shunting and hepatic injury
combine to decrease aldosterone inact.ivation in a cirrhotic
(Lieberman and Reynolds, 1967; Rosoff et al., 1975).
Hepatofugal collateral cirCUlation recruits the adrenals as
a drainage. pathway, and this backward flow could increase
aldosterone secretion (Sasano et al., 1974). Increased
intrahepatic pressure may be a stimulus for aldosterone
secretion (Lieberman and Reynolds, 1967; Orloff et al.,
1968~ Bosch at al., 1976). Too, the kidneys may be involved
in increased aldosterone secretion due to an increased
sodium absorbtion by the proximal convoluted tubUles
decreasing sodium delivery to the distal convoluted tubules
(Rosoff et al., 1975).
TheL:l!!:ph System. The lymph system does not actively
produce portal hypertension and esophageal varices: rather,
it becomes a factor only when lymph production can no longer
increase to oppose pressure increases in the HPV and the
esophageal veins. Lymph of different protein concentrations
is produced by the splanchnic bed, a healthy liver, and a
cirrhotic liver. Ascites may be thought of as lymph: in
particular, the quantity of lymph produced that is in excess
of the drainage capacity of the lymph system. Five general
restrictions to lymph drainage influence both portal
54
hypertension and bleeding varices. Blockage of the right
lymphatic duct close to the liver can interfere with hepa-
tic lymph drainage and lymphovenous communications in the
area. of the esophagus may be important t.o variceal bleeding.
Restriction of lymph drainage has deleterious ramifications
in the respiratory system. Operations that inorease thora-
cic duot flow to combat portal hypertension, variceal
bleeding, and ascites have been reported. Asoites has been
theorized to result. from surgical transect.ion of lymphat.ics,
from hepatic outflow blockage, and from increased blood
volume. A number of surgical prooedures have been used to
reduce ascites.
Splanchnic and hepatic lymph production oan dampen
HPV pressure increases. Capillary pressure increases result
in increased movement of fluid from the capillaries to the
extraoellular spaces and therefore increased lymph produc-
tion. Increased HPV pressure results in increased splanohnic
lymph product.ion because the increased HPV pressure will
increase pressure in the splanchnic capillaries; increased
splanchnic lymph production thus dampens HPV pressure
increases. Extrahepatic HPV occlusion in humans and
Macaca mulatta monkeys results in inoreases of splanchnic
lYmPh production until enough collateral channels were
present to bypass the blockage and return pressure to normal;
in the monkeys, this adaptation requires only a week (Child
et al., 1950; Child et al., 1952). Increases in
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postsinusoidal resistance raise the sinusoidal pressure,
and hepatic lymph production can increase enough to block
the transmission of increased pressure from the liver to the
HPV in healthy dogs (Grindlay et al .. , 1949J Nix et al .. ,
1951; Hyatt at al., 1955). In the case of cirrhotic portal
hypertension, splanchnic lymph production can be increased
by HPV pressure increases related to increased flow and
related to increases of presinusoidal resistance the result
of the cirrhotic process.. Increases in postsinusoidal
resistance the result of cirrhosis can increase hepatic
lymph production and increase of splanchnic lymph produc-
tion when the cirrhotic liver does not totally absorb all
the pressure increase resulting from the increase of post-
sinusoidal resistance. Intrahepatic shunts contribute to
this transmission of pressure into the HPV because the
shunts are less permeable to plasma than the sinuBoids that
they replace (Dumont et al .. , 1975).
Lymph drainage from the area of the esophageal
veins opposes pressure increases and, therefore, varix
formation and hemorrhage.. Increased hepatofugal collateral
flow brin9s increased pressure to the esophageal and axygos
veins, and lymph production increases from this area, as it
does in other areas of the body, to dampen some of the
pressure increases ..
Lymph from a healthy liver has a higher protein
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concentration than lymph from a cirrhotic liver or lymph
from the splanchnic bed because the sinusoids in a healthy
liver are more permeable than shunts Ccapil1arized sinu-
soide) in a cirrhotic liver and ordinary capillaries. The
gaps in and between endothelial cells are responsible for
the ease of movement of large proteins from the plasma into
the hepatic lymph. The high permeability of sinusoids is
demonstrated by the work of Mayerson (1963) with dog livers.
He measured the permeability of sinusoids to dextraus of
different molecular weight against the permeability to
70,000 mw albumins and found that his largest dextrans
(412,000 row) diffused only a little slower than the albu-
rains. The work of Dauer et al. (1959) with rat livers also
demonstrates the high permeability of the sinusoids. He
found that the protein concentration of the hepatic lymph
was approximately equal to that of the plasma at a pressure
difference of 4....5 em of wa.ter bet1:1een the HV and the hi1u-TIl
of the liver. Lymph from the spla.nchnic bed and a cirrho-
tic liver has a lower protein concentration than lymph
from a healthy liver (Witte et al., 1968: Witte et al.,
1969: Witte at a1., 1971; Dumont et al., 1975; Ismail and
Aboul-Enein, 1976; Sadek at a1., 1976) because the
splanchnic capillaries and capil1arized ainusoids of a
cirrhotic liver have a similar histologic structure that is
less permeable to plasma than the sinusoids of a healthy
liver. Both splanchnic capillaries and capillarized
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sinusoids (Shaffner and Popper, 1963) possess a thick base-
ment membrane and continuous endothelial cells typical of
capillaries and different from healthy sinusoids. Courtice
et al. (1962) cite experiments with rabbits to support the
view that some additional factor operates to transport
proteins from the plasma to the lymph, but they offer no
speculati.on on what the mechanism might be.
The tho,racic duct provides the primary lymph drain-
age for the portion of the body caudal to the heart
(Warwick and Williams, 1973). The thoracic duct is larger
than the right lympha.tic duct (Warwick and Williams, 1973),
and the liver provides half of the flow tn the thoracic
duct (Dumont and Witte, 1966b). Some lymph drainage is pro-
vided for the right side of the body caudal to the heart
by the bronchomediastinal trunk of the right lymphatic duct;
specifically, the right lymphatic duct drains the right side
of the thorax, the right lung, and the convex surface of
the right side of the liver (Yoffey and Courtice, 1970).
The right lymphatic duct empties through one or several
one-way valves into the notch made by the junction of the
right subclavian vein and the right jugular vein. The
thoracic duct empties through a similar valve or valves
into the same spot on the left side. Several anastomoses
between the right lymphatic duct and the thoracic duct
occur in man (Yoffey and courtice, 1970); therefore,
blockage of the right lymphatic duct is not likely to
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create major problems unless the block is below the first
communication with the thoracic duct. Becauee the right
side of the liver is at the end of the right lymphatic duct,
blockage before the first communication with the thoracic
duct could result in stasis of flow in portions of the right
side of the liver.
Three restrictions of thoracic duct drainaqe (the
size of the ampulla at the lymphovenous junction, the loss
of rhythmic pulsations of the thoraoic duct, and inoreased
venous pressure at the lymphovenous junot.ion) can promote
portal hypertension and varix formation and hemorrhaqe by
restricting increases of lymph drainage. Blockage of the
right lymphatio duct can create resistance to hepatic lymph
drainage, and special lymphovenous communications in the
esophageal area may promote varix formation and hemorrhage.
The size of the ampulla draining the thoracic duct into
the venous system is thought to be a limiting factor for
lymph drainage (Dumont and Mulholland, 1963, Dumont, 1964;
Dumont and Mulholland, 1965, Dumont and Witte, 1966a; Bradham
and Takaro, 1968, Bhalerao et al., 1911; Witte at al., 1971;
Dumont, 1915) .. The round or oval shape of the actual
orifice becomes slit-like when the thoracic duct is dis-
tended, and this further decreases flow (Naitove, 1965,
cited. by Dumont and Mulholland, 19(5). However, Warren et
al.. (1968) challenge the size of the orifice as a factor
limiting lymph flow. Lymph moves through the thoracic duct
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by rhythmic muscle contractions (Kinmonth and Taylor, 1956;
Hall, 1969). If muscles contact in respon.se. to increased
lymph pressure, sustained and abnormally high pressure over
a period of time might reduce flow by exhausting the
muscles (Hall, 1969). Increased venous pressure at the
lymphovenous junction may reduce lymph drainage (Yoffey
and Courtice, 1970). Thoracic duct resistance increases
with increased left inominate vein pressure (W~9ria et al.,
1963) and also with left jugular vein pressure (Szab6 and
~1agyar, 1967); however, left SUbclavian vein pressure is
reported to be normal in cirrhotics (Dumont, 1964: Dumont
at al., 1971). Stasis of flow in the rig'ht lymphatic duct
due to a blockage before the first anastomosis with the
thoracic duct has been reported in humans (Magnenat and
Oelaloye, 1964, cited in Dumont and Witte, 1966a). such a
blockage has the potential to be important to portal hyper-
tension because 20% of hepatic lymph drains through the
right lymphatic duct (Dumont and witte, 1966a). Right-
side stasis of lymph flow may have gone unnoticed in
several cases where thoracic duct cannulation, a surgical
procedure to be discussed later (p. 62), failed to control
bleeding (Dumont and Witte, 1966a). Speciallymphovenous
communications in the esophageal area may promote varix
formation and hemorrhage. Lymphovenous communications are
present throughout the body (warwick and Williams, 1973).
Special lymphovenous communications in the esophageal area
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have an embryological basis because the thoracic duct and
the azygos vein have the Bupracardinal vein as a common
primordium (Dumont and Witte, 1966a and b: Dumont et al.,
1970a). As hepatofugal collateral circulation through the
esophageal veins increases, flow and pressure in the
azygos vein increases and may be transmitted to the
thoracic duct and the local l)'lllph system by these special
lymphovenous communications. The esophageal veins are
thought to be particularly susceptible to hemorrhage
because their greatly increased flow demands increased
lymph drainage and subjects them to great pressure while
their lymph system is exposed to e:>rtra demands because it
is subject to the pressures from the special lymphovenous
communications (Dumont and Witte, 1966a and b~ Dumont et
al., 1970a). An increase in resistance to lymph flow
through the thoracic duct generally would also be expected
because of these special lymphovenous communications.
Ludwig et al. (1968) and Dumont et a1. (1970a) report
retrosternal lymphovenous communications in cirrhotics,
and Dumont and Witte (1966a and b) and Dumont et al. (1970a)
report that RBefs in the thoracic duct of cirrhotics come
from the azygos vein. Lymphovenous communications ser~e
an important homeostatic purpose: they allow lymph produc-
tion in excess of the carrying capacity of the thoracic
duct to be drained into the venous system (Dumont, 1975).
Warwick and Williams (19?3) report that total blockage of
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the thoracic duct in a healthy individual does not result
in back-up of lymph because of the presence of 1ymphovenous
communications.
Increased resistance to lymph drainage and increased
azygos and pulmonary vein pressures are thought to decrease
pulmonary function because they produce pulmonary edema.
This edema is theorized to create a fluid barrier to resist
oxygen diffusion across the alveolar-capillary membrane
(Ruff et a.L, , 1971; Siegel et al., 1974; Arndt at al., 1975),
mechanically compress small adrways (Ruff at 191., 1971) I and
create prolonged increased pressures that CBuse a thickening
of arterial and capillary membranes (Siegel et al., 1974;
Arndt at al., 1975). Poor pulmonary lymph drainage due to
increased flow and pressure in the thoracic duct is an
important reason for this (Ruff et al., 1971; siegel et al.,
1974; Arndt et al., 1975). Increased azygos vein pressure
due to hepatofugal collateral circulation is t.houq'ht; to be
another important reason for the pulmonary edema (Ruff et
al~, 1971; Siegel et al., 1974; Arndt et al., 1975) be-
cause much of the thorax is drained by the azygos vein ..
Increased pulmonary vein pressure causes pulmonary edema
(Dawson at al., 1965), and increased pulmonary vein pres-
sure from azygos vein-pulmonary vein shunting is thought
to be important to pulmonary edema in cirrhotics (Ruff et
al., 1971). This kind of shunting has been reported
(sheLdon et al., 1961bi Nakamura et al., 1965).. Nakamura
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et 09.1 .. (1965, cited in Nakata et al., 1973) report that not
enough. flow passes through these shunts to account for the
oxygen desaturation observed.
Increasing thoracic duct drainage by cannulation or
construction of a lymphovenous anastomosis can reduce
ascites (Dumont and ~J1ulho11and, 1962 i Dumont and Witte,
1966 a and hi Steigman et al., 1967), stop variceal bleed-
ing (Dumont and Mulholland, 1962, Bowers at a1., 1964,
Dumont and Witte 1966b; Cuento and Currie, 1967, Dumont,
1969; Dumont et 09.1., 1970b; Bhalerao et 09.1., 1971; Dumont
at 09.1., 1972), and decrease portal pressure (Dumont and
~1ulholland, 1962; Cuento and Currie, 19(7) and wedged HV
pressure (Warren at al .. , 19(8) .. Thoracic duct flow may be
diverted either into the digestive tract or into the venous
system. When thoracic duct flow is diverted into the
digestive tract, immunologic activity is surpressed pre-
sumably due to the loss of the lymph proteins (Dumont and
Mulholland, 1962 r Mayer and Dumont, 1963; Dumont et 09.1.,
19(4). Lymphovenous anastomoses have had limited surgical
trials (Bhalerao at al., 19711 Dumont et al., 1972~
sar'nyi et al., 1976). The procedure is effective for
ascites but gives inconsistent results with variceal bleed-
ing. The results of surgery to change the lymph drainage
system are mixed--perhaps reflecting the inability to
identify individuals with portal hypertension and bleeding
varices resulting imarily from lymph drainage deficiencies.
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Ascites may be thought of as that quantity of lymph
produced that is in excess of the lymph system's drainage
ca.pacity 1 and its presence may be thought to signify that
changes greater than the body's ability to adapt have
occurred. Baggenstoss and ~i1011aeger (1956) theorize that
ascites develops after uncomplicated HPV blockage only in
those LndLviduals without tvell-developed collateral circula-
tion. Hepatic outflo\ll blockage and increased blood volume
are thought to be major factors overwhelming the body'S
adaptive capacities in cirrhotic portal hypertension.
Autacoid-induced outflow blockage also may be important.
Transection of hepatic lymphatics during construction of an
end-to-side portacaval anastomosis can create ascites
(Witte et al., 1971), but this means is in an unrelated
class by itself. Architectural changes have been mentioned
which create hepatic outflow blockage. l<1adden et al.
(1954) theorize that reversible a.scites, the result of
edema of the fiP\T and HV beds, and irreversible ascites,the
result of fibrotic obliteration of the HV bed, exist.
Zimmon and Kessler (1974) state that severe outflow resist-
ance may prevent a satisfactory response of decreased blood
volume in response to diuretic therapy in cirrhotics with
ascites. Autacoids may create outflow blockage; thus they
have the pot.ential to create ascites. Candidates autacoids
and their possible roles will be discussed in the next
section. Ascites from increased blood volume may result
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from a combination of decreased aldosterone inactivation
and increased secretion (see p. 53) and in particUlar
response to increased secretion by the distal convoluted
tubules in response to increased sodium absorbtion by the
proximal convoluted tubules (Rosoff et al., 1975).
Ascites may be reduced by medical therapy directed
against hypervolemia or one of a number of surgical pro-
cedures. Side-to-side portacaval anastomoses control
ascites well because they offer decompression for both the
portal and sinusoidal beds (Witte et al., 1971). Both
omentopexy (suturing the omentum to the liver and the
abdominal wall to promote collateral circulation)
(Pemberton and Kiernan, 1945; 1flliipple, 1945; Garrido et al.,
1976) and ileoenterectropy (eversion of a portion of the
terminal ileum to absorb ascitic fluid) Neumann et al.,
1957} have been reported to control ascites. Peritoneo-
jugular shunts to drain ascitic fluid from the peritoneum
into the venous system are a recent development, and they
have been successful in several initial trials (LeVeen et
al., 1974; Samp1iner et al., 1976: Wapnik et al., 1977).
Auta.coids. The fourth alterable factor that con-
tributes to portal hypertension, the effects of autacoidal
factors on flow through the liver, is presently hypotheti-
cal. "Autacoid n is a broad term intended in this case to
include any agents that disrupt flow through the liver as a
result of vasoactive properties and that resemble but are
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not humoral or neurohumoral factors (Douglas, 1975a).
Agents released by immunologic reactions; clotting reac-
tions: and from dead, injured, and healthy cells are
potential causes of increased resistance to flow. Seratonin,
kinine, and histamine are obviously suspect, but they are
not the only compounds "lith vasoactive potential. Bacterial
endotoxins are not autacoids, but they apparently cause the
release of autacoids.
Local flow through the human liver is controlled at
several places, each a possible site for the action of
aucacoLde , Inflo"" as well as outflow sphincters may be
involved because the contents of the sinueoids appear to
get well-mixed (p , 22). Knisely et ale (1948, cited in
Elias and Sherrick, 1969) describe inlet sphincters at the
point where inlet venules branch out in a candelabra-like
pattern of s InusoLda , r-mrck (1951, cited in Elias and
Sherrick, 1969) describes aA sphincters within the portal
triad where the HA branohes follow the inlet venules.
Elias (1949a and b, cited in Elias and Sherrick, 1969)
describes sphincters at the entrance of both paraportal
and intralobular arterioles into the sinusoids. Control of
hepatic outflow has been reported at five sitest bulging
Kupffer cells (Ruttner and Vogel, 1957, cited in Elias and
Sherrick, 1969); outlet sphincters at the sinusoidal-central
vein junction {Knisely et al .. , 1948, cited in Elias and
Sherrick, 1969}, although Gibson (1959) specifically denies
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the presence of muscular sph.incters .in this locat.ion; con-
str.iction of the central veins at the entrance to larger
sublobular veins (Popper, 1931a and b, cited in Elias and
Sherrick, 1969; Elias and Popper, 1955: Gibson, 1959);
constriction of the smaller sublobular veins a.t the
entrance to the larger sublobular veins (Elias and Popper,
1955; Gibson, 1959); and annular rings of muscles at the
F-lV-IVC junction (Elias and Feller, 1926, cited in Bauer et
al., 1932: Elias and Feller, 1931, cited in Bauer et al.,
1932; Popper,1931a and b, cited in Elias and Sherrick, 1969;
Snyder, 1942; Gibson, 1959).
Immunologic reactions offer potential for the pro-
duction of autacoids because of the compounds they release
and because they may precipitate clotting reactions and
the release of compounds associated with it. Substantial
enough immunologic activity can be present in a liver to
support the presumption that enough autacoids can be re-
leased to produce an effect, and glomerular lesions may be
a side-effect of this activity. Antibodies may be produced
directly to liver antigens; antibodies may also be produced
to intestina.l antigens made available by circumvention of
the Chase-sulzberger effect and cross-react secondarily
with hepatic antigens. The portal hypertension of primary
biliary cirrhosis may be related to autacoids from
immunologic reactions.
The magnitude of immunologic reactions in a liver
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can be substantial, and a. substantial amount of immunologic
reactions provides the means for release of enough autacoids
to influence flow. The inflammation in the livers of rats
given oral doses of carbon tetrachloride can involve so
great an agtregation of macz'ophaqe.a 'that portal hyperten-
sion is hypothesized to result in part from sinusoidal
clogging (Nakata and Higaki, 1969). Kater et al. (1976)
concluded that a continuous peri.sinusoidal pattern of IgA
immunoglobins is strongly suggestive of alcoholic liver
disease. They arrived at this conclusion after treating
liver sections from 320 individuals with various forms of
liver disease with fluorescent anti-IgA antisera, and their
conclusion is supported by other observations about the
role of IgA in alcoholic liver disease. Increased IgA
levelS in cirrhotic alcoholics are reported elsewhere
(Zetterman and Leavy, 1975; Zinneman, 1975), and Ig~~ is
reported to be the immunoglobin class most increased in
alcoholic cirrhosis (Andre and Andre, 1976). Reports of
19A binding to alcoholic hyaline (Zetterman and Leevy, 1975;
Zinneman, 1975) are supportive because hyaline accumulation
in parenchymal cells is characteristic of alcoholic liver
disease. The increased incidence of glomerular lesions in
cirrhotics may be aside-effect of increased IgA formation
and subsequent antigen-antibody complex formation.
Bradfield (1974) and Andre and Andre (1976) report glomerular
lesions and deposition of 19A antigen-antibody complexes on
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the glomeruli. Bradfield (1974) theorizes that the IgA
antigen-antibody complex deposition is the result of die-
creased phagocytosis due to Kupffer cell bypass, injury,
and death and a decreased complement system: he also
theorizes that the glomerulitis associated with hyper'"
lipoproteinemia is the result of antigen-antibody complex
deposi tion on the glomeruli because the lipoprot.eins over-
whelmed the phagocytic capacity of the liver.
Antibodies may be produced directly in response to
hepatic antigens; they also may be produced in response to
intestinal antigens as a result of circumvention of the
Chase-Sulzberger effect, and these antibodies may then
cross-react secondarily with hepatic antigens. Antibodies
to specific hepatic antigens have been identified in
cirrhosis of several etiologies: alcoholic hyaline
(Zetterman and Leevy, 1975; Zinneman, 1975; Zetterman et
aL, , 1976); possibly to bile ducts (H.iller et al., 1974);
paraportal and intralobular ductules, particularly in
primary biliary cirrhosist liver-cell nuclei (Zinneman,
1975); mitochondria (Dawson et al., 1973); and altered
albumin (Zetterman and Leevy, 1975)--production of altered
albumin is a possible result of disturbed parenchymal cell
function due to the toxic effects of ethanol (Zetterman and
Leevy, 1975). Antigen-antibody activity in the liver may
also result from the cross-reactivity between hepatic
antigens and antibodies to the intestinal antigens made
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available by the circumvention of the Chase....Sulzberger
effect. Cross-reactivity has been demonstrated between
antibodies to intestinal antigens and hepatic antigens in
rabbits (Rabin and Rogers, 1976). In cirrhotics, cross-
reactivity of antibodies to enteric bacterial antigens is
suggested in the reaction to tissue (Simjee et al., 1975;
Sybran et al., 1975), RaC's (Wybran et al., 1975),
rheumatoid factor (Christian at al., 1965), and nuclei
(Simjee et al., 1975).
In a healthy individual, antigens first presented
to the body through the digestive tract will elicit a
decreased response from the immune system when subse-
quently presented by another means (intravenously or sub-
cutaniously, e.g.). This is known as the Chase-Sulzberger
effect.. It has been convincingly demonstrated in dogs
(Cantor and Dumont, 1967) and rats (Thomas at al., 1976)
and less certainly in rabbits (Ra.bin and Rogers, 1976).
Antibodies to enteric bacteria (Christian et al., 1965:
Triger et al., 1972; Wybran et al., 1975; Simjee et al.,
1975), bacterial endotoxin (Simjee et al., 1975), and
dietary antigens (Triger et al., 1972) have been reported.
in cirrhotics, and these observations strongly suggest the
Chase-Sulzberger effect has been bypassed and offers the
potential for cross-reaction with hepatic antigens.
Seven changes and conditions likely in cirrhosis
contribute to the circumvention of the Chase-Sulzberger
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effect. Ii'iret, intrahepatic shunts: cell injury and death;
perisinusoidal fibrosis~ general cell debris, antigen-
antibody complexes, and lymphocytes in the sinusoidal lumen
and the space of Disse; capillaristlltion of the einusoidsi
and hepatofugal collateral circulation all contribute to a
decreased number of and access to cells available for
phagocytosis and thereby increase the availability of bac-
terial and intestinal antigens and bacterial endotoxin to
the immune system. A second change, increased demand for
phagocytosis, detracts from the liver's normal phagocytic
functions (Cantor and Dumont, 1967: Bradfield, 1974;
Bj¢rneboe and Prytz, 1975; Simjee et al., 1975; Zinneman,
1975). A third change, intestinal ischemia, increases
intestinal permeability (Cirrincione and Francona, 1932;
Evans et a L; , 1948, cited in Bar-1Jteir and Conn, 1976;
Renert et al., 1972; Conn et al., 1972; Bar-Meir and Conn,
1976): therefore bacteria, their endotoxin, and other
intestinal antigens could be presented to the portal sys-
tem and the liver in greater-than-normal amounts, and the
need for phagocytosis is greater. The toxic effects of
endotoxin present in greater-than-normal quantities are a
fourth change circumventing the Chase-Sulstberger effect.
Salmonella enteriditis endotoxin exerts a direct toxic
effect on reticuloendothelial function of rat livers
{Ruggiero et al., 1976}; thus other endotoxins may reduce
phagocytic ability. Also, endotoxin is thought to have
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adjuvant properties because it is a lipopolysaccharide
(Simjee et al., 1975; Thomas et al., 1976) • The adjuvant
properties of endotoxin are a fifth change. Thomas et ale
(1976) speculate that the Chase-Sulzberger effect results
from depressed T-cell activity that yields little a-cell
stimulation and subsequent antibody formation. The
adjuvant nature of endotoxin is thought to permit bypass
of T-cell mediation and to stimulate a-cells directly. The
question of T-cell and a-cell stimulation may not be quite
as simple as Thomas et ale (1976) suggest, however.
Sanchez-Tapias et ale (1976) describe an increased presence
and activation of only T-cells in alcoholic hepatitis and
increased presence and activation of both T-cells and B-
cells in patients with chronic, active hepatitis and prim-
ary biliary cirrhosis. Direct ethanol poten.tiation of
lymphocytes is a sixth change. In vitro lymphocyte trans-
formation in blood from patients with chronic active
hepatitis or alcoholic hepatitis is potentiated by small,
non-toxic amounts of ethanol and acetaldehyde (the break-
down product of ethanol whose subsequent transformation to
acetic acid is the rate-limiting step in human ethanol
metabolism). When clinical and laboratory evidence of
alcoholic hepatitis SUbsides, so does the ethanol and
acetaldehyde potentiation. Potentiation does not occur
with lymphocytes from patients with fatty livers, acute
viral hepatitis, or inactive cirrhosis, however {Zetterman
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and Leevy, 1975). These observations suggest that ethanol
is causing liver damage and simultaneously may be inter-
fering with the Chase-Sulzberger effect by action on the
lymphocytes.
Primary biliary cirrhosis is primarily a disease
of older women (Baggenstoss et al .. , 1964; Kew at al .. , 1971;
Shaffner, 1975), and presents a perplexing problem to anyone
who studies portal hypertension. Autacoids offer a possible
explanation for the portal hypertension observed.. Only in
advanced stages does it resemble cirrhosis; in all but the
late stages, the evident lesion is the destruction of bile
ducts. Inflammation and fibrosis of the paraportal and
intralobular bile ductules, as well as the whole portal
tract, occurs with proliferation of bile ductules and
ductular epithelial cells within and outside the bile ducts
in the portal tracts. Often, portal hypertension is
present at this early stage (Mc.r-Jlahon, 1931; Popper and Zak,
1958; Baggenstoss et al., 1964: Zeegan at al., 1969;
Dawson et al. , 1973; Shaffner, 1975; Popper and Kent, 1975;
Bauer et al., 1976). In the late stages of the disease,
the liver becomes cirrhotic following necrosis of the
inflamed proliferating ductules and the production of septa
which radiate from the portal tracts to connect the HPV's
and ltV·s. It is surprising that portal hypertension appears
before major cirrhotic changes (Sherlock, 1959; Hoffbauer,
1960; Zeegan at al., 1969 i Kew et al., 1971 i Dal>lS0n at al.,
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1973; Popper and Kent, 1975; Bauer et al., 1976; Lebrec et
a1., 197621.). Portal hypertension may depend upon inflamma-
tion of the portal tra.cts, and this inflammation could dis-
rupt the prebiliary HA plexus and Create HA"'HPV anastomoses
(Hoffbauer, 1960) or compress and destroy portal tracts
(McMahon, 1931; Zeegan at a1., 19691 Bauer at al., 1976).
However, patients with portal hypertension are seen without
portal tract damage, HV obstruction, or sinusoidal obstruc-
tion (Rew et 21.1., 1971; Lebrec at al., 1976a). The early
appearance portal hypertension in primary biliary cirrhosis
has not been adequately explained and autacoids may be in-
volved. Primary biliary cirrhosis presents a picture of
active generalized inflammation and antigen-antibody
reactions, and the course of the disease is not correlated
with biochemical or immunologic factors {Geubel at al.,
1976}. Geubel at al. (1976) suggests that the lack of
correlation is because iromuno1ogic reactions are responses
to the disease process and not to the etiological agent.
Whether the immunologic reactions are the primary cause of
the d.isease or a reaction to the disease process is not
important because autacoids would be released by the
immunologic reactions.
Endotoxin may promote portal hypertension indirectly
through autacoids whose release it causes. Some of the
hepatic manifestations of endotoxin shock in hyperlipemic
rats result from constriction of HPV inflow, mediated by
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the alpha-adrenergic receptor (IJatour et al., 1974).
Similar results, although not as precisely defined in terms
of location and means, were obtained by Nolan a.:nd Ali
(1975) for endotoxin shock in rats with fatty livers.
McKay et a l.. (1966) observed .swelling of Kupffer cells one
hour after injection of endotoxin in pregnant rats, and
this swelling might be the result of anoxia resulting from
HPV inflow blockage. In rabbits, radioactively.... labeled
endotoxin is sequestered in the liver, spleen, platelets,
and leukocytes (Braude et al., 1955); thus three parts of
the body other than the liver have an opportunity to inter-
act \'I7ith endotoxin and release vasoactive substances, and
one, the spleen, is upstream from the liver. Endotoxin
causes aggregation of rabbit platelets and release of
seratonin (Des Prez et al., 1961). In addition, Kobold et
al. (1962) report that when endotoxin is mixed wi.th dog
blood, seratonin (pp. 75·-78) and histamine (pp. 78-88),
two vasoactive substances discussed later, as well as an
unidentified vasoactive substance are released. Thi.s latter
substance is important to endotoxin shock. Its actions are
not blocked by antagonists alpha-adrenergic, HI-antihistamine,
or seratonin. Its properties resemble those of several
kinins, a class of vasoactive substances also discussed
later (pp. 75-78). Filkins (1969b) reports that a cow~ina­
tion of plasma, platelets, and endotoxin are necessary for
the decreased flow seen in response to endotoxin
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administration to rats.. Filkins' (1969b) findings are con-
sistent with findings of Nies at al .. (1968). Nies et al.
(1968) rel?ort that in different experimental animals endo-
toxin shock is: l} monophasic, with increases in concentra-
tions of histamine parallel with the increases in the
severity of shock, and 2) biphasic, with an initial drop in
pressure which is correlated to the blood levels of kinin.
The gut can become ischemic from changes in pres-
sure and flow and may release endotoxin, seratonin, hista-
mine, and a vasodilator substance consequent to these
factors which create portal hypertension: these compounds
could disrupt hepatic flow. The portal circulation in
portal hypertension is drastically abnormal and probably
results in gut ischemia.. Portal pressure can rise so much
that the mesenteric veins become much enlarged, and the
veins in the anterior abdominal wall may carry so much
collateral flow that they bulge out in a striking and
characteristic caput medusae. The esophageal veins are
recruited to carry much of the splenic and gastric venous
flow, and they become enlarged, twisted, and vulnerable to
hemorrhage. With this much pressure in the venous drainage
system of the gut and the likelihood of open arteriovenous
shunts in its vascular bed, some portions of the gut can
be expected to have poor flow and be a little ischemic.
Considering the dynamic nature of blood flow, the whole gut
might be a little ischemic; certainly portions with signi-
ficantly reduced flow at anyone moment would be in dire
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need, actively releasing vasodilator substances.. Much of
the body's seratonin is found in the gut (Douglas,1975c).
In an ischemic gut, histamine release also seems probable
as it is found in the intestinal mucosa (Douglas, 1975b),
and is synthesized by intest.inal bact.eria (Douglas, 1975b).
It is suspected to be a vasodilator substance act.ive in
control of microcirculation (Schayer, 1962, Douglas, 1975b;
Beaven, 1976a). Kobold and ThaI (1963) have identifi·ed a
vasoactive polypeptide released by an ischemic gut which
is present in the lumen of the int.estine and dependent upon
bact.erial activity and pancreatic proteolytic enzymes.
The action of this subst.ance is similar to that. of
bradykinin and in addit.ion to the actions of histamine and
seratonin.. Their work also documents the release histamine,
seratonin, and kinins. Their experiments do not eliminate
the effects of bacterial endot.oxin; thus increased permea-
bility to endotoxins may evoke the release of histamine,
kinins, and seratonin through endotoxin-blood interactions.
The creation and release of seratonin and kinins
appears to be a likely result of antigen-antibody reactions,
generalized inflammation, and blood clotting, and because
these three conditions seem likely to be present in a
cirrhotic liver, this supports the possibility that sera-
tonin and kin ins are created and released in the liver and
contribute to local interruption to flow and portal hyper-
tension. Leukocytes (Melmon and Kline, 1967) as well as
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antigen-antibody reactions (Mias at al., 1968) and activa-
tion of the complement system (Douglas, 19750) can generate
kinins. Blood clotting is observed in a cirrhotic liver as
a result of cell injury and slow or stagnant blood flow.
The cascade of reactions in blood clotting is similar to
and interfaces with some of the reactions of kinin produc-
tion (Douglas, 1975c). Rinin production and endotoxin
shock both activate the Hageman factor (XII) of blood
clotting (Douglas, 1975c). Kinin production and clotting
may lead to seratonin release because platelets contain
seratonin (Douglas, 1975b).
A large number of polypeptides with similar
pharmacological properties are called kinins (Douglas, 1975c),
and kinins have t.he potential to be important autacoids on
the basis of their action in the liver, their production,
and the fact that the liver is not responsible for their
breakdown. Bradykinin decreases flow in an isolated, per-
fused rat liver (Filkins, 1969a) and is strongly implicated
in the initial response of the biphasic response to endo-
toxin shock in monkeys (Nies et a1., 1968). In humans,
intravenous bradykinin is associated with decreased
splanchnic resistance and no change in free or wedged HV
pressures (Feruglio at 21.1., 1964a). It is interesting that
Lukjan (1975) found a decrease in levels of kininogen (the
kinin precursor) and an increase in kininase activity in
cirrhotic patients. cell lysis results in the release of
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kininases (Douglas, 1975c). Moreover, activated Hageman
factor (XII) can initiate endotoxin shock in a prepared
animal (Latour et al., 1974) as well as initiate kinin
production (Soltay et al., 1971). Kinins have a ha.lf-life
of about fifteen seconds; they are broken down by enzymes
in the blood and lungs but not the liver (Douglas,1915c).
The short half-life, independent of good or poor liver
function, raises doubts about the suitability of kinins as
autacoids which mediate portal hypertension; however,
because hepatic inactivation is not important, a.ny k1nins
produced in the liver would survive at least fifteen
seconds--presumably enough ti.me to exert their vasoactive
effects.
Seratonin (5-hydroxytryptamine) may be an autacoid.
Approximately 90% of the body's seratonin is found in the
qut, and most of the remaining 10% is found in the plate-
lets. Metabolism in the liver and lun<;Js is important to
its disposal (Douglas, 1975b). Seratonin is released from
the plasma by endotoxin (Kobold et al., 1962) and clotting
(Douglas, 1975b). It decreases hepatic blood flow in rat
livers (Levine et al., 1964) and constricts the HPV and HA,
but not the HV in dog livers (Andrews and Butterworth,
1958). It also decreases HA and HPV flow in dogs (rc1ahfouz
and Aida, 1967). Cirrhotic rat livers show a decreased
uptake of seratonin (Ahtee et al., 1974). In cirrhotics,
platelets have a decreased content and uptake of seratonin,
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and seratonin binding to "tissue" is defective (Ahtee at a.l., ,
1974). Chiandussi et a1.. (1963) increased blood concen-
trationsofseratonin in cirrhotics by intravenous
seratonin administration, but this produced only a small
decrease in hepatic blood flow; pulmonary metabolism may
have reduced seratonin's effect in this case. Seratonin is
most likely to be released in a cirrhotic liver as a result
of clotting, but release by endotoxin and an ischemic 9ut
appear to be likely possibilities too.
Histamine. Histamine may have actions in the liver,
the splanchnic bed, and the esophagus to promote portal
hypertension and bleeding varices. These hypotheses are
little more than speculation presently, because very little
experimental work has been done to investigate them.
Histamine is readily available from hepatic tissue damage
and the stomach. The muscles around medium-sized sub-
lobular HV's and the HV-IVC junction are likely locations
for histamine action in the liver, and histamine can
easily be available to these liVeS in higher-than-normal
concentrations in a cirrhotic liver. Increased blood con-
centrations of histamine also may increase gastric and
splanchnic flows and increase flow through the submucosal
esophageal veins from dilation of esophageal smooth muscle.
As a result of these actions and several others, anti-
histamines may have important therapeutic roles.
Histamine is available to a cirrhotic liver, the
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splanchnic bed, and the eeophagus,from several sources.
Histamine is recognized as an important mediator of gastric
secretion, but its precise role is still under investiga-
tion (Douglas, 1975b; Beaven, 1976a). Regardless of its
exact interactions, it appears in the HPV during digestion
in substantial quantities. Trauma to hepatic tissue causes
histamine release from the mast cells, and the presence of
bile salts also causes histamine release (Douglas, 1975b).
As tissue injury and the presence of bile salts are to be
expected in a cirrhotic liver, local production of histamine
seems inevitable. As has been previously noted (p. 70),
intestinal ischemia increases the permeability of the gut to
intestinal contents, and this may introduce bacterially-
produced histamine. Also, histamine is stored in the
intestinal mucosa (Douglas, 1975b) and may be released as
a result of intestinal ischemia. Intestinal ischemia
releases hista.mine indirectly because of the gut's increased
permeability to endotoxin, t..rhich in turn causes histamine
release. Antigen-antibody reactions, generally (Douglas,
1975b), as well as IgE reactions that take place on the
surface of mast cells in hypersensitivity, specifically
(Beaven, 1976b), are also known to release histamine.
Seratonin has been shown to cause histamine release from
dog blood (Moore et al., 1963) and cat blood (Feldberg and
Smith, 1953).
Humans possess HV musculature in enough quantity
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around medium-sized (diameter greater than 400 microns)
sublobular veins and at the HV-IVC junction to support
speculation that HV constriction can interrupt hepatic
flow. Humans do not possess (Miyake, 1929, cit.ed by Bauer
€It al., 1932; Baueret al., 1932: Snyder, 1942; DuMais, 1944;
Elias and Popper, 1955; Gibson, 1959) the spiral muscles
present in dogs (Arey, 1941; DuMais, 1944; Thomas and
Essex, 1949; Elias and Popper, 1955) and rats (Du..l\i{ais,
1944j Thomas and Essex, 1949; Elias and Popper, 1955), and
this spiral musculature accounts for the great sensitivity
of dog livers to histamine (Arey, 1941; Thomas and Essex,
1949; Elias and Popper, 1955; Gibson, 1959). Humans have
not been thought to have enou<jh HV musculature to interrupt
hepatic flow (letter dated 12 October, 1976, from A. R.
Baggenstoss, ~1.D., Department of Pathology, ~1ayo Clinic,
Rochester, MN; letter dated 13 December, 1976, from T. B.
Reynolds, M.D., Department of Internal Medicine, University
of Southern California School of r1edicine, Los Angeles, CA);
however, Miyake (1929, cited by Bauer €It a1., 1932)
describes "substantial" longitudinal HV musculature, Snyder
(1942) describes lI much fl longitudinal and ring HV musculature,
and Gibson (1959) reports longitudinal and ring HV muscula-
ture and observes that medium-sized sublobular HV's possess
more musculature than HPV's of similar diameter. \'\iallach
and Popper (1950) describe central vein-sublobular vein and
sublobular vein-sublobular vein junctions and theorize that
62
constriction of the musculature around sublobular veins at
these locations increases resistance to flow and acts as
an important element of central necrosis in thE!! cirrhotic
process. Gibson (1959) concurs with the observations of
Elias and Popper (1955). Gibson (1959) observes that HV
musculature thins out from the HV-IVC junction and stops
abruptly with medium-sized sublobular veins and speculates
that these muscles at these junctions are the chief :HV
sphincter mechanism. Muscular rings at the HV-IVC junction
are observed in humans (Bauer et al., 1932: Snyder, 1942;
Gibson, 1959 i ~.qalker et al., 1960; Moreno et al., 1962).
These muscles in dogs are sensitive to histamine and pro-
vide a model for possible histamine action in humans.
Walker et ala (1960) report constriction of the terminal
1.5-2.0 em of the HV in dogs in response to histamine and
hepatic trauma. Bauer et ala (1932) report abolishment of
epinephrine- and histamine-induced hepatic outflow blockage
after removal of the terminal 5 cm of the intrahepatic HV
in dogs. Because the HV spiral muscles of dogs are con-
tinuous with the HV-IVC sphincter muscles (Bauer et al.,
1932), the lack of histamine sensitivity of the spiral
muscles after HV-!VC sphincter muscle excision may be
related to trauma from the removal. Moreno et al. (1962)
report constriction of HV-IVC sphincter muscles in dogs
after intrahepatic parenchymal injection of radiopaque dye
preceeded by procaine injection. This constriction was not
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the result of dye irritation of the HV vasculature, and
they postulated that the HV-IVC sphincters were stimulated
to constrict by a substance released from a "histamine-
likel! reaction evoked by local damage at the injection site.
A blood reservoir function of the liver strengthens
the argument in favor of the potential for some kind of
outflow blOCkage. A blood reservoir capacity has been
demonstrated in cats (Griffith and Emery, 1930, Green"'lay
et s.L, , 1969; Lautt and Greem'iJ'ay, 1976), dogs (Bauer et al.,
1932; Katz, 1938; Moreno, 1964; ~1oreno et al., 1967), and
in humans (Horeno et al., 19(4). In portal hypertension,
the blood reservoir controls "'Tould be pushed far beyond
their normal limits by autacoids. The probable results
would be recruitment of intrasinusoidal sinusoids and
increased lymph flow. ~Then the intrasinusoidal sinusoids
are filled and the lymph drainage capacity is surpassed,
ascitic fluid will weep from the surface of the liver and
HPV pressure will increase.
Histamine concentrations at the HV radicles of
cirrhotic livers and systemically may be qreater in
cirrhotics than in healthy individuals. Histamine presum-
ably can create an outflow blockage because it escapes
hepatic inactivation and arrives at the HV musculature. In
humans, the liver is the principle site of histamine in-
activation (Eiseman, 1962; Douglas, 1975b), the lungs are
an important secondary site (Douglas, 1975b), and enzymes
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are present in the blood (Beaven, 1976a). 11. histamine con-
centration 50 times greater than normal can enter the liver
through the HPV and result in no increase in the HV hista-
mine concentration in healthy dogs (Drapanas et al., 1965).
Histamine escapes hepatic metabolism in cirrhotics because
of decreased hepatJc function from cell injury and death and
because of extra- and intrahepatic shunting (Eiseman, 1962).
Hepatofugal collaterals and intrahepatic HPV-HV shunts
contribute to histamine appearance in the HV bed in
different ways. Extrahepatic shunting bypasses the IN's
entirely; however, int.rahepatic shunting provides a means
for histamine to escape hepatic inactivation and reach the
HV system. Moreover, as the systemic circulation acquires
greater concentrations of histamine, the Ell. will deliver
more histamine into the liver and the and HA-HPV
shunts will become more important.
The contribution of histamine to portal hypertension
and bleeding varices may go beyond that of an autacoid
constricting HV musculature. Histamine may increase flow
into the portal system and esophageal veins. Histamine
opens the human gastric oapillary bed and increases flow
(Peters and Womack, 1961), as one might expect from a
gastric secretagogue. Increased gastric flow may be a
Significant factor in the total increased f Low in portal
hypertension. Ercan and Turker (1976) describe a means by
ifJhich histamine can increase intestinal flow" They observed
8S
a small pressure drop followed by a pre.ssure increase in
the cat mesenteric circulation in response to histamine
administration. H2-antihistamines blocked the pre.asure
rise. Histamine causes a slight arteriolar constriction in
cats and arteriolar dilation in dogs, monkeys, and humans
(Douglas, 1975b). The selective antagonism reported by
Ercan and Turker (1976) is supported by Chipman and Glover
(1976) for hwnan peripheral circulation although they found
the actions of HI and H2 antagonism reversed. DeCarIe and
Glover (1974) and DeCarIe et ale (1976) report that l"dsta-
mine relaxes the esophageal smooth muscle of the oppossum,
and DeCarIe and Glover (1974) report that histamine relaxes
the esophageal smooth muscle of monkeys. Cohen and Snape
(1975) report that the H2-antihistamine metiamide increases
the lower esophageal sphincter pressure in normal,
anesthetized oppossums. SUbmucosal esophageal varices are
the veins varices most likely to hentorrhage because they
have the poorest support and are the most vulnerable to
trauma. The reports cited above suggest how histamine is
important to variceal bleeding: Increased histamine con-
centrations in the esophageal veins relax esophageal
muscle; this relaxation increases flow through the rela-
tively weak and vulnerable submucosal esophageal veins.
The greater the histamine concentrations, the greater the
esophageal muscle relaKation and the greater the flow
passing through to the deep submucosal veins.
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A number of observation.s from experiments unrelated
to control of hepatic outflow lend indirect support. to a
role for histamine in portal hypertension and variceal
bleeding. Cirrhotics have an increased incidence of ulcers
and exacerbation of ulcers (Clarke et 13.1., 195B; Douglas,
1975b). Patients who have undergone shunt surgery have
increased systemic histamine concentrations (Stopik et a1.,
1976)~ Work with dogs indicates that increased systemic
histamine concentrations are responsible for gastric hyper-
secretion after HPV obstruction (Gregory, 1957~ Gregory,
1958) and portacaval shunts (Clark et al., 1959; Silen and
Eiseman, 19591 Silen and Eiseman, 1961~ Eiseman, 1962:
Peters and Carter, 1966). Bypass of hepatic histamine in-
activation could be the common denominator between HPV
obstruction and portacaval shunting. If enough histamine
is present in the systemic circulation to create gastric
hypersecretion, two ideas seem appropriate: The increased
systemic histamine concentrations may contribute to the
decreased peripheral resistance observed as a part of the
hyperdynamic cardiovascular state present in cirrhotics.
Also, if a good deal of histamine is escaping inactivation,
histamine concentrations in the HV may be elevated and of
importance to portal hypertension. Bailey et al. (1976)
report success in the control of hemorrhage from gastric
and esophageal erosions of patients in fulminant hepatic
failure by treatment with intravenous H2-antihistamines
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(cimetidine and metiamide) .. They ascribe this success to a
decrease in gastric acid secretion, which they believe pre-
cipitated the bleeding by erosion. However, their report
does not provide critical evidence that decreased acid
secretion decreased the bleeding, and this raises the
possibility that the antihistamines decreased bleeding by
antagonism of histamine-induced relaxation of both gastric
and esophageal smooth muscle.
Histamine and antihistamines may have a number of
actions important to livers and esophageal varices. If
histamine plays an important role in the production of
portal hypertension and variceal bleeding, antihistamines
may have therapeutic value. Antihistamines, in general,
may work in the liver to decrease hepatic resistance and
cause constriction of esophageal muscle. H2-antihistamines,
specifically,. may selectively block dilation of the gastric
and intestinal vascular beds if the observations of Ercan
and TUrker (1976) and Chipman an.d Glover (1976) apply ..
Work with insulin (P. 52) raises the possibility that one
day cirrhosis ma.y be treated with HA and HP'V infusions of
hepatotropic substances. If histamine, or any other
autacoid, contributes significantly to decreased hepatic
flow, antihistamines, or other specific antagonists, wouLd
valuable adjuncts to infusion therapy because they would
open outflow and increase hepatic perfusion. In the growth
of other tissues histamine may be a hepatotropic substance
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(Douglas, 1975b). If so, this would contraindicate anti-
histamine therapy. Different histamine receptors might be
responsible for HV constriction and cell growth, however;
thus, the possibility exists for selective blockade and
stimUlation. The role of anti-histamines might be extended
to include liver transplants. Grana et al. (196B) suggest
that ischemic dog livers generate toxic products (autacoids)
that increase resistance to hepatic d.rainage. If histamine
is released by an ischemic liver, anti-histamines in the
liver perfusate would open up the hepatic circulation and
limit damaqe, The action of vasopressin may be related to
histamine actions in the liver (Refabek, 1967, p. 64).
Portal HYEotensive Act.ions of Vasop:ressin. Vaso-
pressin decreases HPV pressure in humans (Davis et al.,
1957; Schwartz €It al., 1959; Heimburger et al., 1960;
Shaldon and Sherlock, 1960: Schenck et al., 1962; Nusbaum
€It al., 196B; Barr €It al., 1975; Conn €It al., 1975; Throm-
ford and Sirinek, 1975; Sirinek et al., 1976a and b). The
portal hypotensive action of vasopressin results from a
decrease in portal flow and also may result from decreases
of HPV system and hepatic resistance.
vasopressin decreases flow into the portal system
by constriction of splanchnic arterioles and may decrease
flm.,r by closure of submucosal arteriovenous shunts. Con-
striction of the splanchnic arterioles is the mechanism
most often cited to explain vasopressin's portal hypotensive
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action. Splanchnic arteriolar constriction reduces portal
pressure because it decreases flow into the portal system,
and it reduces variceal bleeding because it reduces hepato-
fugal collateral circulation. A vasopressin-induced de-
crease in HPV flow' has been observed in dogs (Holtz, 1932;
Wiggers etal., 1946; Heimburger et a1., 1960; Drapanas
et a1., 1961; Butz et al., 1962; Peters et a1., 1962;
Feruglio et 211., 1964b; Shoemaker, 1964; Texter et a1.,
1964; Mahfouz and Aida, 1967; Cort et al., 196fb Nusbaum
et al., 1968; Hanson, 1970; Fingeroth at 211., 1973;
Skivolocki and Thromford, 1973; Wilson et 211., 1976), cats
(Clark, 1928: Holtz, 1932; McMichael, 1932; Cohen et al.,
1970; Krarup, 1975), and humans (Davis et 211.,1957;
Shaldon at al., 196121' Schenck et a1., 1962: Peruglio at
0.1., 1964b; Nusbaum at al., 1968; Barr et al., 1975; Erwa1d
et al., 1976). Vasopressin also is thought to decrease
flow into the portal system by closure of splanchnic sub-
mucosal arteriovenous shunts (Eisman et al., 1959; Johnson
et al., 1960; Edmunds and West, 1962). The observations of
Nusbaum at al. (196B) and Wilson et ala (1976) are con-
sistent with this theory.
Vasopressin is thought to decrease resistance in
the portal system and the liver. Vasopressin has been re-
ported to decrease resistance in the portal system
(Shoemaker, 1964; Texter et al., 1965) and this will
decrease portal pressure if flow does not increase.
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Aronsen and Nylander (19661» present angiograms of dogs to
substantiate their claim that vasopressin dilates the extra-
hepatic HPV. That vasopressin may decrease intrahepatic
resistance is suggested without experimental evidence by
some authors and in conjunction with experimental evidence
by others. Butz at ale (1962) transposed the HV and IVC
in dogs so that the splanchnic drainage did not flow through
the liver. In these dogs, hepatic resistance decreased in
livers treated with vasopressin. Reduction of resistance
could result from HPV dilationJ alternatively, it could
involve a mechanism suggested by the work. of Holtz (1932).
Holtz (1932) observed a decrease in hepatic resistance in
dog livers treated with either vasopressin or oxytocin.
When the 5 mni of the av closest to the IVC was excised,
effects ',..lare abolished. McMichael (1932) observed a
vasopressin-induced decrease in HPV pressure in cats with
the superior mesenteric artery clamped and concluded that
intrasinusoidal resistance had decreased. He speCUlated
that presinusoida1 arterioles which qovern the flow into
the HA-HPV shunts had been constricted and decreased flow
into the HPV. Although the prebiliary capillary plexus is
a suitable vascular bed for his theory, his conclusions
must be considered tentative because he measured only
carotid artery HPV pressures, and a clamp on the superior
mesenteric artery did not allow him clean separation of
splanchnic and hepatic actions. Eiseman et ale (1959)
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suggest that vasopresain relaxes contractile elements in
the outflow control of the liver but offer no experimental
data or citations. Because Boltz (1932) is cited else-
wher'e in the paper, the lack of a citation may be an oromie-
sion. Kessler (1968) and Rab~l et a1. (1976) worked with
cirrhotics. Both state, without explanation, that vaeo-
pressin decreases hepatic resistance. Rabj2S1 et al. (1976)
refer to "transinu6oidal resistance f ' and Kessler (1968)
states that vasopressin works on the hepatic vasculature.
Hanson (1970) states that vasopressin reduces hepatic
resistance and cites Kastens and Haxhe (1966). vasopressin
also could decrease intrahepatic resistance through antagon-
ism of histamine, if histamine plays a role in portal
hypertension. Re~abek (1967) observed both therapeutic
and prophylactic antagonism of histamine-induced hypoten-
sion by intravenous vasopressin infusions in rats and
guinea pigs. Vasopressin may antagonize the actions of
histamine, because it acts directly on the contractile ele-
ments of smooth muscle (Brazeau, 1975). On the other hand,
rJlah f ou z and Aida (19(1) report a vasopressin-induced
increase in hepatic resistance in dog livers.
Intrahepatic Actions of Adrenergic !\'J;r~onigts.
Hepatic inflow appears to be under alpha-adrenergic control.
Work th isoproterenol, a beta-adrenergic agonist, and
epinephrine suggests that hepatic outflow is under beta-
adrenergic control. Both isoproterenol and vasopressin
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appear to be able to decrease hepatic outflow resistance.
Hepatic inflow appears to be under alpha-adrenergic
control. Greenway et al. (1967) observed that hepatic nerve
stimulation in cats increased HPV pressure and was blocked
by the alpha-adrenergic. antagonist phenoxybenzamine.
Latour et al. (1974) found inoreased HPV pressures in
hyperlipemic rats subjected to endotoxin shock by injection.
When the livers were sectioned after India ink injection.s,
Latour et al. (1974) found carbon particles only in the
portal tracts. Pretreatment of the rats with phenoxybenz-
amine resulted in decreases of BPV pressures before endo-
toxin injection and prevented endotOJdn-induced liPV pressure
inoreases; moreover, carbon particles could be found through-
out the liver. Friedman et al. (1951) report that
dibenamine, another alpha-adrenergic aota<1onist, dilates
canine liPV and HV systems constricted in response to
hemorrhagic shock. Daniel and Pritchard (19S1b) observed
constriction of intrahepatic lIP'! branches in response to
epinephrine and hepatio nerve stimulation in dogs, cats,
rats, and monkeys in angiograms. Their observations
coupled with the observations of Greenway et al. (1967)
strongly suggest that the alpha-adrenergic receptor con-
trols HP'! constriction in the oat. The work of Latour et
al. (1974) strongly implies that rat HPV systems have
similar nervous controls. Because HPV constriction has
been observed to be related to alpha-adrenergic action in
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several animals by different investigators, one is lead to
suspect that the same controls exist in humans.
Isoproterenol appears to decrease hepatic resist-
ance, particularly hepaticoutflo,"l resistance. Didichen
and Schenck (1970) report a decrease in hepatic resistance
concurrent with an increase in mesenteric blood flow in
dogs given isoproterenol intravenously. Butt: et al. (1962)
report an isoproterenol-induced decrease in hepatic
resistance in dogs subjected to an infrahepatic portacaval
t.ransposition. Schon and Labat (l971) perfused isolated
dog livers with isoproterenol at constant pressure and
observed a statistioally significant increase in SA and
HPV flows and a statistically significant decrease in lymph
production. The decrease in liver weight was below the
level of statistical significance (T-test, p 0.8): however,
they perfused the livers in a plastic bag and weighed them
on a tray suspended from a balance. Fluid trapped in the
bag or on the tray may have influenced their resul t8. In
view of the nearly significant values reported and the sus-
pected imprecision of weight determination, one cannot con-
clude that isoproterenol did not decrease liver weight.
Taken collectively, the increases in flows and decreases
in lymph production, and probably weight, strongly suggest
that isoproterenol reduces outflow resistance.
Epinephrine appears to be able to decrease hepatic
outflow resistance and dilate the sphincters at the HV-IVC
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junction. Epinephrine pretreatment prevented constriction
of the HV-IVC sphincter observed by Moreno at aL, (1962, p.
58) and allowed unrestricted drainage. In addition, in two
dogs subjected to some extra "stress tt , drainage of the dye
was unrestricted. Their postulation of a t'histamine-like"
reaction (p. 83) prompts comparison of their observations
with the observation or Andrews et al. (1955) that epine-
phrine antagonizes the action of histamine in dog livers.
Bauer et aI , (1932) observed that a 10\1'3 concentration of
epinephrine decreased HPV pressure and liver volume concur-
rent with an increase in outflow. After removal of the
5 nun of the HV closest to the Ive, similar concentrations
caused a weak increase in HPV pressure and an increase in
liver volume. A high concentration of epinephrine increased
HPV pressure and liver volume while decreasing outflow. An
intermediate concentration increased portal pressure and
decreased liver volume. In cat and rabbit livers, low
concentrations of epinephrine decreased liver vo-Lume and
increased outflow, and high concentrations increased liver
volume and decreased outflow (Deysach, 1941). Andrews at
al. (1955) reported reduced HV outflow in dog livers per-
fused with high concentrations of epinephrine and low
concentrations either reduced or increased flow. Liver
volume increased with high concentrations and decreased with
intermediate and low concentrations.
HV constriction in response to beta-adrenergic
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stimulation does not appear to be of major importance in
dogs. Constriction becomes important only with high epine-
phrine concentrations, for the contractions in response to
small and intermediate concentrations are not evident until
the action on the HV-IVC sphincter is eliminated. Both
Bauer et al. (1932) and Andrews et ala (1955) reported HV
dilation with small and intermediate concentrations and HV
constriction with high concentrations. The contractions of
the flV system in response to low and intermediate concentra-
tions of epinephrine presumably are overshadowed by the
dilation of the HV-IVCsphincters (Bauer et al., 1932).
This suggests that the muscles that constrict in response
to low concentrations are found deep to the MV-IVe
sphincters, contract weakly, and do not control resistance
ordinarily. Longitudinal muscles around the larger BV
channels seem suitable candidates, and they are also found
in human livers (Miyake, 1929, cited by Bauer et al., 1932;
Snyder, 1942; Gibson, 1959).
Isoproterenol and vasopressin both may decrease
hepatic outflow resistance. Isoproterenol and vasopressin
have been used in combination to decrease HPV pressure in
dogs (Skivolocki and Thromford, 1973; Sirinek and Thromford,
1974; Sirinek et al., 1976b) and in humans (Sirinek and
Thromford, 1975). This combination is particularly
interesting because HPV pressure is selectively decreased
while the cardiovascular side-effects of both appear to be
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cancelled. Vasopressin alone decreases cardiac output and
increases peripheral resistance, and isoproterenol alone
increases cardiac output and decreases peripheral resist-
ance. That these cardiovascular side-effects are cancelled
is significant. It ia even more significant that a
decrease in SPV pressure occurs while an iaoproterenol-
induced increase in mesenteric flo\4 is in competition with
a vasopressin-induced decrease in mesenteric flow. If
isoproterenol and vasopressin both decreased intrahepatic
resistance, this could account for the decrease in H:PV
pressure.
The observations of the actions of the isoproterenol-
vasopressin combination and the work of Holtz (1932) sug-
gest vasopressin dilates the HV-IVC sphincter. Holtz (1932)
observed that pituitary extract, a combination of vaso-
pressin and oxytocin, decreased HPV pressure and liver
volume and increased outflow in dog livers. 'r'he effect was
abolished when the 5 rom of the HV closest to t.he IVC "las
removed. Curiously, Holtz (1932) found that. oxyt.ocin was
20 times more potent than vasopressin in this respect.
Oxytocin therefore dilates a sphincter that also may be
dilated by epinephrine and very possibly by beta-adrenergic
action.. It is pUZZling that Holtz (1932) found oxytocin a
more pot.ent element of pituitary extract than vasopressin
because vasopressin dilation of the HV-IVC sphincter is
suggested by other work. Additional experiments identifying
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the intrahepatic actions at vasopressin and oxytocin would
appear to be profitable because vasopressin dilation of the
HV-IVC sphincters could be a common denominator between
vasopressin and isoproterenol and could antagonize the
action of histamine at this location. Other HV segments
also may be dilated by vasopressin and isoproterenol.
If vasopressin and isoproterenol have similar effects
on the same anatomic structure, they also might have a com-
mon biochemical mechanism, but neither glycogenolysis nor
the intracellular intermediate 3'-5' cyclic adenosine
monophosphate appear to be potential common mechanisms for
isoproterenol and vasopressin. The beta-adrenergic recep-
tor is believed to responsible for glycogenolysis in the
liver, but the evidence is incomplete (Innes and Nickerson,
1975). vasopressin stimulates hepatic glycogenolysis in
dogs (Bergen at al., 1960) and rats (Kirk and Hems, 1975;
Keppens and DeWulf, 1975). The ability of glycogenolytic
substances to dilate portal venules, sinusoids, sphincters,
central veins, and hepatic arterioles in the rat is
directly related to glycogenolytic activity (McCuskey,
1966). Speculation about glycogenolysis and HV-!VC
sphincters dilation seems inappropriate in view of the
actions of Beratonin. It promotes glycogenolysis also
increases hepatic resistance to flow in rats (Levine et al.,
1964). 3'-5' cyclic adensosine monophosphate does not
appear to be a common denominator for isoproterenol and
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vasopressin either. 3'-5' cyclic adenosine monophosphate
has been postulated as a common denominator for vasopressin
and isoproterenol actions in rat kidneys (Levi et al., 1971).
In humans , 3' -5' cyclic adenosine monophosphate has been
linked to the ADH action of vasopressin (Brazeau, 1975) and
to the action of the beta-adrenergic receptor (Koelle, 1975).
In addition, adenosine nucleotides, especially 5'-adenosine
triphosphate (a breakdown product of 3'-5' cyclic adenosine
monophosphate via the enzyme phosphodiesterase) and S'-
adenosinediphosphate have been shown to dilate hepatic
arterioles in rats (McCuskey, 1966). However, Jard and
Bockaert (1975) state that the production of 3'-5' cyclic
adenosine monophosphate and biological activity are not
always parallel in mammals, and two studies have shown that
vasopressin does not produce an increase in 3'-5' cyclic
adenosine monophosphate when perfused through rat livers
(Kirk and Hems, 1974: Keppen.s and DeWulf, 1975).
Control of the Hepatic Blood Reservoir. Alpha-
adrenergic mediation of strong constriction of the HPV and
constriction of the HV and beta-adrenergic mediation
of strong dilation of the HV suggest different functions
for different hepatic sphincters and a control system for a
hepatic blood reservoir. The controls hepatic blood reser-
voir sted would be beneficial in times of hemorrhage
t d 'N.e ab l.e to account for the regulation ofs ress an JL.. uJ,
venous return in conjunction with breathing that is
observed. Moreno (1964) and More··n·o ~t· 1v a. (1961) demon....
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strate and discuss the liver's role in the regulation of
venous return in healthy humans and dogs (p. 52). Gibson
(1959) states the human HV-IVC sphincters appear sub-
stantial enough to control venous return during heavy
breathing but adds, !t ••• the amounts seem smaller than would
be expected if their actions played a part in the dailY
economy of the body." The controls discussed also would be
beneficial in times of hemorrhage and stress because they
would reduce the relatively non-essential splanchnic and
HPV flows, mobiliz·e blood in the liver fo·r the rest of the
body from the intrahepatic HPV and BV systems, drain some
of the fluid from the extracellular spaces, and possibly
reduce circulation to the periphery of the liver. These
controls are consistent with the hypothesis of Moreno et al.
(1962) that epinephrine opens the liver for the release of
blood.
HPV constriction decreases hepatic flow indirectly
through a feedback system that influences splanchnic resist-
ance, and this can work in concert with the hypothesized
controls of the hepatic blood reservoir. Portal resistance
is so small in comparison to splanchnic resistance that
splanchnic resistance should be considered the regulator of
hepatic inflow in dogs (Mitzner, 1974b), cats (Greenway et
al., 19(7), and presumably humans. Mitzner (1974b) re-
ported that increased HPV pressure in dogs increases splanchnic
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resistance. nis hypothesis for control of HPV flow can be
blended with the observation of the actions epinephrine and
hepatic nerve stimulation: In times of hemorrhage Or stress,
\llhen epinephrine release and hepatic nerve stimulation may
be assumed. to be present, HPV constriction from epinephrine
or nerve stimUlation will reflexly discourage flow through
the relatively non-essential digestive tract. HPV flow
decreases with epinephrine-induced increases in HPV pressure
have been observed in dogs (Bauer, et al., 1932: Hoffbauer
and Bollman, 1950; Daniel and Pritchard, 1951b: Shoemaker,
1964) and Cats (IvicMi chae 1 , 1932). Epinephrine-induced
increases in HPV resistance have been reported in dogs
(Bauer et al., 1932; Butz et al., 1962: Shoemaker, 1964),
and the hepatic nerve-induced increases in pressure have
been reported in dogs (MacLeod and Pierce, 1914; Edmunds,
1915; Bauer et al., 1932; Daniel and Pritchard, 19510:
Greemvay et al., 1967; Greenway et aI., 1969). Increased
HPV pressure, which reflexly increases splanchnic resist-
ance and decreases IlPV flow, also can mobilize fluid from
the extracellular spaces and blood from the sinusoids.
The reflexly decreased HPV flow should lower sinusoidal
pressure and effectively drain some of the extracellular
fluid; thus stored plasma is mobilized to return to the
systemic circulation. Also, a decreased capillary pressure
may decrease the number of sinusoids recruited to handle
flow (Brauer et al., 1953, p. 29; Mitzner, 1974a, p. 29);
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this, also effeotively drains blood from the liver. The
result of UPV oonstriotion for the cardiovascular system is
an increase in blood volume, a partial bypass of the
splanchnic bed, and increased venous return.
Regulation of hepatic flow by a feed back on
splanchnic resistance rather than through changes in hepatic
resistance seems probable for three reasons. Because of the
substantial surface area of the splanchnic bed, a small drop
in pressure could move a great quantity of fluid out of the
capillaries into the systemic circulation thus pressure-
maintenance mechanisms are required (Mitzner, 1974b). If
hepatic resistance controlled hepatic flow, increased hepa-
tic resistance without feedback on splanchnic flow could
pool a great quantity of blood in the splanchnic bed,
because no major alternative routes exist for bypassing the
liver in a healthy individual (Mitzner, 1974b). Observa-
tions of reciprocal reticuloendothelial system function
bet"leen the spleen and the liver fit with Ravenna IS (1940)
theory and Mitzner's (1974b) report about the interplay
between HPV pressure, splenectomy and splanchnic resistance
(p. 46). Esophageal varices and the collateral circulation
may be the partial result of enough increase in hepatic
resistance to influence hepatic flow and to overload the
lymph system.
A decrease in hepatic outflow resistance can
mobilize fluids from the extracellular spaces, mobilize
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'blood from the sinusoida, and provide a more direct route
to the systemic circulation than the lymph system for
glucose and plasma proteins during times of hemorrhage or
stress.. Epinephrine decreases liver volume in dogs
(Edmunds, 1915; Bauarat al., 1932; Andrews at al., 1955)
and cats (Clark, 1928; McMichael, 1932). Decreased liver
volume is also observed in response to hepatic nerve
stimulation in dogs (Bauer at al., 1932) and cats
(Griffith and Emery, 1930; Greenway et al., 1967; Greenway
et al., 1969). It is reasonable to assume that epinephrine
and hepatic nerve stimulation have similar actions on the
HV system because they act similarly in the HPV system.
Reduced outflow resistance and consequently sinusoidal
pressure result in a net movement of extracellular fluid
back into the sinusoids and, therefore, back into the
systemic circulation. Also, a decreased pressure may
decrease the number of sinusoids employed to handle the
flow (Brauer et al., 1953, p. 29; Mitzner, 197 4a, p , 29)
and thus the volume of blood in the liver. Glucose from
epinephrine-induced hepatic glycogenolysis and plasma pro-
teins can be important as osmotically-active compounds
available to maintain plasma volume; they also play
important roles individually: Glucose as an energy source
and plasma proteins in immune responses and clotting. As
decreased sinusoidal pressure presumably increases HV flow
at the expense of lymph flow, more glucose and plasma
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proteins reach the systemic circulation via venous drain-
age, a quicker pathway than lymph drainage. The conse-
quence of decreased outflow resistance for the cardiovascu-
lar system is an increased cardiac output subsequent to
increased venous return and blood volume from the mobiliza-
tion of fluid and proteins from the extracellular spaces
and of blood from sinusoids.
Blood may be mobilized from intrahepatic blood
vessels by the constriction of muscles around capacitance
vessels of the HPV and HV systems. Greenway et al. (1967)
suggested that hepatic nerve stimulation decreases liver
volume by constriction of capacitance vessels. Friedman et
al. (1951) report that dibenamine, an alpha-adrenergic
antagonist, dilates canine HPV and HV systems constricted
in response to hemorrhagic shock. This is exactly the
response one would predict from this hypothesis of hepatic
flow control. Two previously discussed studies support
these observations (Bauer at a1., 1932, p. 66; Daniel and
Pritchard, 1951a, p. 65). Constriction of HPV and nv
capacitance vessels, both HPV and HV, provide the cardio-
vascular system with an increased venous return and blood
volume, which increases cardiac output. The HPV constric-
tion may increase HPV pressure and ref.lexly increase
splanchnic resistance, resulting in a partial bypass of
splanchnic perfusion.
In rats, cats, and monkeys, hepatic nerve
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stimulation occasionally create a restricted intrahepatic
circulation (Daniel and. Pritchard, 1951b). Serial antio-
grams show a marked decrease in peripheral hepatic perfu-
sion and a shorter transit time. This streamlined hepatic
flow, presumably available to the liver in times of
hemorrh.age and stress, maintains high UPV pressure. This
keeps splanchnic resistance high, which diverts flow away
from the relatively nonessential splanchnic vascular bed
and decreases the time and volume of blood involved in
hepatic perfusion. The cardiovascular system receives an
increase in venous return and responds with an increased
cardiac output. Gibson (1959) discounts the Lmporcenoe of
this restricted circulation on an anatomical basis.
Different functions for different portions of the
HV syscem are suggested by the observations of several
investigators and the hypotheses of control of the hepatic
blood reservoir. Apparently, the sublobular veins that
control drainage from central veins and other smaller sub-
lobular veins control sinusoidal drainage and pressure.
The larger sublobular veins, the collecting veins, and the
HV'e; are capacitance vessels, and their capacity is regu-
lated in part by their longitUdinal muscles. The HV-!VC
incters control the drainage from the capacitance
vessels. During hemorrhage or trauma, one would expect the
smaller sublobular vein muscles to dilate in response to
initial low concentrations of inephrine and mobilize fluid
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from the extracellular spaces and blood from the sinusoids.
Constriction at higher concentrations of epinephrine and
greater levels of nerve stimulation (Bauer et al., 1932, p.
94; Deysach, 1941, p. 94r Andrews et al., 1955, p .. 94)
should increase sinusoidal and HPV pressure. The observa-
tions of central necrosis as an agonal change (Popper, 1949)
and sublobular vein constriction as its cause (Wallach and
popper, 1950) are consistent with the hypothesis that
sublobular vein musculature can control sinusoidal pressure.
Weak constrictions of the larger sublobular veins, the
collecting veins, and HVls are well-suited to the task of
mobilization of stored blood without an increase intra-
sinusoidal pressure (Bauer et aL, 1932, p. 94) .. In times
of hemorrhage and stress, weak contractions would increase
outflow without interferring with the decrease in sinusoidal
pressure necessary to recruit plasma and blood from the
sinusoids. During the initial stages of hemorrhage and
stress, low concentrations of epinephrine and 10\<1 levels of
hepatic nerve stimulation would dilate the HV-IVC sphinc-
ters, constrict the HV capacitance vessels (Bauer et al.,
1932, p. 94), and thus facilitate the mobilization of hepa-
tic blood. As epinephrine concentrations and the level of
nerve stimulation increased, the HV-IVC sphincters would
constrict; they could constrict enough to influence HPV
pressure (Bauer et 13.1., 1932, p. 94). It would be
advantageous to have the rrv-IvC sphincters able to influence
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HPV pressure. The immediate post-sinusoidal musculature
would be subject to locally high concentrations of vaso-
dilator autacoids released by ischemic cells. Autacoids
in lower concentrations would reach the HV-IVC sphincters
due to dilation. As a result, the IiV-IVC sphincters would
be less sensitive to ischemia and better able to maintain
high HPV pressure in the face of a prolonged need to divert
flow from the splanchnic circulation.
The hypotheses of alpha-adrenergic control of HI'V
constriction and weak constriction of the HV, and bata-
adrenergic control of the dilation of the HV system are not
consistent with everything that is known about the control
of hepatic flow. Innes and Nickerson (1975) report that
epinephrine increases splanchnic flow in humans. This con-
tradictien to the hypothesis presented may be the result
of some elemental disagreement between the hypothesis and
fact, or the contradiction may be the result of a particu-
1ar concentration of epinephrine and really no contradic-
tion at all. Also, any hypothesis of hepatic flow control
that involves only adrenergic neurotransmitters offers a
simplistic explanation at best.
Vasopressin Research. Research with vasopressin is
concerned with the search for a vasopressin analogue that
possesses all no undesirable side-
of " • i· ··t t't.s and with the techniques of vaaopreas.an acnum s z at.a.on ,
tura et a1. (197 and b) fferent vasopressin and
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oxytocin receptors in different areas of the rat's body,
and this is the theoretical basis fOr research with vaso-
pressin analogues.
Amino acid-substituted vasopressin analogues offer
an altered three-dimensional compound. The prototype of a
vasopressin analogue with an altered structure and differ-
ent actions is oxytocin, which has quite different actions
from vasopressin but differs only by substitution of two
amino acids. At the number three position, vasopressin has
phenylalnine, an amino acid with an aromatic ring attached
to the backbone structure by a CH2, while oxytocin has
isoleucine, with a four-carbon side-chain in an iso con-
figuration. At the number eight position, oxytocin has
leucine, which possesses a four-carbon side-chain different
from isoleucine only in the configuration of its side-
chain, while vasopressin has agrinine, a basic amino acid
with a long side-chain of carbon, hydrogen, and nitrogen
molecules.
The three-dimensional structures of oxytocin and
vasopressin are similar. According to Jard and Brockaert
(1975), oxyt.ocin and lysine vasopressin have t.wo beta-
turns. One beta-turn includes the number seven through
number nine amino acids1 the second beta-turn is wit.hin the
ring and includes the number two through number five amino
acids. Jard and Dockaert (1975) also state that in oxytocin
and vasopressin hydrogen bonds exist between the nitrogen
lOB
of the number nine amino acid and the carbonyl oxygen of
the number six amino acid, and between the nitrogen of the
number five amino acid and the carbonyl oxygen of the
number two amino acid. Additionally, in oxytocin, a third
hydrogen bond exists between the nitrogen of the number
eight amino acid and the carbonyl oxygen of the number five
amino acid, and the phenyl group of the number two amino
acid (tyramine) is folded over to lie in the same plane a.s
the ring of amino acids. Jard and Bockaert (1975)
acknowledge that the three-dimensional descriptions pre-
sented above may not be pres.ent in the body because they
were determined in test solutions different from the solu-
tions encountered in the blood. (The three-dimensional
structure of proteins can be different in solutions of
different ionic composition.) Brazeau (1975) states that
the disulfide bond and the exact size of the ring are
essential to the activity of the vasopressin nonapeptide.
Jard and Bockaert (1975) state that the disulfide bond, the
two beta-turns, and the hydrogen bonding between the amino
acids at position five and position nine are important to
the activity of oxytocin and vasopressin.
The effects of a number of different amino acid sub-
stitutions have been studied. Brazeau {1975} states that
removal of the number nine amino acid, glycine, totally
inactivates vasopressin. He also states that deamination
of that glycine results, not in inactivation, but in
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increased ADH actiVity~ that the basisity of the number
eight amino acid is important to the ADH activity; and the
length of the side-chain on the number eight amino acid,
but not its composition, is an important factor to
oxytocin. Altura (1975a) states that for vasopressin's
pressor activity and binding, an aromatic side-chain,
rather than an open-chain compound, is needed on the number
three amino acid. He further states that the number two
position needs a phenol side-chain, especially its hydroxyl
group, for binding and pressor activity. Jard and Bockaert
(1975) state that the hydroxyl group on the number two
amino acid in vasopressin is fundamental to its binding
ability but less important to its ability to stimulate.
They also state that, in the number eight posit.ion in
vasopressin, the d-isomers of lysine and arginine have
greater ADH and pressor activities than their respective
I-isomers and that substitution of the amion acid threonine
for glutamine at the number four position in vasopressin
and oxytocin increases ADM activity and decreases pressor
activity ..
No vasopressin substitution analogue has been
able to control HPV pressure and bleeding without deleter-
ious cardiovascular side-effects. The vasopressin analogue
phenylalanine2-lysineB vasopressin (called felypressin
[Brazeau, 1975] or octapressin [Feruglio, 1964b]) is an
example of a vasopressin substitution analogue. It has a
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greater pressor activity than ADH activity (Tsa1ta.r4~ dt·
r... ...""... al. ,
1964; Schwartz, 1970; Brazeau, 1975). Tsakaria et ale
(1964) report no deleterious cardiovascular side-effect.s
with it.. Feruglio et a1. (1964b) report increased sys-
t.emic blood pressure; and, Segel et. ale (1963) found in-
creased systemic blood pressure and decreased cardia.c out-
put, heart. rate, and stroke volume as welL Brazeau (1975)
report.s no cardiac effects.
Triglycyl vasopressin is an example of the ot.her
major form of vasopressin analogue under study, amino acid-
addition a.nalogues. Triglycyl vasopressin is a vasopressin
nonapeptide with a triglycyl peptide attached to the number
one amino acid. This tripeptide endows the compound with
~ vprolonged action (Rezabek, 1967; Cort et al., 1968; Ryncl
et al., 1974: Aronsen et al., 1975) by virtue of the slow
release of the vasopressin nonapeptide by enzyme action
(Aronsen et al., 1975). In dogs treated with triglycyl
vasopressin, no cardiac arrythmias or decreases in cardiac
output were observed, in fact, cardiac output increased pre-
sumably due to increased venous return (Cort et al., 1968).
Reports with human subjects sound promising. Cirrhotics
with bleeding varices have been treated successfully with
triglycy1 vasopressin (Aronsen, 1972) and triglycyl-1ysine8
vasopressin (Aronsen et al., 1975), and cardiac arrythmias
1i/,rere not observed.
Because no vasopressin analogues have been reported
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to have significantly different. actions and to minimize
confusion, all compounds used in research cited in this paper
are referred to as vasopressin, whether the compound was
vasopressin, a crude e:Ktract thought to be vasopressin, or
a vasopressin analogue.
The techniques of vasopressin administration also
have been studied. The choice of bolus injection or con-
tinuous infusion, intravenous versus superior mesenteric
artery infusion, and adminiseration of high or 10Vl concen-
trations of vasopressin have been stUdied. Thromford and
Sirinek (1975) compared the responses of patients to a
bolus injection of 15 units of vasopressin over five minutes
to the responses of patients given 40 units of vasopressin
intravenously over the course of an hour. Curiously,. in
the first 15 minutes, less vasopressin had been administered
by continuous infusion than by bolus injection, but the
reduction in Hl'?'V pressure was greater. Continuous infusion
also reduced HPV pressure for a longer time, reduced
cardiac output for a shorter time, and caused less abdominal
pain and substernal discomfort. Barr €It al. (1975) tested
two different and important ideas about vasopressin therapy.
In dogs, superior mesenteric artery and intravenous infu-
sions were compared with a standard dose, similar to a
human dose, and one-fifth of the standard dose. Inter-
estingly, no difference was found between the results of
the superior mesenteric artery and intravenous infusions on
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cardiac output, systemic blood pressure, HPV pressure, UPV
flow, and superior mesenteric artery flow. Even more in-
teresting is the observation that a reduction of the dose
to one-fifth the original cuts the deleterious cardiovascu-
lar effects by a greater amount than the decrease in
superior mesenteric artery flow and the decrease in HPV
pressure. Johnson et al. (1977) conducted a prospective,
randomized clinical trial of intravenous and superior mesen-
teric artery vasopressin administration to alcoholic cirrho-
tic patients for control of variceal bleeding. They ob-
served no significant difference between the ability of
the two methods of administration to control bleeding but
did observe a significantly greater number of complications
(catheter-related and cardiac) among the patients treated
by superior mesenteric artery infusion. On the basis of
their observations, they conclude intravenous vasopressin
is a preferable method of administration to superior
mesenteric artery infusion.
Nusbaum and Conn (1975) hypothesized about the
creation of the side-effects of vasopressin administration.
After analyzing the data presented in two other papers
(r'1i11ette at al., 1975; Sirinek and Thromford, 1975), they
suggested that individuals respond to vasopressin by
either large portal effects relative to cardiovascular
effects or vice versa. These two responses occur in a
ratio of 1: 1. Ackncrtdedging it as a l'I flimsy hypothesis"
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needing investigation,. they propose that the amount of
liver bypass through portal-systemic shunting is an
important factor determinln.g the relative amount of oardlo-
vascular response to vasopressin-M,the greater the proportion
of shuntlng, the greater the proportion ofcardiovasoular
effects to portal effects. Nusbaum and Conn (1975) dld not
mention intrahepatic shunting, capillarlzatlon of the
sinusoida, and liver cell damage, but these factors also
would appear to be important. This hypothesis of t'~usbaum
and Conn (1975) may involve a mechanism other than splanchnic
arteriolar constriction for vasopressin action on SPV
pressure. Hepatic bypass from portal-systemic shunting
may be important primarily because it bypasses intrahepatic
effects of vasopressin. The result is the same, relatively
increased cardiovascular effects, but the reason is
because fewer intrahepat.ic actions are possible. Both
hypotheses lack experlmental data and need testing.
Conclusions. Conclusions can made about the role
of different factors in portal hypertension, the role of
different factors in esophageal variceal formation and
hemorrhage, the various possibilities for histamine action
in portal hypertension and variceal bleeding, and about
the different actions of vasopressin.
Dif factors that promote portal hypertension
are important at different times during the progression of
1 hypertension in cirrhos all of these factors
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are not necessarily present in eve.ry case of cirrhosis.
Three time periods. can be hypothesized. In the earliest
stage, portal hypertension is promoted by three factors
that cpez-at;e within the normal hepatic architecture. An
intermediate stage is recognizable by the emergence of
factors that operate above the sinusoidal level. At this
intermediate stage, factors of local importance. work with
factors that act on a larger scale to create resistance to
hepatic flow, but no major changes are present in the
hepatic arChitecture. The final stage can be characterized
morphologically from major interruptions of the liver
architecture (isolation of healthy cells within broad bands
of connective tissue). These changes mark the emergence of
intrahepatic shunting and the compression of HV radicles as
major factors in the production of portal hypertension.
The earliest stage of portal hypertension is the
result of swollen cells, RaC's, leukocytes, and clotting
occluding the sinusoidal lumen and local constriction of
sphincters. Swollen parenchymal, Kupffer, and endothelial
cells are often present and are known to be capable of
increasing HPV pressure. Cell swelling can be due to
accumulation of substances in healthy cells or occur just
before cell death. As the lumen of the sinusoids narrows,
RBC's and leukocyt.es may stack up and further block flow.
Cell death can also draw leukocytes to the area. Clotting
seems a probable accompaniment to stagnant flow and cell
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death. Cell injury and death, leukocyte-cell interactions,
and clotting may release autacoids that could cause local
sphincter constriction a.nd further flow decreases.
Increases in pressure in this early stage are probably
dampened by local increases in hepatic and HPV system lymph
production, recruitment of unused sinusoids, and HPV
vascular compliance both intrahepatically and extrahepa-
tically. The changes of the early stage are important to
portal hypertension because they reduce the liver·s capacity
to compensate for the effects of other factors, later. In
addition, local degeneration of sinusoids will give rise to
the later major architectural changes.
Although these cases are rare, full-blown cases of
portal hypertension and esophageal varices can occur with-
out changes in the hepatic architecture as a result of
cell swelling, fibrous tissue deposition, a combination of
the two, or from increased flow into the HPV. This kind of
cell swelling or fibrous tissue deposition differs from
that which works in concert ",lith other factors because it
occurs diffusely throughout the liver and not in patches
as it does in cirrhosis. Increases in HPV flow alone may
result in portal hypertension and varices, usually this is
the result of an arteriovenous fistula draining directly
into the HPV. This, too, does not qualify as an ordinary
case of portal hypertension and varices. Autacoids could
be working unrecognized in concert with cell swelling and
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fibrous tissue deposition when they produce portal hyper-
tension. Autacoids may also ",lork alone to produce porta..l
hypertension, as Was hypothesized earlier (pp. 1:2-13) for
the portal hypertension of prima.ry biliary cirrhosis.
In the intermediate stage of portal hypertension of
cirrhosis, factors other than local ones become important,
and the changes of the final stage are not yet prominent.
The important factors are intrahepatic shunting, the
inability of the lymph system to increase hepatic drainage,
autacoidal factors, and increa.sed flow into the HPV.
Intrahepatic shunting increases HPV pressure by bypassing
the pressure drop offered by capillaries (HA-IiPV, rL"\.-HV, and
HPV-EV)~ increasing the HV pressure (HA-ID! and HPV-HV) and
providing easy comrnunication for the increased HV pressures
to the HPV (HPV-HV), and from contraction of the connective
tissue surrounding shunts--connective tissue which arises
from recent synthesis and from the collapse of the stroma
around ehunt.s , Lymph flot4 becomes a factor in the inter-
mediate stage, not because it actively contributes to portal
hypertension, but because it has reached the limit of its
capacity to oppose it. Later, ascites will signal the fact
that sinusoidal pressure has increased lymph production to
such a level that lymph drainage is insufficient and lymph
is forced through Glisson's capsule. If histamine and
other autacoids have a role in the production of portal
hypertension through constriction of sphincters, especially
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HV sphincters, they would become i.mportant at this time.
Histamine and other autacoids will probably be released by
the interactions in sinusoids lined with dead and injured
cells; in which antigen....antibody reactions are taking place;
and in which RBC's, leukocytes, and clots are collecting.
As conditions worsen, more autacoids will pass unaltered
through sinusoids and shunts to come in contact with HV
sphincters. As the concentration of autacoids increases
in the HV system their effects will no longer be localized
because larger HV's will be constricted, affecting larger
areas of the liver. Increased flo\<1 should become a factor
at the intermediate stage. It results from changes in
splenic, gastric, and intestinal flow controls. Increased
gastric flow may be a result of the ex.tended presence of
autacoid 51 that open arteriovenous shunts: if so, this is
the time when the effects would appear because collateral
channels would have appeared and intrahepatic shunting
would be available to allow the blood concentrations to
increase. Of the four factors important at the intermediate
stage, intrahepatic shunting is the most important element
of portal hypertension. It not only increases pressure
directly, but it advances liver disease by robbing liver
cells of blood flow, promotes the creation of autacoids,
and provides a pathway for those autacoids to reach the HV
system unaltered.
The final stage of portal hypertension occurs when
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intrahepat1c shunting and HV compression by nodules o.f
parenohymal cells become important. The distinction between
the 1ntermed1ate stage and the f1nal stage 1s most easily
recognized morpholog1ca11y by the change from an essentially
normal morphology to micronodular or macronodular morphology.
The distinction between the interrnediate and final stages
of the portal hypertension of cirrhosis can also be drawn
by functional criteriat Restricted lymph drainage, auta-
coids, and increased flow into the HPV continue to be
important, but intrahepatic shunting and HV compression
from parenchymal cells encased in connective tissue capsule
rise in importance, and the final stage is reached when
intrahepatic shunting and HV compression dominate the
situation.
Esophageal varices are created and hemorrhage
because of increased hepatofugal collateral circulation and
the vulnerability of the submucosal esophageal veins, but
the contributions of the lymph system and histamine to
variceal formation and hemorrhage have yet to be assessed.
Because the majority of splenic vein flow is diverted
into the esophageal veins, increased flow probably is a
major element of the formation and hemorrhage of esophageal
. The La.ck of support from connective tissue andvar1ces. .
muscle plus the proximity to the esophageal lumen combine to
f t..h..e. v·ulnarabllity. of the submucosalmake a strong case or ... . Q
esophageal veins as an element of variceal formation and
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hemorrhage. The role of the lymph system in variceal
bleeding is not completely understood. If substantial
lymphovenous communications exist bet\tleen the azygos veins
and the thoracic duct, this is an important factor because
the veins will be less able to cope with increased flow and
more likely to hemorrhage. Histamine relaxation of
esophageal muscle may also contribute because wholesale
rerouting of gastric drainage through the esophageal veins
provides substantial quantities of histamine to the area.
Relaxation of esophageal muscle results in increased flow
through the vulnerable and poorly-supported submucosal
esophageal veins. From present knowledge, histamine
appears to have more potential importance to variceal
bleeding than the lymph system, but not enough is known
about the actions of either to make a definite judgment
possible ..
Histamine has three possible actions favoring
portal hypertension and variceal bleeding that appear to be
both probable and potentially important. Substantial
extrahepatic shunting and the potential for gastric drain-
age to bypass the liver via the esophageal veins both
would permit histamine to reach the proper locations in
adequate quantities. If the increased incidence and exacer-
bation of ulcers in cirrhotics i8 due to elevated blood
concentrations of histamine, it suggests that histamine may
cause increased gastric and possibly intestinal flows into
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the HPV. Second, substantial intrahepatic shunting favors
histamine as an agent respons.ible for HV constriction as
does the liver's downstream location from the stom.ach and
the probability of histamine release from a sick liver. In
the absence of a blood reservoir function in humans, the
possibility of histamine constriction suffers for the ,,;rant
of sufficient HV musculature. If a blood reservoir func-
tion does exist, the likelihood that sufficient ltV muscula-
ture exists is greatly enhanced. Thirdly, if histamine
does dilate esophageal muscle, an important result would be
an increase in flow through the submucosal esophageal veins
because their tributary channels must pass ~hrough the
relaxed muscle layers. All three of these hypotheses of
histamine action lack experimental evidence.
Vasopressin appears to have two likely that
oppose portal hypertension and variceal bleeding and three
actions that are uncertain. First, vasopressin cert.ainly
decreases flow int.o t.he HPV system constriction of
splanchnic arterioles, and a decrease in flow from selective
closure of splanchnic submucosal arteriovenous shunts does
not seem unlikely. Although the evidence is not as strong
because of the paucity of experimental t-3ork, esophageal
smooth muscle constriction is a second likely action of
vasopressin. Support for this idea comes from a small
amount of experim.ental work, obvious theoretical potential,
and clinical observations of abdominal and substernal
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cramping. IU?V dilation is an uncertain vasopressin action.
Hepatic outflow resistance may be greater than HPV resist-
ance in most cases of portal hypertension; therefore HPV
dilation may not have an important effect on HPV pressure.
A decrease in intrahepatic resistance is a second uncertain
action of vasopressin. Vasopressin may dilate hepatic
sphincters and thereby decrease intrahepatic resistance.
This hypothesis of vasopressin action suffers from lack o·f
evidence detailing presence of and the capacity for action.
If vasopressin is important as an autacoid antagonist, the
implication for portal hypertension and liver disease is
that a major element, the contribution of autacoids, has
been overlooked in the past. The lack of experimental evi-
dence makes this idea speculative at the moment. That a
major element of portal hypertension and liver disease has
been overlooked seems doubtful enough to make one hesitant
to assign much importance to it. Specific histamine
antagonism to vasopressin's portal hypotensive action.
Obviously, this hypothesis must face the uncertainties of
histamine action as well as hist~.ine antagonism. However,
because an antihistamine role for vasopressin has been
reported and vasopressin is thought to work directly on
contractile elements, providing a mechanism for histamine
antagonism, this speculation does not seem too far-fetched.
Introduction to the Experiments. The experiments
carried out in this study were designed to determine if
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vasopressin has an intrahepatic action in the rat liver and
to assign any action found to inflow or outflow control.
The work of Schon and Labat (1971) is an obvious modeL,
Their method was modified by the use of a constant flow with
continuous pressure measurement rather than constant pres-
sure with flow measurement because flow measurement \>1ithout
flo'tN'msters is more cumbersome and less accurate than direct
readouts of perfusion press·ure. Continuous pressure measure-
ments also can be easily correlated with continuous readings
of weight. Another modification was the perfusion of livers
on a wire weighting tray, Which allowed free drainage of
fluid. If changes in pressure were not accompanied by
weight changes, it was assumed that changes in resistance
had occurred presinusoidally, and it was assumed that
changes in pressure associated with weight changes were the
result of changes in post-sinusoidal resistance. In all
experiments, an alpha-adrenergic agonist, phenylephrine,
was used to provide a model of inflow constriction and a
beta-adrenergic agonist, isoproterenol, was used to provide
a model of outflow dilation. In later experiments, hista-
mine was tested in order to provide a model of outflow
constriction and in the hope of later being able to test
for antihistamine properties of vasopressin and the
adrenergic agonists.
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~1ATERIALS AND METHODS
Rat livers v?ere perfused~dth saline and with sever-
al concentrations of different drugs \'lhile the absolute
pressure and "leight changes were r eooxded , Pressure and
"leight changes were used to identify the location of action
as pre- or post-sinusoidal. Because the perfusions were
done at a constant f10\l'l rate, changes in pressure were pre-
sumed to reflect changes in resistance. The group A livers
proved unr-eward.Lnq as an experimental series, and the group
13 livers were run af t.erwards as a pilot series . Both Group
A and B livers were perfused with saline and with several
concentrations of different drugs in saline. Vasopressin
was used to determine if it has an intrahepatic action and
to identify any action as pre- or post-sinusoidal.
Phenylephrine, an alpha~adrenergic agonist, and phentolamine,
and alpha-adrenergic antagonist, were used to identify the
role of alpha-adrenergic action and to provide a model of
increased pre-sinusoidal resistance. Isoproterenol, a beta-
adrenergic agonist, and propranolol, a beta-adrenergic
antagonist, were used in order to identify the role of beta-
adrenergic action and to provide a model of decreased post-
sinusoidal resistance. Histamine, an autacoid, was used
to provide a model of increased post-sinusoidal resistance,
and it was hoped that later it could be used to identify
any interactions between it actions of alpha-
pn~r~·ic and beta-adrenerg ." .agon:tsts anCt vasopress:tl1.
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In the group A series, livers were taken from 350-
400g white, male rats (Sasco, Inc., Omaha, NB). Two rats
were housed per cage without oare and fed Purina Rat Chow
(Ralston Purina, Checkerboard Square, St. Louis, MO) and
tap water ad lib. Heparin (Sigma Chemioals, St. Louis, MO~
#H-3l25), isoproterenol (Sigma Chemicals, St. Louis, MO;
iI-5627), phenylephrine (Sigma Chemicals, St. Louis, MO~
#P-6126), propranolol (Sigma Chemicals, St. Louis, MO:
iP-OS84), phentolamine (Ciba Pharmaceutical Co., Summit,
NJ; Regitine Mesylate injection), and vasopressin (Sigma
Chemicals, St. Louis, MO; f,V-2875) were employed. Three
liters of both 10-6m phentolamine and lO-6m propranolol
were prepared in advance and stored in Pyrex flasks bet"leen
0° and 5° C during the three weekS of experimentation.
Enough 100 ml quantities of the drugs solutions were pre-
pared each day from frozen stock solutions and stored
between 0° and 5° C. Large quantities of saline for drug
solutions and perfusions was prepared in advance and stored
in half-gallon bottles of non-chemical resistant and non-
heat resistant glass between 0° and 5° C. The recipe for
saline was a modified Krebs solution (Prosser, 1973),
adjusted to pH 7.4, with O.Olg/liter of ascorbic acid added
to stabilize the drugs. The water "ms from the Olin Hall
distilled water taps, and it was further deionized in a
deionizing column (Barnstead Still and Sterilizer Co.,
Boston r 1'11\; #0802-Standard) three times. The water was
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stored in five-gallon jugs of non-heat-resistant and non-
chemical-resistant glass. The 100ml quantit.ies of saline
and drug solutions were kept in 250 ml Pyrex flasks and.
stored between 0° and 5° C until used.
The perfusion apparatus consisted of Tygon tubing
from a 37° C water bath, through a finger pump (Sigma Motor
Co., Middleport, NYr model T-8), to a wire mesh weighting
tray suspended from a force transducer (Grass Instrument
Co., Quincy,MAr #FT 03 B). Two lines led off the main
line, close to the finger pump. The line closest to the
pump led to a manometer used to calibrate the pressure
rransducer. This line was flooded and the manometer was
closed during liver perfusions. The second line led to the
pressure transducer (Stratham Laboratories, Inc., Hato Rey,
Puerto Rico r lJiodel P 23M). Pressure and weight measure-
ments were recorded continuously on a Beckman nynograph
(Beckman Instruments, Inc., Schiller Park, ILr type R-4l1).
Absolute pressures and changes of weight were recorded.
The tubing that emerged from the finger pump, the base of
the water monometer, the line into the pressure transducer,
and the open end of the tubing secured to the weighting
tray were approximately at the same height in order to
minimize static pressure differences. The perfusion rate
was between 15 and 16 ml/min and constant during anyone
day. Transit time through the system was approximately 60
seconds.
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The sequence of events for each liver perfusion be-
gan with an intraperitoneal injection of 1,000 USP-JA units
of heparin. Ten minutes passed before the rat was swung by
its tail and killed by concussion. Within that ten-minute
interval, saline was placed in the water bath to allow it
ten minutes to come to 37° C. All drug solutions had a
ten-minute warm-up prior to infusion to bring them to 37° c.
Through a midline incision, the HPV '\I,as cannulated with
plastic tubing of a diameter close to that of the HPV. The
liver was removed by cutting the ligaments and the HPV
without concern for the proximity to the HPV or the cannula,
but care was taken to cut the HV close to the substance of
the liver. The cannulated liver was placed on a dissecting
tray; approximately 50 rol of 37° C saline was poured over
it to facilitate manipulation; the lobes of the liver were
arranged in an orderly fashion; and the liver was trans-
ferred to the weighing tray, and the cannula was plugged
into the perfusion apparatus. The liver rest.ed on the tray
with the caudal portion up. On most occasions, the liver
and cannula were manipulated in order to achieve a minimum
perfusion pressure, and once this pressure was established,
the liver and perfusion apparatus were not disturbed.
Less than t.en minutes passed between the death of each rat
and the beginning of perfusion. Each liver was perfused
with saline until steady pressure and weight readings were
observed; typically this required approximately ten minutes.
1.0, or 0.1 units/lite.r; isopro-
-8
or 10 m; or phenylephrine at
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Two ten-minute perfusion perioA~ f.·ol·l·o~~ed. v·
u..""" ·asopressin, at
a concentration of 10.0,
terenol at lO"'4m, lO·6m,
10-5m and lO-9m were infused during the first ten-minute
period. Either phentolamine or propranolol were infused
during the second ten-minute period. E'our livers 't'lere run
at each concentration of isoproterenol, phenylephrine or
vasopressin, two of them with phentolamine and two of them
with propranolol. The order of isoproterenol, phenyLephzLne ,
and vasopreaaan experimentation, as well as the order of
concentrations within each drug series and the order of
blocking agents was randomized. At least one saline control
was run each day. The flow rate was varied with several
control livers to verify change of pressure and weight with
change of flow rates. ,!Ihe open end of the tubing at the
water bath was dipped in saline between removal from one
fla and placement into another when perfusion solutions
were changed. The tubing was flushed with distilled water
at the end of each day a.nd the beginning of each day.
The flow rate of 16 till/min was chosen on the basis
of comparison bet'Vleen published estima.tes of HPV flow in
healthy ra.ts and the data from the work of Sundet (1975),
which employed a similar perfusion apparatus and methods.
S 1 (1975) ~"or.k s·u·gg··e··st o th·at resistance to flow variesundet s .... ,~ ""
with flow rates in healthy livers. Sixteen ml/min is a
flow rate within a range of estimates of nonlal flow and
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is within the range of flow rates at which resistance is
not changing according to Sundet (1975). Phentolamine was
chosen as an alpha-adrenergic antagoni.st because it
offered competitive inhibition. Because a hist.ologic
difference, though small, was noticed between damage to dog
livers ischemic for 45 minutes and those ischemic for
longer periods (Grana et al., 1968), t.he period from the
death of the rat to the end of the perfusion was kept to
less than 45 minutes in order to minimize the effects of
ischemia. The infusion sequence of saline: then isoproter-
enol, phenylephrine, or vasopressin: then phentolamine or
propranolol was intended to provide a baseline for pressure
and weight for each rat and to offer models for pre- and
post-sinusoidal resistance and of competitive antagonism of
drug action against which to evaluate the action of
vasopressin.
Because the trials with the group A series of livers
failed to show any reproducible responses to drug infusions,
a number of changes in the methods were instituted and the
group B trials were run in the hope of identifying a method
and a range of concentrations which would show responses
to drug infusions. The data from the group A series of
livers contained no reproducible results; and the group A
series was almost totally without response to drug infu-
sions. The trial of IO-3m isoproterenol in the last group
A liver was done under different conditions than the other
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drug trials, and the res.ponse to it and its antagonist sug-
gested that a change in the methods would result in repro-
ducible responses to drug infusions. A number of chang-es in
the methods were instituted to eliminate elements of the
methods which were thought to int·erfere with responses to
drugs. Changes were made in the protocol of the prepara-
tion of saline and drug sOlutions to minimize the chances
for contamination and the time the drugs spent at 31° C.
The perfusion apparatus was changed to eliminate unneces-
sary portions and to shorten the transit time of solutions
through the apparatus. A bubble-catcher was installed to
catch bubbles which otherwise would have passed into the
liver and blocked perfusion. Nembutal pre-treatment was
employed to eliminate the trauma from concussion death and
to allow surgery on a live rat. Surgery on a live rat
decreased the time of hepatic anoxia prior to perfusion.
Conditions for the group B series were identical to
those of the group A series except for the following changes:
Rats premedicated with Nembutal were injected inrraperi-
toneally with 0.04 mg in saline five minutes before the
heparin injection, and the surgery was performed on live
rats. The HPV distal to the cannula was clamped to mini-
mize blood loss. The liver spent between five and eight
minutes without HPV flow and less than three minutes ~dth­
out HA flow. The perfusion apparatus differed in several
T.. ·h··e.· pr.·en.sur·e. t·r·ansducer was calibrated separatelyrespects.. '"
The sequence of drugs was
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from the system, and the line to the Irlanometer was removed ..
A closed, flooded,. vertical tube was p1aeed on the main
line between the line to the pressure transduoer and the
weighing tray to catch bubbles in the saline. Some tubing
was eliminated from the earlier appa.ratus, which shortened
the transit time to approximately 40 seconds ..
The saline for saline infusions a.nd drug solutions
was made up a.s needed from stock solutions of ions stored
between O· and 5° C. The saline for the saline washes and
for the drug infusions was often measured cold and the
100 ml aliquots placed in the water bath in Pyrex flasks
to warm to 37° C; about as often the saline was placed in a
600 ml Pyrex beaker, and the beaker was placed in a drying
oven until it 'Vi/armed to above 31° C and then placed in the
water bath to cool to 37° C.. This second method was
employed because it required less time.. Stock solutions
of all drugs were kept frozen and new solutions were used
each day.. Drug solutions were mixed from stock solutions,
stored between 0° and 5° C, approximate1y 30 seconds prior
to infusion. In the group B series of 1ivers, histamine
(Sigma Chemicals, St. Louis, MOr 4fH-1250) was tested in
addition to all the drugs tested in the group A series ..
The group B series of livers is divided into two groups:
those livers from rats not pretreated with Nembutal and
those from rats pretreated with Nembuta1.
ferent for the group B
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series. A perfusion period to establish steady baselines t
typically ten minutes, was followed bya1ternating infusions
of a drug solution for five minutes and saline for eight
minutes, to a limit of three combinations per liver. Three
combf.nations were run because the base:l.ines of saline-
perfused livers remained steady at least that long and the
overall time between hepatic ischemia from surgery and the
end of perfusion was kept close to 45 minutes. Histamine
was tested in concentrations of lO-2m through 10-7m in non-
Nembutal-treated livers and in concentrations of lO-5m
through 10-7m in Nembutal-treated livers:. Isoproterenol
was tested in concentrations of lO-2m through 10-7m in
non-Nembutal-treated livers and in concentrations of IO-3m
_I::
through 10 .»m in NerCtbutal-treated livers. vasopressin was
tested in concentrations of 0.01 through 100.0 units/liter
in non-Nembutal-treated livers and in concentrations of 0.1
through 10.0 units/liter in Nembutal-treated livers.
Phenylephrine was tested in concentrations of IO-3m through
10- in non-Nerobutal-treated livers; phentola.mine was
tested in concentrations of 10-6m through 10-9m in non-
Nembutal-treated livers; and propran0101 was tested in con-
centrations of 10- through 10- in non-Nembutal-treated
livers. Thirty-five non-Nembutal-treated experimental
livers '\'\1ere run and one non-Nembutal-treated liver ",ras
perfused with saline as a control. Fourteen Nembutal-
treated experimental livers were run and three
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Nembutal-treated livers 'trlere perfused with saline as con-
trols.
In the analysis of the methods, a range of varia-
tion was defined as ordinary from observations of trials
with drug solutions and saline solutions. A pressure
variation of 0.5 em of wetter and a weight variation of
O.05g was observed. in response to drug solutions that did
not create any greater change and in response to saline
infusions. Ten livers were perfused 'i'.rith saline under the
conditions of group A livers, one liver was perfused with
saline according to the dictates of the non-Nembutal-
treated group B series, and three livers were perfused
under the conditions of Nembutal-treated group B livers to
establish the action of saline infusions.
The criteria to recognize a chang-e were set from
data. To be counted, a change needed to be greater
than 0.5 em of "vater or 0.05 g, and it needed to be abolished
by perfusion with saline or antagonized by the specific
blocking aqent., In cases where t.he changes were not com-
pletely removed or antagonized, only the portion reduced
or antagonized was counted as a change. In those oases
the saline waah over ....compensated for the change in-
by the s , only the amount of the initial, drug-
change was oounted as a ohange ..
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DATA
The results from the trials with the group A and
group B livers are presented in Tables 1-6. In addition,
some observations on the experiments are presented.
A number of observations werE! made during the per-
fusions. These observations concern blood loss durinq
surgery, appearance of the abdominal vi scera and the HPV,
blanching of the livers during perfusions, the action of
the bubble-catcher on pressure, the patterns of pressure
and weight as they stabilized at the beginning of each per-
fusion, and the lack of a difference in the variat.ions
observed during periods of drug infusion and periods of
saline infusion. Litt.le bleeding was observed from
Nembutal-t.reat.ed rats during surgery. Variation in the
amount of blood loss during surgery without. Nembut.al pre-
treatment resulted from cerebral, thoracic, and/or abdom-
inal hemorrhage produced by concussion, and a small con-
tribution resulted from HJ?V bleeding. Blood loss in
Nembutal-treated rat.s was a small and consistent. amount
much less than the blood loss from surgery on non-
Nembutal-treated rat.s. In rats given Nembut.al, the
abdominal viscera were much redder (a bright red) and the
HPV was much larger than in rats not pretreated with
Nembutal. In addition, patches of 1.iver containing blood
were much less frequent in livers from Nembut.al-treated
rats than in the livers front non-Nembutal-treated rats.
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Table 1. The number of t.rials t.hat eXhibit.ed changes or
did not exhibit. changes and t.he changes of perfusion
pressure and weight observed during the perfusion of
isoproterenol, phenylephrine, and vasopressin into livers
from group A rats. Changes less than o. 5 cm of water or
0.05 g are not counted as changes.
Isoproterenol
m
10-3
10-4
10-6
10-8
Trials
No Change Change
o 1*
4 0
4 0
4 0
Cha.nges Observed
(em of water, g)
(+36,-0.1)*
• • •
.. ..
*Perfused under different conditions t.han other
group A livers.
Phenylephrine
m
Trials
No Change Change
3 1
4 0
Vasopressin
Changes Observed
(em of water, g)
(+26,+0.2)
...
Trials.
units/l NO Change Change
Changes Observed
(em of tvater, g)
4 0 ···10
·
0
4 0 ···1
·
0
0 · ··0
·
1
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Table 2. The number of trials that exhibited changes or
did not exhibit changes and the ohanges of perfusion
pressure and weight observed during the perfusion of
histamine and propranolol into livers from non-Nembutal-
treated group B rats. Changes less than 0.5 em of water or
0.05 9 are not counted as ohanges.
Histamine
m
10-2
10-4
10-5
10-6
10-7
In
Trials
No Change Change
o 1
4: 1
5 1
o 1
1 0
Propranolol
Trials
NO Change Change
Chanaes Observed
....... J _ . . __. . _
(em of water, g)
(-1,-.2)
(-1,-.2)
(0,-.1)
(0,-.1)
•••
Changes Observed
(em of water, g)
10-5
10-6
10-7
10-8
:2 0 • • •
:2 0
··
•
:2 0
···
1 0 ···
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Table 3. The number of trials that exhibited changes or
did not exhibit changes and the changes of perfusion pres-
sure and weight observed during the perfusion of phent.ol-
amine, phenylephrine, and propranolol into livers from non-
Nembutal-treated group B rats. Changes less than 0.5 em of
water or 0.05 9 are not. counted as changes.
Phentolamine
m
10-6
10-7
10-8
10-9
m
10-3
10-4
10-5
10
10-7
-8
m
Trials
No Change Change
1 1
2 0
1 2
2 0
phenylephrine
Trials
No Change Change
4 0
5 2
6 1
2 a
1 0
1 0
Propranolol
Trials
No Change Change
Chanaes Observed
M
(em of water, g)
(+2,0)
...
(0,-.25), (0,-.15)
,. ..
Changes Observed
• i 1-
(em of 'vater, g)
...
(+3,+.2), (0,-.3)
(+1,0)
...
e ••
.. "
Changes Observed
(em of water, g)
10-5
10-6
10-7
10-8
a
··"2
a
···2
0 •
··2
0 ···1
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Table 4. The number of trials that exhibited a change or
did not exhibit changes and the cha.nges of perfusion pres-
sure and weight observed during the perfusion of i.sopro'"
terenol and vasopressin into livers from non-Nembutal'"
treated group B livers. Changes less than 0.5 crnof water
or 0.05 9 were not counted as changes.
Isoproterenol
m
10-2
10 ... 3
10-4
Trials
No Change Change
o 2
4 1
a 5
2 0
Changes Observed
(em of "/ater, g)
(0, .... 15), (0,-.3)
(0,-.3)
(+1,-.1), (0,+.4),
(+2.5)1,(0,+.2)#,
(+1,-.2)
...
( ) # , ( ) # Trials on the same day on consecutive
livers.
Vasopressin
unitsll
100
10
4
2
1
.1
• 01
Trials
No Change Change
2 1
3 0
o 1
1 0
4 4
6 a
2 0
Changes Observed
(em of water, g)
(+2,+.15)
·..
(+1,0)
·..
(+1,+.1), (0,-.15),
(0,-.1), (-1,-.1)
· .. .
·..
13B
Table 5.. The number of trials that e:xhibited ohanges or
did not exhibit ohanges and the ohanges of perfusion pres-
sure and weight observed during the perfus.ion of histamine
and vasopressin inte livers from Nembutal-treated group B
rats. Changes less than 0.5 em of water or 0.05 g are not
counted as changes.
Eistamine
m
Trials
No Changes Change
Changes.Observed
(em of water, g)
-------------"-------------
10-5
5xl0-6
10-6
7xl0-7
-75xl0
3xl0-7
10-7
1
1
2
1
1
1
1
o
o
o
o
o
o
1
Vasopressin
·..
.. .
·...
·..
·..
(+1,-.1)
Trials
units/l No Changes Change
ChEtnges Observed
(em of water, g)
10 2 0 .. .. ..
1 0 .. · ..2
5 0 .. · •1
2 0 .. · .... 5
0 .
·
..
.. 1 4
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Table 6.. The number of trials that exhibited changes or
did not exhibit ohanges and the changes of perfusion pres-
sure and v,might observed during the perfusion of
isoproterenol into livers from Nembutal-treated group 13
rats. Changes less than 0 .. 5 em of wa.te.r or 0.05 9 are not
counted as changes.
Isoproterenol
urn
10-3
-45xlO
5xlO-5
10-5
Trials
No Change Change
0 2
0 3
0 4
1 0
1 0
Changes Observed
(em of water, g)
(+1,0), (+1,0)
(+2,0), (+2,-.2),
(+1.5,0)
(+1,0), (+1,0),
(+1,0)#,(+5,+.35).
...
( )#, ( )#, Trials on the same day on oonsecutive
livers.
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All livers blanched dramatically in the first few moments.
Both the livers from Nembutal-treated and the non-li1embutal-
treated rats had patches that did not disappear but par-
tially blanched with perfusion and patches that dis-
appeared during the course of the perfus.ion. The bubble-
catcher decreased the pulse pressure without changing the
average pressure as bubbles collected in it. It was also
observed that as the VOlume of gas trapped increased the
decrease in pulse pressure increased. The livers were
typically perfused for approximately 10 minutes before the
pressure and weight reached stable levels • The perfusion
pressure dropped to stable value in all but three group A
livers i and in these, pressure increased in one and remained
stable in the other two. Pressure dropped to a stable
value in all non-Nembut.aL-Ere.at.ed group B livers.
Pressure dropped to a stable value in all but one Nembutal-
treated group B liver, which had a rise in pressure to a
stable value. Weight changes prior to a stable value
varied: often weight leveled before the Dynograph was ad-
justed to its range of fluctuation. When it could be
observed, weight usually decreased to a stable level. No
variation in pressure and weight was observed dur-
ing periods of drug infusion that produced no major changes
than during periods of saline infusion or during the per-
fusion of saline control livers.
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DISCUSSION
The experiments reported here offer few conclusive
results; therefore they raise doubts about the adequacy of
the methods to demonstrate the actions of the drugs and
raise questions about possible variables and their
importance. Some observations made during the experiments
give rise to speculation about the mechanisms controlling
the washout of blood from the sinusoids.
The action of the drugs tested on livers in groups
A and B were infrequent, inconsistent, and rarely according
to expectations. Differences in drug actions can be
gleaned between the livers of group A and group B, and
between Nembutal-treated and non-Nembutal-treated livers
in group B. From these results, the conclusion can be
drawn that the methods were not adequate to demonstrate
the hepatic actions of the drugs.
Vasopressin produced only a few inconsistent re-
sponses (Tables 1, 4 and 5). Knowledge about vasopressin's
actions in a rat liver was the primary goal of these
investigations. Vasopressin was tested to determine if it
possessed an intrahepatic action and to locate that action
as pre- or post-sinusoidal if it did occur. During the
group B trials, it was hoped that the opportunity would
4f 4t a.nta.g.on· 47.e·d the action of hista-arise to determine ~ ~. ~-
of· R.e!abek (1967) suggests that vasopressinmine. The work €A
h '1' to ant.a~on4~e the action of histamine.as the ab~ ~ty '! ~€A
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Vasopressin is often used to treat variceal bleeding, and a
decrease in portal pressure is believed 1:0 be an important
element of its hemostatic action. An intrahepatic action
could be important to vasopressin's portal hypotensive
action, and little work has been done on this aspect of its
action.
Previous work suggests that vasopressin decreases
portal pressure by dilation of the HV-IVC sphincter; there-
fore, one would expect a decrease in pressure and a
decrease in weight from drainage of fluid from the extra-
cellular spaces. Only in the non-Nembutal-treated group B
livers (Table 4) were responses to vasopressin observed,
and only at a concentration of 1.0 unit/liter did a sub-
stantial number of changes occur. No pattern of change in
the magnitude of responses in concert with change of con-
centration was observed. At a concentration of 1.0
unit/liter, only four of eight trials had any response to
vasopressin infusion. Among these four trials only two had
pressure changes and both increases and decreases of weight
were observed among these four trials. In addition, only
one change, a 0.15 9 weight decrease, was greater than 1.0
f 1 0 C· ha·n.ges of 1. 0 em of water or 0.1 9em 0 water or .• g.
are little greater than the observed variation, and they
are suspect because they are small. since the changes in
response to vasopressin were few, of small magnitude, and
of inconsistent type, one cannot conclude that vasopressin
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does or does not have a hepatic ac1:J,.'b 1
·on, muc ·e88 speculate
on its location or compare these responses to expectations ..
Isoproterenol, the beta-adrenergic agonist, produced the
most responses of any drug tested, but its responses were
often of small magnitude and inconsistent type. Isopro-
terenol was employed to provide a model of a decrease in
post-sinusoidal resistance, and it was hoped to be able to
experiment later with the role of beta-adrenergic action in
comparison with the actions of vasopressin and histamine.
Previous work suggests that isoproterenol decreases post-
sinusoidal resistance by dilation of the HV-IVC sphincter
and/or a generalized HV dilation; therefore, one ,('lOuld
expect a decrease in perfusion pressure and a decrease in
weight from drainage of the extracel1ular spaces.. HV
dilation could result in no change in weight if the effects
of decreased capillary pressure were offset by increase in
the volume of HV capacitance vessels. Among the group A
livers, (Table 1) the one trial among the thirteen run in
which isoproterenol elicited a response was run under con-
ditions different than the other t\'1e1'1e. That no response
was observed among these twelve tria1s argues against their
methods as adequate to produce responses. The one success-
ful trial resulted in a 36 em of ~later decrease in pressure
and a 0.2 g decrease in weight. The effect seems likely to
be the result of isoproterenol because propranolol, a beta-
adrenergic antagonist, abolished all of the pressure
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decrease and 0.1 9 of the weight decrease, because the size
of the press.ure decrease appears too large to be the result
of chance, and because decreases in ·p·.e..rfu·.s.J..~o·n. pressure and
weight changes are consistent with expectations. Non-
Nembutal-treated group B livers sho\<1ed few pressure changes,
only one of which was greater than 1.0 em of water. A
number of weight changes were greater than 0.1 g, but some
were weight. increases and some were weight decreases. No
pattern of responses to increasing concentrations was
observed and inconsistent pressure changes and conflicting
weight changes were observed in response to similar concen-
trations on the same day in consecutive livers. Nembutal-
treated group B livers (Table 6) showed consistent pressure
changes that were small and contrary to expectations; few
changes in weight that were substantial but of different
types; no pattern of responses to increasing drug concentra-
tionsr and different pressure and weight changes in response
to identical concentrations on the same day in consecutive
livers. Nine of ten trials run at concentrations of 10-3 m
and 10-4 In produced increases in pressure, but only three
of the nine increases were greater than 1.0 cm of water and
the attendant weight changes were few, substantial, and con-
t d L t T·. f.",S· only con""i""tent effect of Lsopro t.exeno l in·.ra ·0 ory. .. u '"
th 8· e.. r.J..'e.~. (T.ab.le~· ~ and 6) was a small pressuree group B _ ., "i
of..· 10-4 m and higher in theincrease at concentrations
d this is in directNembutal-treated group B livers, an .
there-
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conflict with the large pressure decrease observed in
response to 10-3 m isoproteran.·01· i
v • n the group A series. On
the basis of these results, the method.·•.. s -f'
_0r groups A and B
do not appear to be adequate to allOM . s.u..b.·.sta•. ntia·l·· I
vv· "" repro-
ducible responses to isoproterenol. Also, because the
results do not allow one to define a specific response to
isoproterenol, it is not appropriate to judge the results
on the basis of conformity to expectations.
Phenylephrine, an alpha-adrenerg Lo agonist, did not
consistently produce any changes, and the few changes it
did create were inconsistent. Phenylephrine was used to
provide a model of an increase in pre-sinusoidal resist-
ance , Expectations for the action of phenylephrine arise
indirectly from the resulte of work with epinephrine, nerve
stimulation, and alpha-adrenergic antagonists. Increased
perfusion pressure from HPV constriction was expected as
was a decrease in weight from the decreased capillary pres-
sure that followed decreased flow from constriction of the
small HPV branches. Constriction of the HPV system might
be expected to reroute flow into the larger channels of the
HPV and the liver because of the constriction of small HPV
branches. Only one of eight group A tr isIs (Table 1)
showed a response, a large increase of pressure and a
moderate increase of weight. PropranOlol, the beta-
d L t i .t· "'as scheduled for this trial:a renerg C an agon· s·, w·· ... . .
fore, no data are available about the ef feet of
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alpha-adrenergic blockade on this response. This response
-5
occurred at a 10 m concentration, a relatively high con-
centration, and the wei('fht incre·a"'.·e. cou.. 1···d have 1
':1 .,. .... "" resu.ted
from enough constriction of the l-IV capacitance musculature
to influence post-sinusoidal resistance. Although One may
auspeot; that this response was related to phenylephrine, the
response from this lone group A liver must be considered
suspect without the knowledge of its reaction to alpha-
adrenergic blockade. Only non-Ne:mhutal-treated group B
(Table 3) livers received phenylephrine, and they showed only
occasional responses. Of the two pressure increases, only
one was greater than 1.0 cm of water. The two weight changes
observed were substantial, but one was an increase and the
other was a decrease; alSO, only one weight change occurred
in a trial with a pressure change. The great number of
trials without changes in both g:t'oup A and the non-Nembutal-
treated group B livers provide the strongest argument
against phenylephrine as active under these conditions.
These results make comparison with expectations an unre-
warding task.
Infusion of histamine, a potentially important
hepatic vasoactive autacoid, did not produce any dependable
changes: .. h t·hat were observed wereThe few pressure c·anges
e contrary to expectedsmall, and the weight changes wer
results. Histamine "Jas used in the group B Iiversto pro-
, ·a.~e.. l.'n post-sinusoidal resistancevide a model of an l.ncre 0
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and in the hope of conducting future e)tperiment.s about the
interactions amonq vasopressin, beta-adrenergic action, and
histamine. Histamine was expected to increase perfusion
pressure by constriction of the HV spiral musculature,
possibly by a general HV system constriction, and by con-
striction of the HV-IVCsphincters. Weight was expected to
increase as capillary pressure increased. Constriction of
HV capacitance vessels might cause a weight decrease.
Trials in non-Nembutal-treated group B livers (Table 2) did
not often reeul t in changes. Only two of the four trials
had pressure changes, and these changes ,,,.,ere decreases of
only 1.Dccm of water. All four trials had weight decreases,
two of which were only 0.1 g. These few weight decreases,
contrary to expectations, are puzzling because histamine-
induced HV constriction is the best-documented action among
the actions expected for all the drugs employed. Only one
change was observed in response to histamine in all of the
trials employing N'embutal-treated group B livers (Table 5)
and it was small. One must conclude that histamine did not
have any reproduclble effects under these conditions.
Phentolamine, the alpha-adrenergic antagonist, was
without effect in group A livers and created a few, con-
flicting responses in non-Nembutal-treated group B livers
(Table 3). Phentolal:'I1ine was used to provide competitive
It was e:x:pected to antagonizealpha-adrenergic blockade.
h i an·.d.. to mimic its actions inaction of pheriy l.epl r ne -
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high concentrations. It did not produce any responses in
group A livers. It produced substantial, but inconsistent,
changes of both perfusion pressure and weight in a few
trials, and it produced no patterns of changes in responses
to increasing concentrations. By virtue of its few effects
and the inconsistency of the few changes that it did pro-
duce, one may conclude that it did not produce reproducible
effects under these circumstances.
Propranolol, the beta-adrenergic antagonist, had an
effect on one group A liver and was without effect on any
of the non-Nembutal-treated group B livers tested (Table 2).
Propranolol was used to provide competitive beta-adrenergic
antagonism. One would expect it to antagonize any response
to isoproterenol and high concentration to mimic isopro-
terenol actions. Because it did not elicit a response from
group A livers when it was administered after other drugs
and it did not elicit responses from non-Nembutal-treated
group B livers, one may conclude that it was without effect
under these circumstances. Its antagoni.sm of isoproterenol
One
treated group B livers.
tween the group A series and the group B series.
in the final group A trial seems likely to be real and to
result from the peculiar conditions of that one trial.
Differences between the responses of the group A
and group B livers can be seen in the data as can differ-
ences between the non-Nembuta.l-treated and Nembutal-
Two differences are apparent be-
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difference is the great lack of respon.s. .e l.n the group A
livers compared to the numerous chang··e·'" th ·h
,""oug . small and
inconsistent, in the group B livers. The second differ-
ence is contradictory to the first difference and concerns
the magnitude of the pressure changes observed in these two
groups. The two pressure changes observed in the group A
series were 26 em and 36 em of water and the changes in
group B livers were never more than 5 em of water. IUsta-
mine infusions offer differences between the Nembutal-
treated and non-Nembutal-treated livers of the group B series.
Four of thirteen trials in non-Nembutal-treated livers
showed changes: although only one of nine trials in Nembutal-
treated livers showed evidence of a change. Results from
vasopressin infusions also provide a difference between the
two group B series of experiments. Six of 24 trials with
non-Nembutal-treated livers registered a change and none of
the Nembutal-treated livers registered a change. The re-
sults from isoproterenol infusions provide three differences
between the responses of non-Nembutal-treated and Nernbutal-
treated group B livers. First, pressure changes were con-
sistent e Lemerrt s of the changes that occurred in trials
with Nembutal-treated livers, although pressure changes were
not consistent elements of the changes which occurred in
trials with non-Nembutal-treated livers. All eight trials
. . . ·1 t ted livers had a pressureshOWing changes l.n Nembuta-·rea
·i ht t· 'als showina change inchange. Only three of the e 9 rl. ~
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non-Nembutal-treated Iivers had p.• ressu ·hrec . anges. Even
when only the pressure changes greater than 1.0 em of water
are counted, the difference stands: four of four trials in
Nernbutal-treated livers and one of seVen trials with non-
Nembutal-treated livers. Second, weight changes were con-
sistently an element of the changes in trials with non-
Nembutal-treated livers, but not in trials with Nembutal-
treated livers. All eight of the trials showing change in
non-Nembutal-treated livers had a weight change. Only two
of the eight trials showing change in the Nembutal-treated
livers had a \'lTeight change. As with the pressure changes
mentioned above, if only changes greater than 0.1 9 are
counted, the differences remain: seven of seven trials
within non-Nembutal-treated livers and two of four trials
in Nembutal-treated livers. Third, at a 10-3 m concentra-
tion of isoproterenol, both trials with Nembutal-treated
livers showed a change. but only one of the five trials with
non-Nembutal-treated livers showed a change. This observa-
tion could be questioned because the tt"lO changes observed in
Nembutal-treated livers were the result of only 1.0 em of
water pressure increases.
One may conclude from this \<lork and the work of
others that the methods were not adequate to demonstrate
the hepatic actions of the drugs tested. The results from
B 1 , ers are inconclusive.trials with group A and group ·.·1'1.1
1 . Is at concentrationsIn all but the isoprotereno tr18
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-4
around 10 m in both categories of grou.. p. n Ii'
D ." vera, very
few livers responded to the drugs at all.. In the case of
these isoproterenol trials, the resp,on. ""'e' "'.' •
"" ... were contradictory
and often of small mag'n 4tu'.d·p,_.. Th t· -3
• 'er~al. of 10 m isopro-
terenol in a group A liver is a legitimate class of one
because of its methods, and the inability to reprOduce it
is confusing. The one response to phenylephrine in group ].I",
livers adds to the confusion. Without knowledge of the re-
action to alpha-adrenergic blockade, one must question the
authenticity of this phenylephrine response, but the magni-
tude of the pressure change and its similarity to the
isoproterenol response suggest it is real. The total record
of inconsistent and contradictory responses to drugs and
the observations by others that these drugs do have hepatic
actions suggest that the methods were inadequate to allo\'1
the drugs to have an action.
After the addition of isoproterenol and propranOlol
at the end of the last group A trial produced such impres-
sive results, a number of changes in the methods were
Lat.er , another chan~e, Nembutal Pr retreat-instituted, and ~
ment was added. The protocol and apparatus for the group B
series was designed to elirrdnate some variables thought to
b ''1'"h.'.,,"'.·r·..... sul.t, ft f.romg. roup 13 livers suggest t.hat. e ~mportant...-.. OD "'-
not all the important variables were considered. 1\ number
., an..d several of these appear
of variables are possibi11t1es
capable of interference.
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A number of changes in the Protocol and methods
were instituted to control previou·01,,.
., J uncontrolled vari-
abIes. The protocol for group B had saline warmed to 37 0 C
in beakers in the water bath without drugs. Approximately
30 seconds before infusion, a am"',ll· a.l' l.'qu· ot
"" , \<laa removed
from the 100 ml of saline and replaced by an equal amount
of a concentrated drug solution. Because the aliquot of
concentrated drug solution was typically one milliliter or
less, several swirls of the flask after its addition could
be expected to mix it and maintain the temperature of the
100 ml, solution at 37° C~ this minimi.zed the time the drug
spent in contact with the saline and the time it spent at
37 0 c. The hope was to minimize any deleterious effects
from contact with the saline and to avoid the thermal degra-
dation suggested by the results from the final trial of the
group A series. Saline was prepared in three-liter batches
as needed and rarely was stored for more than a day. The
hope was to minimize any deleterious effects from bacterial
contamination. The perfusion apparatus underwent modifica-
tion. A bubble-catcher was in,stalle d close to the weighing
any bub~.• le·s' w.,·hJ.'c.h', m"J.'g.ht ap·•.. ·p·,ear during.' the timetra.y to catch u
in the tubing and lodge, in the liver. Some tubing was
removed from the system, which shortened the transit time,
in order to decrease the time the drugs spent at 37 0 C
before they reached the liver. AlsO,. the line to the
manometer was eliminated. A shorter and smaller system
made to decrease any effect further.
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should dampen pressure fluctuations t 1
o a esser extent, and
although this had not seemed to be a prohlem, effort was
'Nembutal pretreatment
was begun after a number of trials were run (the non....
Nembutal-treated group B trials) in the hope that spinal
cord, cerebral, and generalized trauma.: the hypovolemic
shock from cerebral, pleural, and occasional visceral
hemorrhage; and ischemia for the period of surgery were
important variables. Nembutal offers anesthesia; no need
for concussion killing; and surgery On a live rat, which
reduces the period of ischemia because itA perfusion could be
maintained during most of the surgica1 period.
A conclusion that the drugs di.d not show reproduc....
ible effects because the methods were inadequate leads one
to speculation about further variables. Likely variables
may be grouped into three general categories: variables
due to physical conditiona, variables due to chemical inter-
actions, and variables due to trauma and nervous system
activity. It seems reasonable that different factors could
be operating in different series of l.ivers and that. several
factors could be at work at one time.. From the list of
likely variables, one may assemble twO additional different,
cat.egories: those variables thought to be important and
those variables not t.hought to be important.
Four ideas about physical conditions were considered
'. ·h· ·tero, limitations of theto be important.: leaks ~n t e sye
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equipment, cannula placement. and d·r·a· f
' . l.nage rom tl1.e
weighing tray. Leaks in the system \>1e·r·e. n t bo o served, and
checks were made throughout the periods of experimentation.
Observations of control livers run.· w~.th~. saline infusions,
livers perfused at different flow rates, of group A and B
perfusions, and of control studies done on the equipment
suggest that the only limitation involved erratic periods
of baseline drift the result of the Dynograph. The equip-
ment was sensitive enough to pick up smaller changes of
pressure and weight than were necessary. Variations during
perfusion were within 0.5 em of water and 0.05 g. Sus-
picion extends to those changes which were 1.0 em of water
or 0.1 g: this suspicion arises from the size of the
changes, not observation of control studies. A.lthough the
angle of the cannula into the HPV sinous at the hilum of
the liver was adjusted to minimize pressure, it is
possible that it could have created artificially high pres-
sures that could have masked pressure changes. It is
possible that fluid pooled on the weighing tray, masking
weight changes. Drainage from the weighing tray was
checked often, and both the wire mesh and the hole in its
center were observed to drip regularly once steady pressure
and ""eight were established. Also, care was taken to see
that the liver rested smoothly on the wire so pooling would
be discouraged.
of. sou.. ·.rcea are possible for chemicals whichA number. c»
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could interfere with the drugs tested or th"'"
... livers employed ..
Heparin and Nembutal could liberate ""'h"""........ i...,cal'
... ..,~.. oompounds,
interfere with others, or act as: chemical compounds them-
selves.. The saline could have been Contaminated with com-
pounds from the glas,s jugs in which it was stored, and com-
pounds could have been created and/or released by digestion,
ischemia, anoxia, or the osmotic pressure created by per-
fusing with saline that does not have adjustm.ents for
plasma proteins.. Heparin and Nembutal could act alone or
react with each other or with effects from shock, trauma,
or nerve stimulation, to interfere with drug action or
hepatic blood flow by release of compounds, interference
wi th other compounds, or on their own as compounds.. vHth-
out a lengthy review of their known actions, a judgment on
these actions is not meaningfUl. It is possible that the
changes in the parenchymal cells induced by Nembutal
(Harvey, 1975) could cause interference with or potentiate
drug actions.. Ions or compounds may have contaminated the
saline as a result of water storage in glass jugs which
were not made of chemical-resistant and heat-resistant glass
i 1 t · ation of the saline ..or as a result of bact.em a· con am~n ,. .
The primary change in the methods from group A to the non-
Nembutal-treated group 13 livers was the elimination of the
warming of drug solutions at 37 0 C for any great length of
be·g.. in·nin.·g of perfusion.. \t~arroing thetime prior to the
saline also could create compounds ~hich could interfere,
especially if contaminants were present.
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It is by no means
certain, because records were not kept but, i
.., u one ·mportant
element of the methods may have been the heating of saline
in the drying Oven. A trace of scum was often noticed
floating at the top of the beaker, and one beakerful was
discarded because of the amount of scum. The rats were not
fasted before their death in hopes of maintaining an HPV
large enough to cannulate. Compounds released from the
digestive process and from blood loss due to concussion or
surgery could have interfered with drug actions or acted on
the liver. Ischemia, anoxia, and/or the osmotic pressure
from a saline solution without allowances for plasma pro-
teins could damage cells or cause the release of compounds
which could interfere with drug action.
A number of sources of trauma to the liver and of
nervous system activity were not well controlled. Although
the perfusion fluids were kept at 37° C, fluids from all
experiments spent approximately 40 seconds at room tempera-
ture in the tUbing of the perfusion apparatus. A large
enough drop in the temperature may have occurred in this
40 seconds to traumatize the liver and to decrease the
activity of the drugs to a level below which they would
have a discernible effect. Although no record was kept,
the room temperature varied widely, from approximately 22°
. ion task, and studyto 290 C. Concussion was not a prec1.s
t the nervous system.was not done on the precise damage 0 .
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Damage may have varied, and t'
cer al.n kinds of spinal cord or
brain damage may be able to influence liver flow and. the
release of compounds which conldeither interfere with drug
action or hepatic flow. The concept of interference with
hepatic blood flow from damage to the brain and spinal cord
is supported by Wakim (1942). He found that the livers of
living frogs and rats after pithing or eNS damage have a
decreased number of active sinusoids as a result of con-
striction. Trauma to hepatic nerves from transection of
the HA, HPV, EN, and the surrounding tissue 'It/ould seem
likely to be a fairly reproducible process because all the
nerves are small, they must all be sectioned to remove the
liver, and the sequence of operations in the surgery was
very similar for each operation. Potential does exist for
variation in the order in which nerves were transected and
in the trauma from the forceps and clamps. r-ianipulation of
the liver during surgery, on the dissecting tray, and on the
weighing tray could have resulted in trauma to the liver
that influenced its responsiveness to the drugs tested.
Swinging a rat by its tail may create nervouS impulses that
could be important. Rats killed by concussion lost variable
amounts of bloodj rats treated with Nembutal uniformly lost
bl d Mhe variation in blood lossonly a small amount of .. 00. L
in the rats killed by concussion provides the potential for
a system activity associ-hypovolemic shock and the nervouo
a ted ~lith it. These responses to hypovolemic shock could
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influence drug action and blood flo.....
" The digestive process
involves nervous system activity, and this could provide the
variation in drug action or control of hepatic blood flow.
Nembutal reversibly depresses the activity of all excitable
tissues (Harvey, 1975), thus, Nembutal interference with
nervous activity could interfere with normal integration of
nervous impulses and thereby interfere with drug action or
hepatic flow control.
Conclusions can be drawn about presumably important
variables and presumably unimportant variables. Digestion,
temperature, concussion and manipulation could be important
variables. The limitations of the system, Nembutal potentia-
tion of drug action, limitations of the saline for perfusion,
anoxia, and temperature do not appear to have been important
variable elements of the methods.
The effects of digestion, temperature, concussion,
and manipulation appear to have been important, uncontrolled
variables in the experiments reported here. A 24-hour fast
prior to experimentation is a comnlon element of many experi-
mental methods. Because the digestive process releases
many compounds, creates nervouS activity, and because the
liver is directly downstream from the stomach and intestines
to receive the products of the digestive process, great
potential exists for a variable influence on drug action
i 1 Temoerature may be pre-and liver flow in all the tr Ci.S. t:
. th roup A series.
aumed to have been an important factor an . e 9 ..• ..
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The ten-minute warming of drug solu.t'1.0ns at 37 C) C no doubt
inactivated some of the drugs and iso t l'
, . proereno 1.S a likely
candidate on the basis of its known cn. ·J.·l Ii bil· .em ca.r am., 1.ty and
the results of the perfusion of Chilled. isoproterenol and
propranolol in the last group A trial. The imprecision of
concussion killing offers a great potential for interfer-
ence in the group A and the non-Nembutal-treated group B
series. Manipulation of the liver could have resulted in
trauma to the liver which influenced its reactivity to the
drugs employed. Although it is not certain that such
handling would traumatize the liver, the fact that the
liver was directly handled raises strong suspicions.
A number of variables do not appear to be important
to the methods: limitations of the perfusion apparatus,
Nembutal potentiation of drug effects, drawbacks from the
composition of the saline solution, anoxia, and the tempera-
ture of the perfused liver. Observati.ons throughout the
course of the work with group A and group B livers deter-
mined that leaks were not a problemr that the pressure and
weight transducers were sensitive enough tomonitor changes
smaller than required; that baseline drift by the Dynoqraph
did not influence results; that the angle of the cannula in
the HPV did not mask pressure changes,. and it would not have
masked weight changes regardless of its action on pressure
f fl 'd on the liver or on thechanges; and that pooling oUJ..
, . .... rernents. Work with bothtray did not influence weJ..ght meaSU
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Nembutal-treated and non-Nembutal-tr· ··t d Iiea e . vers suggests
that Nembutal did not potentiate the a ti f h·
. ce: on 0 te drugs by
binding with the cytochrome P-450 enzymes and blocking
metabolism of the drugs. This idea would be more important
if response.s had been observed in the Ne...l...ut.al-tr a.ted.ULlJ group
B livers, but not in the non-Nembutal-treated group 13
livers. A perfusion solution was used without allowances
for plasma proteins; the work of Filkins (1969a and b) sug-
gests that this was not a major problem, and the saline
solution employed differed little from his. Anoxia from
either ischemia or perfusion without erythrocytes did not
appear to trouble the livers because the final liver of
group A responded dramatically to isoproterenol and pro-
pranolol infusions after a surgical periOd that left the
livers ischemic longer than the Nembutal-treated group 13
livers and a full trial period. Grana et al. (1968) studied
the effects of ischemia on dog livers and suggested that
anoxia causes the release of compounds \'1hioh influence hepa-
tic blood flow. Perhaps the last group A liver reacted
because that long a time was required to wash eut these
anoxic metabolites, but this does not seem likely. The
temperature of the liver subject to the variations of room
t a·nd. pro~.ont·ed.• w~th saline and drug solutionsemperature "''''''' ....
d t..r.a·nsit time may have causedcooled by at least a 40-seoon .
i·n· response to drugs. Again, theseme important variation
observations of the last grouP A liver denies this. The
10-3 m isoproterenol a danc propranolol in this case were
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perfused immediately upon removal from the refrigerator and
placement in the water bath. Lower temperatures typically
decrease the actions of drug.• s " in th· .; s -case ,
... .., <:>. the coldest
solutions had the greatest ac t·Lons , B
"" ...." ecause of the action
of the last group A liver, the decreased temperature of the
liver and perfusate do not appear to have been important
variables.
Observations of the wash-out of blood from group A
and group B livers raise the possibility that sphincter con-
striction and/or vasoconstriction resulted from both nerve
stimulation and the release of autacoidal factors. That
Nembutal-treated livers were better cleared of blood and
their viscera appeared redder suggest vasoconstriction in-
duced by concussion. '1'0 be sure, this effect could be caused
by Nembutal-induced vasodilation. Also, one cannot rule out
the possibilities that all the patches were the result of
constriction mediated by nerve stimulation that gradually
relaxed due to washout; howeve r , nerve synapses are thought
to be well-isolated and not easily subject to wash-out.
Concussion would be expected to create similar conditions
in any part of the liver affected; in the absence of local
influences, one would expect a minimum of differently'"
behaving patches of tissue. The immediate clearing of the
livers was, doubtless, the result of flow through open
channels. Those patches which persisted until the end of
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perfusion probably were caused by lon.g'-e'"n,d,u'~r';, nq ,
.L ooncussion-
induced constriction. Patches which cleared during the
course of perfusion probabl'y, wer'e. re'sul.£..s of
'- the action of
autacoida.l factors. The idea of Grana et a1. (1968), that
liver damage may result. from stasis of flow caused by vaso-
active compounds released during ischemia and anoxia, offers
an explanation for the release of the autacoids that are
hypothesized to produce patches that disappear during per-
fusion. The lightening of dark patches could result from
washout of autacoidal effects produced by local release of
factors and, possibly, from the beginning of the washout
of the effects of nervous stimulation. It may take some
time for flow through blocked sinusoids to washout auta-
coidal factors released originally and during the period of
time until substantial flow is reestablished. A positive-
feedbaok cycle is probably at work: Flow must be re-
established to washout autacoidal factors, which in turn
increase flow, which washes out more factors. Eventually
some of the effects of nervous stimulation may be washed
out too. th t the' l·i',ghtening, of patches isThe conjecture ~ a '
the result of the wash-out of the effects of autacoidal
factors and not the effects of nerve stimulation is sup-
ported by two ideas. First, lightening occurs over the
t·.he disappearance of some othersame period of time as
r os ul t of the action of autacoidalpatches presumably the ~
, d b e thus, they are veryfactors. Autacoids are bloo-orn r
suscept.ible to wash-out.
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Second, neu1:'otransm!ttors, which
mediate the effects of nervous stimU1ation, are not blood-
borne: therefore, they are not as SUSceptible
as autacoids. Furthermore, neurotransrnittors
to wash-out
and. the
entire synapse area are thought to be ""eil-sequestered..
The purpose of this sequestration is to minimize the amount
of neurotransmittor lost with each firing of the nerve.
~,qith markedly decreased flow, due to the effects of nerve
stimulation, the sequestration is even more pronounced , As
a result, autacoidal factors should be washed out much more
easily than the effects of nerve stimulation.
Autacoids are most likely to restrict drainage by
the mechanism suggested by Elias and Popper (1955). Con-
S1:riotioo of segments of the HV in response to autacoids
would be expected to produce patches similar to the ones
observed in perfused livers, and constriction of Hv-tVC
sphincters would be expected. to darken entire lobes
(darkened entire lobes were observed occasionally). In
human livers, sinusoids only drain into the central veins,
which drain into several layers of the H'J; in rat livers I
sinusoids drain into central veins and into several levels
of the HV through channels similar to the ones described
by Elias and Popper (1955). Because of this organization,
HV constriction causes closure of both individual sinu-
soids and groups of sinusoids. The flow from other, open
sinusoids through the constricted sublobular av segments
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antagoniz.es autacoidal-induced HVcon"'+ric.. ··t. i·on.
... lW. • by washing
out aut.acoLda • Eventually, autacoids "··yo...u,l·d· b·e w·"'''''h,·ed
'"' a... away,
the HV musculature would relax and £1 th tt t.h.'·e.
, . ow· roug ..
blocked s Lnusof.dn would be reestablished.
CONCLUSIONS
The methods employed by these experiments were not
adequate to demonstrate hepatic actions of the drugs teeted.
The inadequacy of the methods employed very possibly may
relate to the lack of a 24-hour fast: for the rats prior to
the use of their livers, warming of drug solutions in the
water bath during the group A series, the imprecision of
concussion killing, and manipulation of the liver. Limita-
tions of the system, Nembutal potentiation of drug actions,
limitations of the saline solution, hepatic anoxia, and
the effects of variations of room temperature do not appear
to have been important to the inadequacy of the methods.
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